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Identifying intimate partner violence in different ethnic 
groups in primary care 
 
Abstract 
 
Background 
Intimate partner violence (IPV), including physical, sexual and emotional violence, 
causes short and long term ill-health. Brief questions that can identify women from 
different ethnic groups experiencing IPV who present in clinical settings are a pre-
requisite for an appropriate response from health services to this substantial public 
health problem. 
 
Aim: To examine the evidence for the validity of questions trying to identify IPV in 
different ethnic groups and to determine whether their validity varies between ethnic 
groups. 
 
 
Methods 
Design: A systematic review and the secondary data analysis of a cross-sectional 
survey of four questions (HARK) identifying IPV in a primary care sample. 
Main outcome measures: Systematic review - for each set of index questions 
identified, diagnostic accuracy indices, correlation coefficients, reliability measures, 
validity evidence based on response processes and test content were analysed and 
interpreted. 
Secondary data analysis - diagnostic indices for IPV and its dimensions in three ethnic 
groups were calculated for the four HARK questions combined and for the individual 
HARK questions. 
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Results 
Systematic review – there is no evidence of questions valid for identifying IPV in 
specific ethnic groups, including white groups. 
Secondary data analysis - the optimal HARK cut off score of ≥ 1 was unaffected by 
the participants‟ ethnicity. The diagnostic indices generated using the HARK cut off 
of ≥ 1 remained at a high level, in all three ethnic groups. There were no significant 
ethnic differences in the diagnostic indices of the four combined and individual 
HARK questions‟ ability at identifying either IPV or its dimensions. 
 
 
Conclusion 
From the systematic review and secondary data analysis, there is no evidence that 
questions‟ validity for identifying IPV varies significantly between different ethnic 
groups. The secondary data analysis does provide evidence that four questions (the 
HARK) can identify IPV in self-classified UK census categories of African-
Caribbean, south Asian, and white groups. 
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Chapter 1: Background 
 
 
1.1.  Introduction and Chapter Overview 
 
This thesis is concerned with identifying intimate partner violence (IPV) against 
women in different ethnic groups in primary care. IPV against women is the violence, 
that is perpetrated by a husband or other intimate male partner against a woman, often 
termed domestic violence. IPV includes physical, emotional and sexual abuse. For a 
more comprehensive definition see section 1.3.6.6. My work does not include IPV 
against men as this is quantitatively and qualitatively different from IPV against 
women. Repeated coercive, severe physical and / or sexual violence is commoner in 
IPV against women.[1] 
 
The Ecological Model of IPV (see figure 1, on page 21) lists the factors that influence 
the use of violence in a relationship. This holistic framework proposes that IPV is the 
result of individual, relationship, community and societal features that dynamically 
interact. In the model IPV results when multiple factors from these various spheres 
exist together and not when only one factor exists from a single sphere.[1, 2] 
Identifying IPV in primary care is part of a health service response which should be 
embedded in a wider community response that aims to reduce the level of IPV and its 
health consequences. 
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Figure 1: The Ecological Model[2] 
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This background chapter will describe the theoretical concepts and the literature 
which underpin this thesis and my research questions (see section 1.5.1.). It will 
explain the terms used in my research questions, including their intricacies and 
implications and how and why my two research questions were generated. 
 
In section 1.2., I will examine the case for IPV to be addressed and prioritised by 
primary care. This is achieved by examining IPV prevalence, the health impact of IPV 
and the effectiveness of intervening; as well as considering the role of simple valid 
questions to identify IPV in consultations – particularly during selective clinical 
enquiry. I will explore whether IPV needs identification in order to potentially prevent 
rather than just manage the adverse health consequences of IPV. Additionally I will 
consider how identifying IPV potentially improves the diagnosis of other conditions 
in primary care. 
 
Following this account of my rationale for this thesis, in the next two sections I will 
explore the background to measuring validity and understanding the term ethnicity. I 
will highlight general principles by using examples from IPV research literature. I 
will show how validity is measured and how the term ethnicity is used in IPV 
research papers. 
 
In section 1.3., my thesis focuses on the measurement of validity. I will review the 
different types of evidence that can be used to measure the validity of questions 
aiming to identify target conditions including IPV. This involves exploring models of 
validity that originate from distinct disciplines (health sciences and psychometrics) 
including the classical diagnostic accuracy paradigm, the validation paradigm as well 
as categorical and dimensional models. I will then integrate these complementary 
methods into a framework which is based on existing standards. This framework was 
used to structure the results of my systematic review of research literature describing 
questions aiming to identify IPV in different ethnic groups. This framework allows an 
analysis of the diverse evidence for validity presented in these papers. 
 
In section 1.4., I will explore the concept of ethnicity and how it is used in health 
research studies. I use the phrase “health research” as an umbrella term which 
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includes epidemiological, clinical and health services research. The theoretical and 
empirical relationships between ethnicity and race will be examined in this section. I 
will then expand on the rationale for and potential dangers of collecting ethnicity data 
in health research studies. Subsequently I will present five criteria to assess the use of 
ethnicity data by papers. 
 
In section 1.5., I will review IPV research that has used ethnicity data. This leads to 
the final articulation of my two research questions, followed by an examination of my 
aims with objectives and an outline of my thesis. 
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1.2. Intimate partner violence 
 
In this section I review different areas of IPV research in order to examine the case for 
primary care to address and prioritise IPV. I review studies into IPV prevalence, 
IPV‟s impact on health, interventions used when IPV is identified and the approaches 
used to identify IPV (screening, routine enquiry and selective enquiry). 
 
 
1.2.1.  Is IPV a priority that should be addressed by 
primary care? 
 
A target condition is an identifiable condition which requires some form of action, for 
example further tests or treatment changes.[3] It is not necessarily a disease. Intimate 
partner violence (IPV) could be considered a target condition which on identifying 
should prompt further action by the health care professional (see section 1.2.1.4.2.2, 
page 37). However to consider IPV as a priority health target condition that should be 
addressed by primary care, means that IPV needs to be identified even when a woman 
has no direct physical injuries caused by IPV or accompanying illnesses. Therefore 
health care professionals would need to directly consider and manage IPV itself. This 
is distinct from treating injuries caused by IPV and / or managing the health 
consequences of IPV, (for example depression). 
 
Firstly I consider the prevalence of IPV by introducing a large global World Health 
Organisation (WHO) study and examining a systematic review from the United 
Kingdom (UK) which demonstrated prevalence differences between community and 
clinical populations. 
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1.2.1.1.  Prevalence 
 
Violence against women is a global issue affecting millions who experience it and 
have to live with its consequences.[4] The WHO Violence Against Women study[5] 
found that the prevalence of lifetime physical violence and sexual violence by an 
intimate partner, among ever-partnered women, varied from 15 to 71% in urban and 
rural settings in 10 countries.[6] For more details on this study, see sections 1.2.1.2. 
and 1.5. 
 
A recent systematic review of prevalence studies in the UK found that in community 
surveys lifetime prevalence of IPV varied from 13 to 31% whilst in clinical 
populations it ranged from 13 to 35% with the highest levels found in women 
presenting to Accident and Emergency Departments.[7] IPV prevalence from 
different studies was difficult to compare due to variations in the study population, 
study setting, study designs (self completed and researcher completed questionnaires), 
time frames, age of participants and the definition of IPV used. Some studies included 
physical, sexual and emotional IPV whilst most frequently studies only focussed on 
physical IPV. 
 
The 15 UK prevalence studies in this systematic review confirmed that study 
population (community verses clinical) was associated with a variation in prevalence. 
Community populations had significantly lower IPV prevalence.[7] This was 
exemplified by two of the studies from this systematic review. A computerised self 
completion method in a nationally representative sample of 24,498 women and men 
showed that the adjusted lifetime prevalence of physical, emotional, financial abuse, 
threats or force was 25% and the incidence was 5%. The lifetime prevalence of sexual 
assault was 23% and the incidence was 3%.[8] In contrast, a study by Richardson and 
colleagues of 1,207 women attending general practice found a physical IPV lifetime 
prevalence of 41% and IPV incidence of 17%.[9] 
 
The prevalence of IPV tends to be higher in women attending health care services 
than in those participating in community surveys even when these studies are set in 
the same geographic population.[10] These prevalence studies clearly indicate that 
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IPV is common in clinical populations. This includes primary care but also in other 
clinical settings. For example, the lifetime prevalence of severe domestic violence 
experienced by psychiatric inpatients is between 30 to 60%.[11] I now examine 
studies that have looked at the health impact of IPV. 
 
 
1.2.1.2. Health Impact 
 
The National Center for Injury Prevention and Control in the US reports that 5.3 
million episodes of domestic violence occur each year, causing 2 million
 
injuries with 
550,000 requiring medical treatment.[12] In the UK, two women are killed by their 
current or former partner each week.[13] Apart from the obvious immediate effects of 
physical injuries, IPV also causes other short and long term health problems. 
 
The WHO Violence Against Women study comprehensively measured the health 
impact of IPV around the world.[14] Following interviews with 24,097 women in ten 
countries, pooled analysis of all sites found significant associations between lifetime 
IPV experiences and suicidal attempts (3.8 [95% CI 3.3-4.5]), suicidal thoughts (2.9 
[95% CI 2.7-3.2]), vaginal discharge (1.8 [95% CI 1.7-2.0]), memory loss (1.8 [95% 
CI 1.6-2.0]), dizziness (1.7 [95% CI 1.6-1.8]), pain (1.6 [95% CI 1.5-1.7]) and 
difficulty with daily activities (1.6 [95% CI 1.5-1.8]). Other controlled studies from a 
wide range of settings, have also shown associations with gynaecological conditions 
(including sexually transmitted diseases) and chronic pain as well as gastrointestinal 
conditions.[15] 
 
A cross-sectional study has shown that IPV was associated with 8% of the overall 
disease burden in women aged between 18 to 44 years in Victoria, Australia. 73% of 
the disease burden attributed to IPV was due to poor mental health (depression, 
anxiety and suicide) and 22% due to substance abuse (tobacco, alcohol and illicit drug 
use).[16] In women aged less than 45 years, IPV was the most important risk factor 
out of the eight major risk factors for ill health. These risk factors included high blood 
pressure, high cholesterol and body weight. IPV was double the risk of illicit drug 
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use, the risk factor closest to it which contributed less than 4% of the disease burden. 
High blood pressure only accounted for 1% of the disease burden in this age group. 
 
Many of the health impact studies of IPV focus on the effects of physical IPV. 
However psychological IPV has also been found to produce long term adverse 
physical and mental health effects.[17] Coker and colleagues found using a random 
digit dial telephone survey of 13,912 women and men aged between 18 to 65 years 
that logistic regression models that included both psychological and physical IPV 
scores, higher psychological IPV scores were more strongly associated with current 
poor health, depressive symptoms, substance abuse and developing either a chronic 
disease, chronic mental illness or an injury.[17] 
 
More recently Yoshihama and colleagues,[18] engaging with the WHO‟s cross-
national research endeavour, in Japan found that the impact of emotional IPV only 
was similar to the impact of emotional IPV with physical or sexual IPV. They 
concluded that health care professionals needed greater awareness about the effects of 
emotional IPV. Ludemir and colleagues,[19] found that during pregnancy 
psychological IPV was strongly associated with postnatal depression which was 
independent of both physical and sexual IPV. Sexual IPV has also been shown to be a 
separate dimension of IPV which can occur with or without physical IPV.[20, 21] 
 
A systematic review of IPV health impact studies showed that IPV significantly 
increased the risk of mental illness and substance abuse.[7] This systematic review 
included a meta-analysis which examined actual physical IPV and threats of physical 
force as risk factors for mental health problems in women.[22] In this meta-analysis, 
the strength of association as well as temporality was examined. A significant 
association was found between physical IPV and depression, post-traumatic stress 
disorder (PTSD), suicide, suicidal thoughts, alcohol abuse and drug abuse. Depression 
and PTSD were the most frequent mental health sequelae of physical IPV. When 
physical IPV stopped, depression decreased. Both depression and PTSD reacted to 
whether physical IPV was present or absent. Additionally a dose-response 
relationship showed that physical IPV‟s severity and duration was associated with 
depression and PTSD‟s severity and prevalence. This suggests a causal relationship 
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between physical IPV and adverse mental health outcomes.[22] In women attending 
general practice physical, emotional and sexual abuse has been found to be associated 
with depression.[23] More recently, it was found in general practice that women who 
had ever been afraid of a partner on average had higher depressive symptom scores 
than women who had never been afraid.[24] Additionally, increased psychotic 
symptoms have been shown to be related to assault including domestic violence.[25] 
The full array of potential health outcomes of IPV against women are listed in figure 
2, on page 29. 
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INTIMATE PARTNER VIOLENCE 
   ↓ 
             __________________________________________________________ 
             ↓                                ↓ 
FATAL OUTCOMES   NON-FATAL OUTCOMES 
Homicide     ↓ 
Suicide 
Maternal mortality        ____________________________________________________________________ 
AIDS-related  PHYSICAL   CHRONIC    MENTAL 
  HEALTH   CONDITIONS   HEALTH 
  - Injury   - Chronic pain syndrome - - Post traumatic stress  -Insomnia 
  - Functional impairment    - Irritable bowel syndrome  - Depression   -Suicidal 
  - Poor subjective health   - Gastrointestinal disorders  - Anxiety     ideation 
  - Permanent disability  - Fibromyalgia   - Phobias/panic attacks -Somatoform 
  - Severe obesity            - Chronic pelvic / abdominal pain - Eating disorders    disorder 
     - Chronic headaches   - Sexual dysfunction 
      - Low self-esteem 
          - Substance abuse 
  NEGATIVE HEALTH  REPRODUCTIVE  
 BEHAVIOURS           HEALTH 
  - Smoking   - Unwanted pregnancy 
  - Alcohol and drug abuse  - STIs/HIV 
 - Sexual risk taking            - Gynaecological disorders 
  - Physical inactivity  - Unsafe abortions    
 - Over-eating            - Pregnancy complications   
     - Miscarriage/low birth weight   
             - Pelvic inflammatory disease 
Figure 2: Health outcomes of intimate partner violence against women[1, 15, 128] 
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There have been numerous studies looking at the health impact of IPV on the children 
within affected families. A recent longitudinal cohort study showed that children 
whose mothers had experienced IPV had higher health care utilization and costs, even 
if their mothers‟ abuse stopped before they were born.[26] IPV has been found to be 
an independent risk factor for deficit in gestational weight gain during pregnancy[27] 
with evidence of IPV being associated with low birth weight.[28] In the developing 
world it has been suggested that IPV is a factor in under two year old mortality as 
well as child malnutrition.[29] Children exposed to severe and recurrent IPV are more 
likely to be admitted with acute malnutrition.[30] Many children live with IPV with 
negative impacts on their health and development.[31] Children exposed to IPV often 
experience emotional and behavioural problems.[32] Identifying IPV within families 
containing children requires child protection issues to be examined. 
 
A case has been made for health care professionals identifying, prioritising and 
managing women experiencing IPV on the basis of the evidence described so far. This 
shows that IPV is a major public health problem, as it is common and associated with 
multiple health conditions including a detrimental effect on children‟s health. 
Additionally, as women affected by IPV are frequently isolated, health care 
professionals are in a unique position often being the only professional to have 
contact with these women.[33, 34] 
 
However it has also been argued that high IPV prevalence, IPV‟s considerable health 
impact and health care professionals‟ distinct role in potentially identifying IPV are 
not sufficient to transform IPV into a condition that should be addressed directly or 
prioritised by primary care. Hence IPV researchers have looked for further evidence 
of benefit for when health care professionals identify and intervene in IPV, 
contending that this is required if IPV itself, is to be recognised as a priority health 
target condition with  
“a specific role for health services in responding to it other than in the management of 
its health consequences.”[33, 35] 
 
This further evidence includes research into the interventions that can be offered when 
women are experiencing IPV. This has looked at whether the adverse health outcomes 
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which can accompany IPV can be prevented. I now summarise the body of research 
into IPV interventions. 
 
 
1.2.1.3. IPV Interventions 
 
It has been proposed that if IPV can be identified early, interventions could be 
developed to prevent adverse mental and physical health conditions.[17] Evidence 
from a systematic review originally suggested that in women experiencing current 
IPV either who have actively sought help or are in a refuge, referral to a domestic 
violence advocate may decrease abuse, increase quality of life, social support and 
safety behaviours. [36] The most recent Cochrane systematic review based only on 
randomised controlled trials comparing advocacy interventions for women with a 
history of IPV against usual care found that intensive advocacy (for 12 hours or more) 
could reduce physical IPV one to two years after the advocacy intervention for 
women recruited in domestic violence shelters or refuges.[37] It is unknown whether 
intensive advocacy has a beneficial effect on these women‟s quality of life or mental 
health; or whether less intensive advocacy in healthcare settings for women living 
with the perpetrators of violence is effective. Psychological interventions may be 
effective for women who have also either sought help or been in a refuge as opposed 
to those who disclose on screening.[7] System based interventions involving staff 
training, clinician prompts, referral measures, waiting room posters and audit found 
increased identification of IPV and referral to domestic violence services.[36] There is 
little evidence for the effectiveness of giving advice on safety planning and 
behaviour.[38, 39] Parenting interventions with female survivors and their children 
improved behavioural and emotional outcomes for both mothers and their 
children.[40] 
 
Overall, research into interventions does seem to suggest that some of the potential 
gain from preventing IPV‟s adverse health outcomes is achievable. However this is 
based on evidence for women who are actively seeking help as there is currently an 
absence of evidence for women who have been identified pro-actively by health care 
professionals. A study that does identify abused women who are pregnant or with 
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infants, in primary care will be reporting on the clinical outcomes of general health 
and depression following an IPV intervention of 12 months of non-professional but 
trained and supported mentor mother support.[41] I will now examine the research 
into the different approaches used to identify IPV. 
 
 
1.2.1.4.  Approaches to identifying IPV 
 
In this section I will review the approaches used to identify IPV (firstly screening, 
then routine enquiry and lastly selective enquiry) in order to continue assessing the 
case for primary care to address and prioritise IPV. The relationship (i.e. the supposed 
dichotomy) between screening and routine enquiry will be considered (see section 
1.2.1.4.2.1.). 
 
 
1.2.1.4.1.  Screening 
 
Effective IPV screening can be defined as a process whereby those who don‟t 
necessarily perceive that they are at risk of IPV as well as those already affected by 
IPV or its sequelae, are asked a question, to identify individuals who are more likely 
to be helped than harmed by an intervention to reduce the risk of IPV.[42] IPV 
screening can only be promoted if it improves health outcomes for women. The 
Wilson screening criteria are a list of principles that should ideally be fulfilled by an 
effective screening programme,[43] including an IPV screening programme. There 
has been wide debate and research examining whether screening for IPV is 
beneficial.[44] This has partly been driven by the many US professional organisations 
which advocated the introduction of IPV universal screening without evidence to 
support this recommendation.[45-49] Overall the conclusion from systematic reviews 
is that there is currently inadequate evidence to support universal screening in health 
settings.[50-52] 
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1.2.1.4.2.  Enquiry 
 
Compared to IPV prevalence, IPV‟s health impact, IPV interventions and IPV 
screening, there has been much less quantitative research looking at the effects of 
enquiring (both routinely and selectively) about IPV. 
 
1.2.1.4.2.1. Routine enquiry 
Routine enquiry has been advocated by those who have rejected the public health 
approach of IPV screening.[53] They have argued that it is inappropriate to apply the 
Wilson screening criteria when IPV is not a medical illness that needs to be diagnosed 
but rather a health-related risk factor that needs to be identified, in the same way that 
smoking, and obesity are identified in general practice, i.e. by using regular and 
repeated enquiries in routine consultations.[33, 54] Proponents of routine enquiry 
contend that it has a broader remit than screening in that identification via disclosure 
is not the principal aim with less pressure for women to disclose IPV. Instead routine 
enquiry‟s purported added benefits are that it can be used as a vehicle to provide 
supportive information about IPV to women whilst simultaneously decreasing 
stigma[55] and changing society‟s attitudes towards IPV. 
 
I think that these goals would apply equally to a well constructed screening program. 
In effect renaming screening, routine enquiry, does not resolve that the Wilson 
screening criteria are not supported by current existing evidence.[56].There is still a 
need to show that both screening and / or routine enquiry are effective and safe.[35] 
There is sometimes an assumption that as asking questions is not an invasive test, that 
it must be a safe exercise. This was not borne out in a qualitative study which showed 
that some general practitioners managed IPV disclosure in a potentially unsafe way – 
breaking confidentiality and undertaking couple counselling.[57] 
 
 
1.2.1.4.2.2. Selective enquiry 
Selective enquiry has also been referred to in IPV literature as targeted 
identification,[35] trigger enquiry, case finding[58] and diagnostic evaluation.[59] 
Asking about IPV and identifying IPV facilitates the diagnostic process. This is 
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different from the routine enquiry of all women and IPV screening, as well as being 
quite separate from offering IPV interventions. Despite the lack of quantitative 
evidence, identifying IPV independent of interventions has been recognised as an 
important task [52, 60] which is a part of good quality clinical care. I now expand on 
the benefits of selective enquiry. 
 
The process of hypothetico-deductive
 
reasoning[61] that is undertaken in arriving at a 
likely diagnosis for the cause of the patient‟s symptoms is affected by knowing that a 
woman is experiencing IPV. For example, in order to decide whether a woman‟s 
symptom of chronic pelvic pain with deep dyspareunia is more likely to represent 
endometriosis, (a pathological diagnosis signifying the presence of endometrial glands 
and stroma outside of the endometrial cavity) or to be related to IPV requires 
identifying whether IPV is present. Chronic pelvic pain with deep dyspareunia could 
be related to IPV either indirectly due to emotional distress or possibly more directly 
due to soft tissue inflammation from repeated forced sex. Regardless of whether 
coercion is involved the woman may not enjoy having sex with her partner who is 
abusive in other ways which has led to a medicalisation of her symptoms. Identifying 
IPV may avoid the cycle of repeated gynaecological referrals, invasive tests for 
example, laparoscopy with or without biopsies whilst the gynaecologist has to try to 
differentiate between symptomatic and asymptomatic endometriosis. Attributing a 
woman‟s symptoms to the diagnosis of endometriosis is aided by knowing whether 
IPV exists. A woman experiencing IPV may indeed have symptomatic endometriosis 
which requires treatment but the clinical picture cannot be fully judged without a 
complete history, including the social history and a frank discussion with the woman 
about her personal circumstances. In at least one third of women with chronic pelvic 
pain, no organic cause is found on laparoscopy.[62] Most recently in 487 women with 
chronic pelvic pain, 70% had no endometriosis on diagnostic laparoscopy with 55% 
having no obvious pathology.[63] Instead psychosocial factors, including abuse, have 
been found to be strongly associated with chronic pelvic pain, including 
dyspareunia.[64] 
 
The psycho-social context always affects symptoms and how they are expressed, 
hence the importance of the social history when taking a medical history. An 
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important part of the social history is whether a woman is experiencing IPV. The 
association between social circumstances and disease has long been recognised.[65] 
Most recently a WHO report on health inequity recognized the unequal distribution of 
power, including gender inequity underlying poor health.[66] At the grassroots level 
mental health professionals have queried whether asking about IPV is relevant to the 
history taken when assessing mental health.[67] 
 
I would argue that the clinician having knowledge of whether IPV exists, following 
selective enquiry as part of a diagnostic assessment, directly affects the diagnosis or 
exclusion of some conditions (for example anxiety) as well as management of 
conditions (for example depression). Hence, a woman who presents with mild or 
moderate depression and is experiencing IPV needs to have this identified. This can 
then allow a detailed examination of the woman‟s situation and her own resources. 
Prescribing antidepressants may serve to only circumvent this pertinent discussion. 
The importance of careful interpretation of research findings to guide treatment in 
individual cases of depression seen in clinical practice has been highlighted.[68] 
Identifying exposure to IPV is also central in potential cases of child protection.[69] 
 
The majority of women experiencing IPV do not present to primary care with acute 
injuries. Instead they are far more likely to present with medically unexplained, non-
specific symptoms such as chronic pain (headache, abdominal pain and 
gynaecological pain), mood disturbances (anxiety, depression) or addiction (alcohol 
and other drugs).[70, 71] Women may choose not to disclose their experience of IPV 
for a number of reasons. They may find it difficult to disclose unless they are 
specifically asked by health care professionals. They may decide that non-disclosure 
is appropriate after assessing the risks and benefits to them personally of 
disclosure.[67, 72] Or they may think that it is not relevant to disclose IPV. This may 
occur if women do not make a connection between their symptoms and their 
experience of IPV. 
 
Health care professionals as well as women attending primary care need to be able to 
make a link between medically unexplained symptoms (for example headaches, 
abdominal pain, dyspareunia) and IPV, as well as mental health conditions (for 
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example depression and anxiety). The bio-psycho-socio-immunological mechanisms 
that may be at play in IPV have been described.[73] Less well known than the direct 
effects of trauma mediated via physical and / or sexual IPV, are the indirect stress 
effects which are thought to be mediated via the over-responsiveness of the autonomic 
nervous system, with the sympathetic nervous system producing excess, un-
modulated stress hormones. Tension headaches may result due to increased muscle 
contraction caused by the sympathetic nervous system. Migraine due to 
vasoconstriction mediated by increased norepinephrine and serotonin levels, followed 
by rapid vasodilatation and pain. Sustained hypertension could be related to increased 
peripheral vascular resistance mediated via increased alpha-adrenergic tone during 
chronic stress. Cortisol, catecholamines, cytokines and Th cell balance are thought to 
be related to depression and post traumatic stress disorder (PTSD). It has been shown 
in a small group of women who did not smoke, abuse drugs or alcohol, were not 
pregnant or medically ill but did have PTSD with a history of childhood sexual 
trauma, that they had significant increased immune activation, demonstrated by 
increased biological markers (CD45RO / CD45RA lymphocyte ratio) compared to 
matched controls.[74] In women with lifetime IPV related PTSD, salivary cortisol 
was raised compared to women exposed to IPV who did not develop PTSD.[75] In 
the offspring of rodents who were repeatedly stressed during gestation, structural 
alterations have been shown in their brains and their hypothalamic pituitary adrenal 
axis.[76] The importance of further research into how the experience of IPV changes 
psychological, biological, neurological, behavioural and physiological pathways has 
been recognised.[77] 
 
Identifying that IPV is occurring may be a fundamental step enabling health care 
professionals and their patients to understand previously unexplained 
presentations.[78] A health care professional suggesting a link between a woman‟s 
symptoms and her experience of IPV may help patients to begin to deal with their 
predicament rather than avoiding it by proceeding into a cycle of repeated referrals 
and investigations. For example, a patient with chronic unexplained headache should 
at some point trigger an enquiry about IPV with an aim to avoid inappropriate 
investigations or treatments[59] that fail to address the underlying issue.[79] This 
approach may avoid inappropriate referrals (for example to a neurologist). Another 
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example is of a young woman with insomnia. This may also trigger asking questions 
about IPV, perhaps avoiding ill thought out treatment for sleep disorders with 
benzodiazepines. Asking about IPV and identifying IPV potentially facilitates the 
diagnostic process. 
 
Identifying IPV should prompt further action by the health care professional.[72] 
According to expert consensus opinion,[71] this should ideally include carefully 
listening to the woman (whilst reassuring her that IPV is not her fault and that it is 
common), discussing safety planning, considering her children, making her aware of 
local and national support services (including the domestic violence and refuge 24 
hour helpline) and providing follow up. It is important that each woman is made 
aware of her options whilst at the same time being supported in the decisions that she 
makes.[53] 
 
A health care professional‟s support over the long term may help the woman in being 
able to change her own situation[71, 80] even without formal referrals. Health care 
professionals who respond appropriately to women who are identified as experiencing 
IPV (i.e. listening, being non-judgmental, compassionate, caring, and confidential 
whilst validating the woman‟s experiences) facilitate this process despite women 
rejecting intervention or referral to an external agency. 
 
The research into IPV prevalence, IPV health impact, IPV interventions and the 
important benefits of selective enquiry in identifying IPV, as described above, all 
support that IPV should be addressed and prioritised by primary care. My review 
supports identifying IPV for its own sake in order to potentially prevent the adverse 
health consequences of IPV (which is quite separate from only managing the adverse 
health consequences of IPV once they are present) and to improve clinical diagnosis 
generally. Regardless of whether IPV is identified using selective clinical enquiry, 
routine enquiry or screening, simple, brief and valid questions are required that can be 
used in consultations to identify women who are or have experienced IPV. 
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Valid questions that can identify women from different ethnic groups experiencing 
IPV who present in clinical settings are a pre-requisite for an appropriate response 
from health services to this substantial public health problem. 
 
I have examined the case for IPV to be prioritised and addressed by primary care 
whilst highlighting the importance of identifying IPV. I now consider the background 
to measuring the validity of questions. 
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1.3. Measuring Validity 
 
Throughout this section, most prominently in my account of the five integrated 
categories of validity evidence (see section 1.3.6.), I will employ questions used to 
identify IPV as examples. This aids understanding of how validity can be measured. 
 
In this section, I will first look at the role of measurement in scientific research, 
focussing on how measurement is used in the health sciences to evaluate medical 
tests, including questions which are part of a clinical history. I will then contrast how 
questions have been evaluated in different disciplines particularly the approach taken 
to measurement error. This leads to a description of the diagnostic accuracy paradigm 
and the validation paradigm both of which can be used to establish whether questions 
are valid, i.e. are measuring what they are supposed to measure. Categorical and 
dimensional models are then considered which capture the differences between the 
diagnostic accuracy and validation paradigms. Multi-dimensional scaling incorporates 
categorical and dimensional models. This union is mirrored by the integration of the 
diagnostic accuracy and validation paradigms within the 1999 Standards for 
Educational and Psychological Testing. These Standards represent a logical 
categorisation of the disparate body of evidence which can be used to describe the 
validity of questions. Five sub-sections then describe the five categories of validity 
evidence which are described within the Standards. These are based on the 
consequences of testing, relations to other variables (which include criterion 
performance studies, i.e. diagnostic accuracy and criterion correlation studies, 
association studies and known group comparisons), internal structure, response 
processes and test content. A separate sub-section (1.3.6.4.) draws attention to 
correlation, a statistical method which features heavily in a number of the methods 
used to measure validity (criterion correlation studies, association studies and internal 
consistency reliability). Attention will be drawn to the commonality of different 
correlation coefficients. 
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1.3.1.  Measurement 
 
Measurement is central to all quantitative scientific research regardless of whether it 
is in the natural sciences, social sciences or health sciences. Different disciplines have 
often developed quite separate ways of looking at the common problem of 
measurement without engaging with methods and theories in other fields.[81] 
 
In health sciences, medical tests are often evaluated to see if they are measuring what 
they are supposed to measure. This is the classical definition of validity. Medical tests 
can identify physiological derangements, establish prognosis, monitor illness, 
diagnose illness or identify target conditions.[82] A medical test does not just have to 
be a biochemical blood investigation, microbiological test (for example urine culture) 
or imaging study (for example chest radiograph). A medical test can also refer to 
questions when taking a patient‟s history or a manoeuvre when performing a clinical 
examination. The potential power of the clinical information collected in a 
consultation to make a diagnosis has been strongly argued by Sackett and 
colleagues,[61, 83] who highlighted the potential of simple clinical observations not 
only to inform diagnosis and therapeutic responsiveness but possibly also to ascertain 
prognosis. 
 
Hence it is important to know whether questions in histories or manoeuvres during 
examinations measure what they are supposed to be measuring or to know what their 
measurements mean. This is especially true in resource poor environments where one 
may not have recourse to further expensive technical investigations or even in well 
resourced environments where a definitive diagnostic investigation, a so-called gold 
standard, may not exist. In these two scenarios health care professionals may rely 
primarily on the clinical history and examination to guide management of the patient. 
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1.3.1.1.  Questions and their evaluation 
 
Questions used for measuring have been used and evaluated differently in the fields of 
health sciences, psychometrics, psychology (including measurement of intelligence 
and personality) and education. I will now consider the differences and similarities in 
the way these questions are used in medicine and psychometrics. 
 
In medicine, questions are central to taking a clinical history and the first part of any 
clinical encounter with a patient. The history helps to formulate a short list of possible 
diagnoses, also known as the differential diagnosis. Diagnosis has commonly referred 
to a disease or illness but diagnosis is now also conceptualised as identifying a target 
condition. A target condition rather than just meaning a disease can also include any 
identifiable condition which requires some form of action, for example further tests or 
treatment changes.[3] There are many aspects of taking a history in which identifying 
target conditions (for example, whether a patient is a smoker) is separate but can be as 
important as making a diagnosis. Intimate partner violence (IPV) is not a disease but 
refers to a social issue which can also be a risk factor for poor health. Therefore IPV 
can be considered a target condition which on identifying should prompt further 
action by the health care professional (see section 1.2.1.4.2.2., page 37). 
 
In psychometrics, questions are also used in a variety of ways but not in the context of 
a clinical history. For example educationalists may use questions in an exam to 
separate out students with different grades according to their ability in a subject. 
Market researchers may use questions addressed to the general public to decide the 
name of a new product. In contrast to a clinical history, participants‟ responses to 
often closed questions are utilised in a variety of formats including written 
questionnaires, computer presentations or face to face interviews. These questions are 
individually often referred to as items whilst if grouped together to measure one entity 
they can be called a scale, an assessment tool, a toolkit, an instrument or a 
questionnaire. This variety of terms all refers to a group of questions. 
 
Similarly in clinical histories, open and closed questions are also often grouped 
together in different ways for example, the history of the presenting complaint, or the 
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social history; and in system based groups for example, questions about the 
respiratory system or more specific sets of questions to make a possible diagnosis 
such as asthma in children. Questions can be grouped together to identify more 
precise target conditions for instance asthma related to cat fur in children. Structured 
parts of histories can also be thought of as a scale or a measurement tool, in the same 
way that questions are viewed in the discipline of psychometrics. 
 
In psychometrics, the measurement error associated with using questions to measure 
an entity is formalised with an assumption that any response to a question is subject to 
an error. Respondents may interpret questions differently which may only partially be 
accounted for by misinterpreting the question. They may also respond to questions in 
a biased manner depending on the exact wording of the question or make a mistake 
writing the answer on to the answer sheet. Within psychometrics there are established 
methods to try to reduce the measurement error which involves scrutiny of individual 
items (questions) and the whole scale (group of questions). It has been argued that this 
provides more valid and reliable information than the information generated by 
questions in a typical clinical history.[81] 
 
Health care professionals often rely heavily on their personal clinical skills to 
diagnose conditions, rather than using measures and questions that have been 
psychometrically tested. This approach has been criticised due to its reliance on the 
clinical skills of individual health care professionals. For example, if the health care 
professional has helped the patient to feel comfortable and relaxed, the history 
obtained will be more reliable. It has been thought that too little consideration has 
been given to whether the questions used in a history are psychometrically valid.[81] 
Clinical disagreements have been demonstrated in histories. For example, when 57 
men complaining of chest pain were interviewed by three cardiologists, it was found 
that if one cardiologist diagnosed that a patient had angina, the other two only agreed 
with him 55% of the time.[84] The need for reproducible, reliable and accurate 
clinical measurement has been recognised by biomedical researchers with an 
emphasis on finding out what data is relevant and worth seeking out in the history as 
well as what is best to ignore.[61] In general practice, the introduction of the Patient 
Health Questionnaire (PHQ) represents an attempt to provide valid and reliable 
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questions with which to assess severity and monitor clinical depression, as opposed to 
just using a clinical history and clinical judgement.[85-87] Psychiatry has also made 
use of psychometric principles of validity in structured interviews, for example the 
Diagnostic Interview Schedule.[88] Other health researchers trying to measure what 
was thought to be un-measurable including subjective states and quality of life in a 
valid and reliable manner have also turned to psychometrics.[89] 
 
In both medicine and psychometrics establishing that a question is identifying what it 
is supposed to identify needs evidence. This can be crystallised down into two basic 
types of research methodologies encapsulated by the diagnostic accuracy paradigm 
and the validation paradigm. Both paradigms are trying to measure validity. I now 
describe these two paradigms in more detail below. 
 
 
1.3.2.  Classical diagnostic accuracy paradigm 
 
The phrase “classical diagnostic accuracy paradigm” was recently used in a 
methodological review study.[3] “Paradigm” is defined by the Oxford Dictionary as 
“an example or pattern, especially one underlying a theory or methodology.”[90] In 
the present context, the use of “paradigm” emphasises that all diagnostic accuracy 
studies depend on preceding empirical research providing evidence to develop and 
support the use of the reference standard. The reference standard is equivalent to the 
criterion used in criterion validity (see section 1.3.6.2.1.). 
 
Diagnostic accuracy involves comparing the results of the test under evaluation (an 
index test which I will refer to as the index questions) to a reference standard. 
Diagnostic indices are then generated (such as sensitivity and specificity) which 
express how well the index questions are able to identify those with the target 
condition as classified by the reference standard.[91] 
 
Yerushalmy published the first paper assessing the performance of a medical test 
using sensitivity and specificity whilst referring to accuracy in 1947.[92] Over the 
years medical researchers have predominantly depended on this paradigm[93] with 
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little change to it apart from more accuracy indices being devised including predictive 
values, likelihood ratios and diagnostic odds ratios.[94] 
 
Central to diagnostic accuracy studies is the role of the reference standard which has 
to decide whether the target condition is present or absent in all participants. The 
reference standard is a test which is either known to be able to determine whether a 
target condition is present or absent without errors (i.e. a gold standard) or more 
pragmatically, it is the best existing method at determining whether the target 
condition is present or absent. Hence diagnostic accuracy studies invariably depend 
on preceding empirical research that has provided evidence to support the use of the 
reference standard. 
 
The philosophy of applying a diagnostic accuracy model to IPV, a social issue which 
cannot be defined by a perfect gold standard can be debated. However IPV is like 
many if not all medical conditions for which a perfect reference standard (i.e. a gold 
standard) does not exist. Instead satisfactory reference standards have been developed 
for IPV identification. These are invariably a long set of questions, normally used in 
and devised for research settings. Researchers often try to improve existing 
unsatisfactory reference standards prior to embarking on diagnostic accuracy studies. 
This evolution of reference standards can be seen in the IPV field.[95] 
 
The majority of diagnostic accuracy studies have focussed on investigations as 
opposed to evaluating questions that form part of a clinical history. There are 
exceptions. For example, it has been shown that when answering yes to three or more 
of the CAGE questions (cut down, annoy, guilt, eye-opener), there is a likelihood 
ratio of 250 for alcohol dependency or abuse.[96] The CAGE questions have been 
found to be more predictive of alcohol dependence than computer-assisted laboratory 
data profiles.[97] Smoking for more than 40 pack-years (likelihood ratio 8.3), having 
a self-reported history of chronic obstructive airways disease (likelihood ratio 7.3) and 
age over 44 years (likelihood ratio 1.3) are significantly associated with the diagnosis 
of obstructive airways disease.[98] 
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1.3.3.  Validation paradigm 
 
The term “validation paradigm” in relation to evaluating diagnostic tests was also 
used in a recent methodological review study.[3] The underlying characteristic of this 
methodology is that there is no existing high quality reference standard. This results in 
the central measurement challenge. Therefore unlike diagnostic accuracy studies, 
studies using the validation paradigm are not necessarily based on earlier empirical 
research into a reference standard. 
 
Test validation as a concept has been known and used for years. Validity has been 
traditionally divided into content, construct and criterion validity which were seen as 
relatively independent characteristics of a measure that needed to be autonomously 
determined. This use of terminology has evolved (see section 1.3.6.). 
 
Conventional methods originating from the arena of psychometrics, psychology and 
social sciences have been commonly used to evaluate questions which endeavour to 
measure or tap into latent traits, for example depression or anxiety. There is extensive 
theory about the use of questionnaires and their validity.[81] 
 
The Women‟s views of birth (WOMB) antenatal satisfaction questionnaire is an 
example of a health tool, developed using psychometric methods from the validation 
paradigm including examining traditional face, content and construct validity as well 
as internal consistency reliability.[99] Baker developed the Patient Career Diary 
(PCD), a measure of patients‟ attitudes towards health care (at the interface between 
primary and secondary care) also using face validity, construct validity and internal 
consistency reliability.[100] Neither the WOMB nor the PCD contained questions that 
were designed to be used within a clinical history in order to diagnose an illness or 
identify a target condition. 
 
When evaluating diagnostic tests (including questions) with no acceptable reference 
standard, applying the concept of a clinical test validation could provide a significant 
methodological advantage over the traditional diagnostic test accuracy paradigm.[3] 
The validation process uses a variety of methods to try to establish whether questions 
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can serve their purpose by exploring meaningful relations between index test results 
and other relevant clinical characteristics. 
 
The current reference standards that identify IPV are long questionnaires (see 
Appendix A). These have been developed using a variety of methods which are a part 
of the validation paradigm, for example factor analysis used in the development of the 
Composite Abuse Screen (CAS).[101] This use of the validation paradigm has 
occurred as there can never be an absolute gold standard for identifying IPV. This is 
because IPV is an opaque entity which probably means many different things to 
individuals. Therefore though a question, for example asking about abuse, may 
purport to measure IPV it could actually be irrelevant in identifying IPV (see section 
1.5.1.). Additionally, identifying IPV depends on a woman‟s willingness to disclose 
her experience of IPV to a health care professional. This though is in common with all 
questions in a history (for example when obtaining a sexual history). 
 
 
1.3.4.  Categorical and dimensional models 
 
An alternative way of conceptualising the differences between the diagnostic accuracy 
paradigm and the validation paradigm is by considering the categorical and 
dimensional models which were summarised by Devins.[102] The categorical model 
in common with the diagnostic accuracy paradigm has a clear division between cases 
and non-cases. In the dimensional model, “caseness” is a matter of degree with no 
clear separating boundary between cases and non-cases. It is the theoretical basis of a 
construct which should determine whether a categorical or dimensional model is the 
more appropriate representation of any particular construct.[81] By construct I mean a 
hypothetical unifying variable. A construct has been thought of as a “mini-theory” in 
order to explain the relationships among various behaviours (or attitudes).[103] For 
example, IPV can be interpreted as a construct that helps to explain the connections 
between physical, sexual and emotional violence. A construct may underlie a cluster 
of related questions.[89] Construct is often used interchangeably with the terms 
“dimension,” “domain,” “area,” “attribute,” “trait” and “concept.” 
 
  
47 
For a construct which varies quantitatively and qualitatively at different severities it is 
most apt to use the categorical model (for example urinary tract infection diagnosis 
based on culture). A categorical construct‟s severity would be lowest in instances that 
minimally satisfy diagnostic criteria whereas individuals labelled as non-cases would 
be free of the construct and in effect not have the disorder. For a construct which 
varies only quantitatively at different severities it is most suitable to use the 
dimensional model. Sometimes the understanding of a construct may change so that 
the most appropriate model used to conceptualise the construct alters. For example, 
hypertension was once treated as a categorical construct in that a diastolic blood 
pressure of less than 90mm Hg was deemed normotensive, not requiring treatment 
whilst a diastolic blood pressure of more than or equal to 90mm Hg was hypertensive, 
requiring treatment. Now an enhanced understanding of hypertension and how this 
impacts on health outcomes has resulted in an individual‟s cardiovascular risk 
affecting the level of blood pressure at which treatment is initiated.[104] Therefore 
different actions are required at different blood pressure levels. Hence blood pressure 
is now treated more as a dimensional construct, with a continuum, as opposed to only 
having a categorical structure, dividing the population into those with hypertension 
and those without.[81] 
 
Multidimensional scaling represents an endeavour to bridge these 2 models. It permits 
a variety of attributes to be measured dimensionally, in such a way that results can be 
used to both categorise and determine the extent to which these categories are 
present.[81] The development of the Composite Abuse Scale, a reference standard 
used to identify IPV, made use of multidimensional scaling.[101] The four 
dimensions of IPV defined by the CAS (physical abuse, emotional abuse, severe 
combined abuse and harassment) were identified from the analysis. They were not 
immediately obvious from the data but were inferred from how individual items 
grouped together. The Composite Abuse Scale was endorsed by the National Centre 
for Injury Prevention and Control,[105] as it has demonstrated reliability and validity 
for measuring IPV. 
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1.3.5.  Integrating research paradigms 
 
The diagnostic accuracy and validation paradigms represent different research 
methodologies for evaluating tests, including questions. As with the bringing together 
of the categorical and dimensional models in multidimensional scaling much can be 
gained by integrating the diagnostic accuracy and validation paradigms. 
 
Though I have given examples of health research studies above that have used the 
diagnostic accuracy paradigm (see section 1.3.2.) and others that have used the 
validation paradigm (see section 1.3.3.), fewer studies have integrated and used 
methods from both paradigms. A study evaluating the PHQ did use both diagnostic 
accuracy indices and made limited use of the validation paradigm by employing 
kappa to show the agreement between diagnoses of depression made by the PHQ and 
those made by independent health professionals.[85] 
 
IPV identification is unusual in that it is a topic specific research area in which 
researchers have used both the diagnostic accuracy paradigm and the validation 
paradigm whilst trying to find questions which identify IPV accurately. The 
evaluation of questions used to identify IPV in specific ethnic groups particularly 
benefits from these two perspectives. These methodologies are neither conflicting or 
contradictory but instead both help to bring us closer to developing questions for use 
in clinical histories that are both psychometrically robust and clinically useful; either 
able to identify between those with and without IPV or more pragmatically revealing 
how good questions are at identifying between the two. Many of these questions 
identifying IPV are already being used by health care professionals when they take 
clinical histories. Knowing what these questions may be measuring in women from 
different ethnic groups will aid the work of and decisions made by health care 
professionals. 
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1.3.6.  A categorisation of validity evidence 
 
The 1999 Standards for educational and psychological testing contain five categories 
of validity evidence,[106] as listed below: 
A. Validity evidence based on the consequences of testing 
B. Validity evidence based on relations to other variables 
C. Validity evidence based on internal structure 
D. Validity evidence based on response processes 
E. Validity evidence based on test content 
 
This comprehensive framework in effect encompasses and describes the many 
methods used in the validation paradigm. I have adapted these Standards by 
incorporating the diagnostic accuracy paradigm within them (in category B) as 
described in section 1.3.6.2.1.1. See figure 3, on page 50. 
 
This integrative process informed my systematic review of questions trying to identify 
IPV in specific ethnic groups which covers research from both paradigms. It should 
be noted that the Standards focus on the process of construction of valid questions 
whereas my use of validity evidence is to aid my systematic review which appraises 
existing questions. 
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Figure 3: Categories and subcategories of validity 
evidence: 
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Throughout my account of the five integrated categories of validity evidence (see 
sections 1.3.6.1. to 1.3.6.3., 1.3.6.5 and 1.3.6.6.), I use the example of questions to 
identify IPV in different ethnic groups, to aid the understanding of specific categories. 
IPV identification is a research area that is facilitated by using this integrated 
framework. 
 
The Standards for educational and psychological testing at time of publication (1999) 
were innovative as they put aside the longstanding traditional division of validity into 
what was and is known as the three Cs – of content, criterion and construct validity. In 
this “trinitarian” perspective, these three components of validity were considered to be 
relatively separate attributes which had to be independently established.[103] It was 
Anastasi who first contended that content, criterion and construct related validity did 
not relate to consequential individual test characteristics but were simply the 
derivatives of the developmental history of validation testing. He asserted that all 
validity was construct validity[107, 108] which included content and criterion-related 
validity. This was based on the principle that all test scores are based on constructs 
(see section 1.3.4.). Most recently, Streiner and Norman have concurred that validity 
is a unitary construct. They underscored this by drawing a clear distinction between 
validity and validation. They stated that validity refers to an outcome, (hence there are 
not different types of validity, for example content validity does not exist) whereas 
validation refers to the process of assessing validity for which there are many different 
types of testing (for example content validation does exist).[103] 
 
Underlying what at first appears to be rather a semantic transformation in validity 
terminology, is an important principle that validation is a process which at its heart 
involves generating hypotheses which are then tested in a study. The study results 
should allow one to verify the degree of confidence one can place on inferences made 
about individuals on the basis of their score for a set of questions. Indeed the 
Standards highlight the interpretation of test scores by updating validity‟s definition 
to: "The degree to which evidence and theory support the interpretation of test scores 
entailed by proposed use of tests." Validation should be seen as an ongoing process 
which alters the degree of confidence that one draws about the inferences made.[81] 
The validity of a set of questions to identify IPV applies to the application of that set 
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of questions to a specific population not to the questions themselves. Hence it is not 
the questions (or investigations) that are valid but the uses of the questions that maybe 
valid.[89] 
 
I will now describe the five integrated categories of validity evidence. I have also 
incorporated an additional sub-section (1.3.6.4.) on correlation which draws together 
the commonality of what initially appear to be quite different methods of measuring 
validity (criterion correlation studies, association studies and internal consistency 
reliability). 
 
 
1.3.6.1.  Category A: Validity evidence based on the consequences 
of testing 
 
This “consequential validity” was introduced relatively recently to the Standards with 
continuing debate about its place in validation theory and practice. Accordingly there 
have been relatively few ideas about how to estimate consequential validity apart 
from descriptive studies addressing the extent to which anticipated benefits of 
measurement are realized using observations, interviews or other measures.[106] 
Crocker wondered whether validity evidence based on the consequences of testing 
should even be defined as an integral part of the validation plan, suggesting that it 
may then be seen as a socio-political process as opposed to being scientific and 
empirical.[109] 
 
In contrast in the field of diagnostic accuracy, it is well established that index 
questions may discriminate well between those who have and do not have the target 
condition (category B evidence) but still do not necessarily affect the management of 
a condition.[110] Trials evaluating the clinical impact of the diagnostic strategy are 
then ideally needed.[94] Their evidence help health care professionals make good 
decisions about patient management based on tests that inform management that 
improves patient outcome as well as identifying a target condition. I consider that 
diagnostic strategy impact studies generate validity evidence based on the 
consequences of testing (category A). 
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In medicine, it is understood that medical tests ideally need to be evaluated in high 
quality studies prior to their dissemination and implementation in regular clinical 
practice.[3] A variety of study designs are used for this task including the diagnostic 
randomised controlled trial, before-after studies, cohort studies and case-control 
studies with the first deemed to be the most robust. Before-after studies can 
potentially be much quicker, are rooted in normal care and are an alternative if a 
randomised controlled trial is unfeasible or unethical. 
 
 
1.3.6.2.  Category B: Validity evidence based on relations to other 
variables 
 
There are a variety of study types which generate validity evidence based on relations 
linking a test score to other variables. These can be organised into the three 
subcategories described below. The main difference between these subcategories and 
those listed in the Standards for Educational and Psychological Testing is that I have 
added the classification of “Association studies,” as used by Rutjes et al. [3] (see 
figure 3, on page 29). 
 
 
1.3.6.2.1.  Criterion performance studies 
 
Criterion performance studies (the first subcategory) includes diagnostic accuracy 
studies and criterion correlation studies. These studies explore the extent to which 
scores forecast or predict criterion performance. Criterion-related validity indicates 
the effectiveness of a test in predicting an individual‟s specified performance or 
report. These studies involve some type of comparison between the test score and the 
criterion. The criterion is a single empirical measure of the construct under study (for 
example IPV). It is equivalent to the reference standard, i.e. the best existing method 
at determining whether the target condition is present or absent. The standard 
experimental design for criterion performance studies is correlation (see criterion 
correlation studies, section 1.3.6.2.1.2.). This is probably as most measures are treated 
as being dimensional and not categorical. This is partly related to most measurement 
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tools using a dimensional scale with continuous judgements, as opposed to a 
categorical scale with categorical judgements. Psychometricians also tend to treat 
constructs as being continua.[103] 
 
However criterion performance studies could be a classical diagnostic accuracy study 
design, if the construct is categorical and not only dimensional. Diagnostic accuracy is 
also a type of criterion-related validity where the reference standard provides the 
criterion against which the index test is validated.[3] Streiner also draws attention to 
the fact that though traditionally criterion validity has been assessed using a 
correlational study, it could also be assessed by a diagnostic accuracy study whereby a 
2 X 2 table is used to calculate sensitivity and specificity indices as opposed to 
generating a measure of correlation from the 2 X 2 table such as the kappa coefficient 
(see section 1.3.6.4.2.).[81] 
 
There are two types of criterion validity - concurrent and predictive validity. 
Concurrent validity is when a new scale and criterion measure are given at the same 
time and correlated. The criterion measure must be available at the time of testing. 
This methodology is most often used either when a shorter, simpler, cheaper or less 
invasive test is trying to replace a longer, more complex, expensive or invasive test. In 
research into identifying IPV it is when the scores on a new shorter set of questions 
trying to identify IPV are correlated with a criterion measure of IPV (a longer set of 
questions). Questions that not only predict the criterion but that can additionally show 
the changes in sub-scales responsible for the criterion changing maybe more useful 
than the present criterion measure. 
 
Predictive validity is when a new scale generates answers, including identification, 
earlier than the current criterion measure. Hence the criterion measure result is not 
available until some time in the future (this may be days or years later), after the new 
scale has been administered. For example, a diagnostic test may have to await disease 
progression to either confirm or reject its predictions. 
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1.3.6.2.1.1.  Diagnostic accuracy studies 
As mentioned earlier, the classical diagnostic accuracy paradigm compares the results 
of index questions to a standard reference. The index questions should ideally be able 
to identify whether a target condition (for example IPV) is present or absent but their 
ability to do so is not known. Diagnostic accuracy studies all try to measure the 
accuracy of the index questions at identifying the target condition, by assessing the 
degree of agreement between the results of the index questions and the results of the 
reference standard. This established approach is represented in figures 4(a) and 
4(b)[3] on page 56. Accuracy is a phrase originating from measurement theory. It is 
the closeness of agreement between an analytical measurement and its actual true 
value.[111] 
 
In diagnostic accuracy studies one would normally recruit a group of individuals some 
of whom are potentially affected by the target condition whilst some are not. Firstly 
the index questions would be administered to all the participants and would generate 
an index score showing whether according to the index questions that the target 
condition is present or absent. Following this the reference standard would be 
administered to all participants. This would indicate whether according to it that the 
target condition is present or absent. Figure 4(a) illustrates this classical design of a 
diagnostic accuracy study. This then allows the results of the diagnostic accuracy 
study to be compiled in a 2 by 2 table, as shown in figure 4(b). The perfect diagnostic 
accuracy study would have a faultless reference standard identifying the target 
condition without errors, all index scores would be compared to the same reference 
standard with both being administered at the same time. 
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   Target Condition 
               
                Present           Absent 
                 
           
                                                        Index Test + 
  
                         Result      - 
 
      
 
   
  Accuracy measures: 
   Sensitivity    =  TP/(TP + FN) 
 Specificity    =  TN/(TN + FP) 
   PPV              =  TP/(TP + FP) 
   NPV            =  TN/(TN + FN) 
   LR+       =  [TP/(TP + FN)]/[FP/(FP + TN)] 
 LR-               =  [FN/(FN + TP)]/[TN/(TN + FP)] 
    
     
     
 
 
Patients 
 
 Index Test 
Reference Standard 
Cross classification 
 
      FP 
 
      FN 
 
     TN 
 
      TP 
Figure 4(a): Classical design of 
a diagnostic accuracy study 
Figure 4(b): Results of an accuracy study in the case of a dichotomous index test result 
TP, true positive result; FP, false positive result; FN, false negative result; TN, true negative result;  
PPV, positive predictive value; NPV, negative predictive value; LR, likelihood ratio. 
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I will now define and consider the various diagnostic accuracy indices. A relatively 
detailed explanation has been provided as this terminology frequently appears in IPV 
identification papers and this thesis. Despite the regular use of these terms in the 
literature, there are common misconceptions about some of these terms, including that 
the most important characteristics of a test are its sensitivity or specificity. Figure 4(b) 
lists the mathematical formulae used to calculate these diagnostic indices. 
 
Sensitivity refers to how good the index questions are at picking up people who have 
the target condition. 
Specificity refers to how good the index questions are at correctly excluding people 
without the target condition. 
Positive predictive value (PPV) informs us if a person tests positive, the probability 
that she has the target condition. It is also known as the post-test probability of a 
positive test. 
Negative predictive value (NPV) informs us if a person tests negative, the 
probability that she does not have the target condition. It is also known as the post-test 
probability of a negative test.[112] 
The likelihood ratio (LR) of a positive test is how much more likely is a positive 
result to be found in a person with, as opposed to without, the condition.[112] Their 
advantage over predictive values is that they are more constant with prevalence 
changes. 
The post-test odds (PTO) permit the background prevalence to be factored into the 
LR. 
The receiver operator characteristic (ROC) curve is constructed by plotting the 
sensitivity of each individual score against its false positive rate (= 100 – specificity) 
See figure 5, on page 58 which uses the example of creatinine kinase values in 
myocardial infarction. The ROC curve can be used to determine the optimal cut off 
score which maximises the true positives whilst minimising the false positives (i.e. the 
point that has the highest combined sensitivity and specificity, in the top left hand 
corner of the ROC curve). The area under the ROC curve measures the 
performance of a test.[113] Its value can lie between 0.5 (i.e. test has a likelihood 
ratio of 1 for all its cut-off values and so is unhelpful) and 1 (i.e. test perfectly 
separates those who have the target condition from those who don‟t). 
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For some tests and target conditions maximising the true positives (i.e. maximising 
sensitivity) and minimising the false positives (i.e. maximising specificity) may not be 
the most important guiding principal determining the cut-off score. If a false positive 
result was very damaging (for example committed a patient to an invasive test) one 
may choose a different cut off point which minimises the false positive rate (i.e. 
maximises the specificity by being towards the left hand side of the curve). Whereas 
if a false negative result was very hazardous (for example missing underlying 
aggressive cancer) one may pick a cut off point that maximised the true positive rate 
(i.e. maximises the sensitivity by being higher on the curve). 
 
This analysis of the use of sensitivity and specificity in determining cut off points 
should not detract from that which is more clinically and practically informative about 
index questions, i.e. their predictive values. Sackett considered the relative functional 
importance of diagnostic indices and supported that the predictive values (PPV and 
TRUE POSITIVE 
RATE (sensitivity)
≥280  
≥80 
≥40 ≥ 1 
Figure 5: An ROC curve for creatinine kinase values 
in myocardial infarction[61] 
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NPV) are far more instructive than the sensitivity and specificity of index questions in 
clinical practice.[61] The capability of the answers to index questions to change one‟s 
mind from what one thought before administering the questions (i.e. the pre-test 
probability of IPV, also known as the IPV prevalence) to what one thinks afterwards 
(i.e. the post-test probability of IPV, also known as the PPV) is important. If there is a 
large change from pre-test to post-test probability, the index questions are likely to be 
very useful in real clinical practice.[91] Whereas the sensitivity and specificity 
interpret the index questions‟ results retrospectively, it is the PPV and NPVs that 
actually establish the predictive properties of the index questions in the future. Hence 
Sackett argues that when tests are used clinically one does not know who has and 
does not have the target condition. Thus the predictive values of a test (i.e. PPV and 
NPV) are much more useful clinically.[61] However these predictive values can only 
be interpreted alongside prevalence, as invariably predictive values always vary with 
prevalence. As prevalence decreases, PPV decreases with it and NPV increases. 
Therefore even brilliant index questions that have a sensitivity and specificity of more 
than 95% may have a rapidly decreasing PPV as the prevalence falls and so clinically 
be poor index questions which produce no substantial difference between the pre-test 
to post-test probability.[61] 
 
With the pre-test probability (prevalence) of IPV having a very wide variation around 
the world (see section 1.2.1.1.) it is difficult to be prescriptive about laying down pre-
established criteria to classify low, moderate or high predictive values for index 
questions trying to identify IPV. The most clinically useful index questions may be 
those that are found to produce the largest difference between the specific study 
prevalence and the PPV of the index questions in that study. 
 
 
1.3.6.2.1.2.  Criterion correlation studies 
These studies involve correlation between a predictor index test score (of the new set 
of questions) and the criterion score. This forms the criterion-related validity 
coefficient which assesses the validity of the index questions. The criterion-related 
validity coefficient has a number of characteristics in common with other correlation 
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coefficients which I will be covering in section 1.3.6.4., including the different 
statistical methods used to calculate them. 
 
 
1.3.6.2.2.  Association studies 
 
Criterion performance studies require a criterion measure or a reference standard. If 
no reference standard exists (which could be argued is the case with IPV) then an 
association study may need to be undertaken. Association studies include those that 
look at the association between index scores and external variables, convergent 
validity studies (looking at the association between two tests measuring similar 
constructs) and divergent validity studies (looking at the association between two tests 
measuring dissimilar constructs). In association studies it is the underlying theories 
about the target condition (IPV) which generates hypotheses regarding potential 
associations, expressed quantitatively, between index questions and attributes that can 
be evaluated. For example, one may hypothesise that a woman experiencing IPV will 
visit a doctor more often or have worse mental health. If the theory is erroneous, the 
quantitative association may be deceptive. If the hypothesised association is not seen 
between questions trying to identify IPV and other observations (be it an external 
variable or another test score), one has to decide whether the index questions have 
low validity or that the theory is incorrect or both. 
 
 
1.3.6.2.2.1.  Between index scores and external variables 
Association studies measuring correlations of the type and extent of relationships 
between index scores and external variables for example hospitalisation, use of 
services, readmission etc. can evaluate the capacity of a set of questions trying to 
identify IPV to correlate with external variables. 
 
 
1.3.6.2.2.2.  Convergent validity studies 
These studies investigate the relationships between index scores and other tests 
intended to measure similar constructs. Neither test is purported to be a reference 
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standard. However the two should be related, according to the theoretical basis of the 
construct and so should correlate moderately highly. If the correlations between the 
two tests are too high this implies that the new test is unnecessary replication unless it 
has some advantage over the older test (for example is shorter). If the scores on the 
two sets of questions do not correlate, this would point to either a difficulty with the 
new set of questions (for example they are not identifying IPV) or an issue with the 
theory linking the two sets of questions (for example do the two sets of questions 
identify different dimensions of IPV). There would be no way of knowing from the 
results of the correlation alone. 
 
In comparison with criterion performance studies (this includes diagnostic accuracy 
studies and criterion correlation studies), convergent validity is based on more 
assumptions and so is a less robust method. Consequently in my framework, 
convergent validity appears below criterion-related validity which has fewer 
underlying assumptions (see figure 3, on page 50). 
 
 
1.3.6.2.2.3.  Divergent validity studies 
Divergent validity studies: (also known as discriminant validity studies) are closely 
related to convergent validity studies but investigate the relationships between scores 
and other measures of different constructs. These relationships should not correlate or 
have low correlations. 
 
 
1.3.6.2.3.  Known group comparisons 
 
Known-group comparison studies are intended to test hypotheses about expected 
differences in test scores across specific groups of examinees. Study populations 
hypothesized to differ on a test construct (for example non-abused women compared 
with abused women living in a refuge) are assessed using the set of questions trying to 
identify IPV. If the expected mean differences in scores are found, the questions 
identifying IPV are supported. Streiner and Norman also refer to this as construct 
validation by extreme groups or discriminative (not discriminant) validity.[81] Known 
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group comparisons contain an inherent study population bias as ambiguous cases will 
have been eliminated. However they sometimes are a necessary study design when a 
reference standard does not exist. 
 
 
1.3.6.3.  Category C: Validity evidence based on internal structure 
 
The role of validity evidence based on internal structure is constrained in that it does 
not actually tell us what the questions are identifying and whether they are identifying 
what is required to be identified. To achieve this, data external to the questions is 
required (i.e. category A and B). 
 
 
1.3.6.3.1.  What is internal consistency reliability? 
 
For a set of questions to effectively identify a construct requires the individual 
questions in that set, to also represent the same construct, assuming that the construct 
is one-dimensional. Answers on questions should be moderately correlated with each 
other (inter-item correlation) and each individual question‟s score should correlate 
with the total scale score (item-total correlation). This would reflect a high degree of 
homogeneity also known as the internal consistency of the scale which is a type of 
reliability measure. This represents validity evidence based on the internal structure of 
the set of questions.[89] Internal consistency can be measured easily by simply 
administering the questions once to participants as it is generated by looking at the 
average of the correlations amongst all the questions in the group. This advantage 
over other reliability coefficients (see section 1.3.6.3.4.) means that internal 
consistency reliability coefficients are commonly seen in published papers. 
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1.3.6.3.2. Internal consistency and classical test theory 
 
Streiner and Norman advise that in most situations, when measuring a construct the 
set of questions measuring it should be homogeneous.[81] The theoretical assumption 
that if questions are highly correlated, the construct of interest has been measured to 
some degree of consistency[114] arises from Classical Test Theory. In Classical Test 
Theory, any test is constructed from a random sample of all the possible questions 
that could be in the test. There is a supposition that there is a “universe” of questions 
that identify a given trait or behaviour; and that a scale is made up of a random subset 
of these questions. Therefore the questions should be highly interrelated if they are 
assessing the same construct and the scores would be reliable. 
 
 
1.3.6.3.3. When should internal consistency not be considered 
 
Homogeneity should not be measured across different subscales when questionnaires 
are multidimensional.[81] Factor analysis, another type of validity evidence based on 
internal structure, evaluates whether individual questions belong to different 
dimensions. 
 
Factor analysis has been used in the development of long research tools not used in 
routine clinical practice to identify IPV. For example, the 30 item Composite Abuse 
Scale has been shown to measure four dimensions of abuse inflicted on a woman by 
her partner. These dimensions are physical abuse, emotional abuse, severe combined 
abuse (which includes sexual IPV) and harassment.[101, 115] When the Composite 
Abuse Scale is presented to women the questions from each dimension are mixed 
together randomly. It would be illogical to measure the internal consistency of the 30 
questions that refer to different dimensions of IPV together. Instead it is the internal 
consistency of the individual dimensions that has been calculated. 
 
Therefore for new sets of questions trying to identify IPV one needs to decide whether 
the questions operate over one dimension or are multidimensional before deciding 
whether internal consistency estimates have any role in providing validity evidence. 
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For a set of questions that have good content validity (see section 1.3.6.6.) capturing 
physical IPV, sexual IPV and emotional IPV, the questions address different 
dimensions of IPV so internal consistency measures should not be applied across 
them. Some sets of questions trying to identify IPV may only focus on one dimension 
of IPV, for example physical IPV. This would result in decreased content validity 
with regards to representing the whole spectrum of IPV but being uni-dimensional it 
would be methodologically correct to measure the internal consistency of these 
questions. Streiner advises that the aim of a scale is inferential which is more 
dependent on its content than its internal consistency, making the former more 
important.[103] 
 
Additionally, if a test is trying to categorically divide women into different groups, 
then it may be that it contains questions which do not actually relate directly to the 
specific construct and the internal consistency of the set of questions becomes 
irrelevant. 
 
 
1.3.6.3.4. Internal consistency in relation to other reliability measures 
 
Reliability of a set of questions identifying IPV would be evidence that these 
questions were measuring IPV in a reproducible manner. Internal consistency is only 
one type of reliability measurement. The internal consistency reliability coefficient 
does not take into account other types of reliability representing other sources of 
variation (i.e. errors of measurement) such as that caused by different times of test 
administration (test – retest reliability coefficient), observer to observer variation 
(inter observer reliability coefficient) and variation by the same observer (intra 
observer reliability coefficient). The internal consistency reliability coefficient is 
completely independent from these other reliability coefficients.[81] Therefore it does 
not give the full picture of the true reliability for a group of questions identifying IPV. 
Internal consistency reliability for any measure can often be much more positive than 
the actual total reliability. 
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1.3.6.3.5. Statistical methods to calculate internal consistency reliability 
 
Item-total correlation and inter-item correlation are the two principal methods used in 
a number of statistical tests to calculate the internal consistency for a set of questions. 
 
 
1.3.6.3.5.1. Item-total correlation method 
This is a frequently used method for examining the homogeneity of a group of 
questions. It involves checking the correlation of an individual question with the 
group of questions having omitted that question. Each individual question‟s score 
should correlate with the total scale score. A formula devised by Nunnally separates 
an individual question‟s contribution from the whole score.[116] Kline advised that an 
individual question should correlate with the total score above 0.2 whilst questions 
with lower correlations should be rejected.[117] The Pearson product –moment 
correlation coefficient is used if there are more than two response alternatives, even if 
data is not normally distributed (see section 1.3.6.4.1.). The point biserial correlation 
coefficient is used if questions have only two response alternatives (see section 
1.3.6.4.3.). 
 
 
1.3.6.3.5.2. Inter-item correlation method 
A number of different statistical tests used to calculate internal consistency reliability 
use the inter-item correlation method, including the Kuder-Richardson formula 20 
reliability coefficient (used when individual questions are scored dichotomously) and 
Cronbach‟s alpha (an extension of Kuder-Richardson 20 which can be utilized when 
there are more than two response choices). 
 
Cronbach‟s alpha, also known as the Coefficient alpha or alpha, is the most widely 
used statistical method for calculating inter-item internal consistency probably as it 
can be used for both dichotomously scored questions and those with multiple response 
categories, for example the Likert scale. Unfortunately, there is a great deal of 
misunderstanding about Cronbach‟s alpha and what it actually means though it 
ubiquitously appears in papers developing scales. Central to understanding 
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Cronbach‟s alpha is that it not only represents the magnitude of correlations among 
questions but also the number of questions in a scale. Hence by simply doubling the 
number of questions, one increases Cronbach‟s alpha despite the average correlation 
remaining unchanged.[89] 
 
There is also no absolute clear consensus regarding the ideal numerical value for 
Cronbach‟s alpha. Aaronson et al‟s commonly accepted minimal standards for 
reliability coefficients was 0.7 for group comparsions; and 0.9-0.95 for individual 
comparisons.[118] Nunnally agreed that alpha should be > 0.7 but that alpha should 
be no higher than 0.9 as this may imply that some questions were redundant, adding 
little extra information, as they make the same enquiry in slightly altered ways.[116] 
Streiner & Norman sum up that the real problem of having a Cronbach‟s alpha with a 
number between zero and one is that it does not lend itself to commonsense 
interpretations. They emphasise that high alpha values should always be interpreted 
with great caution and never assumed to be inherently good. They state that internal 
consistency should be greater than 0.8 with higher values depending on the use of the 
test and the cost of misinterpretation.[81] 
 
 
1.3.6.4.  Correlation and correlation coefficients 
 
Correlation between two measures is used in a number of methods described above to 
measure validity, including criterion correlation studies, association studies (between 
index scores and external variables, convergent and divergent validity studies) as well 
as all reliability measures including internal consistency reliability. These correlation 
coefficients have some common features. All can be affected by the difference within 
the group being studied and test length. Hence the more heterogeneous and varied the 
study population, with a wider range of test scores, the larger the correlation 
coefficient; whilst the more homogeneous the group, with a narrow range of test 
scores, the smaller the correlation coefficient. Consequently a small correlation 
coefficient could be the result of strict sample selection causing a restriction in 
variance. This can be explored by actually inspecting the scatter plot showing the 
bivariate distribution between the test score and the other measure. This can also 
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clearly illustrate whether the relationship is linear and uniform; or if the two variables 
are related non-linearly but have zero correlation. Different correlation coefficients 
are defined by various statistical methods which I have described below. 
 
 
1.3.6.4.1. Pearson’s product moment correlation coefficient 
 
This is also known as the Pearson correlation, the Pearson‟s correlation coefficient, 
the Pearson product moment correlation and the r value, denoted by “r.” This reveals 
how close the relationship between two measures can be described by a straight 
regression line.[112] Both measures need to be continuous but do not need to have the 
same units. The correlation coefficient is the sum of products divided by the square 
roots of the sums of squares of X and Y and hence has no units. This also makes the 
correlation coefficient lie between -1.0 and +1.0 which relates the closeness of the 
linear relationship between the two measures. If the relationship is strong the 
correlation coefficient approaches +1, if it is weak it moves towards 0 whilst if there 
is a negative relationship (i.e. if one measure goes up, the other goes down) it would 
be closer to -1. 
 
The product moment correlation coefficient presumes equal variability throughout the 
range of scores. This is exhibited on a scatter-plot. It is the best coefficient to use in 
almost all cases if there are more than 2 response alternatives. The product-moment 
correlation is robust enough to produce relatively accurate results, even if data are not 
normally distributed. 
 
 
1.3.6.4.2.  Kappa coefficient 
 
This correlation coefficient is also known as Cohen‟s kappa statistic [119], kappa 
statistic and just kappa. It measures the correlation between two dichotomised 
measures (for example the presence or absence of IPV, alluding to the categorical 
model) as opposed to two continuous measures (for example the degree of IPV 
present, alluding to the dimensional model) when using the product moment 
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correlation coefficient. This approach calculates simple agreement, i.e. the proportion 
of responses in which the two observations agreed. The kappa coefficient represents 
the proportion of responses in the two agreement cells (yes / yes, no / no) in relation 
to the proportion of responses in these cells which would be expected by chance, 
given the marginal distributions. Therefore it demonstrates the degree of agreement 
which has occurred over and above that which would have occurred by chance alone. 
Its weakness is that it is influenced by the average prevalence of the target condition 
(i.e. IPV). 
 
 
1.3.6.4.3. Point biserial correlation coefficient 
 
The point biserial correlation coefficient[120] is mathematically equivalent to the 
Pearson product moment correlation but is used if there is one continuously measured 
variable and a dichotomous variable. 
 
 
1.3.6.4.4. Spearman’s correlation coefficient 
 
This assesses the strength of the association between two continuous variables when 
one cannot assume that the data were sampled from a particular type of distribution 
(i.e. a non-parametric statistical test).[112] 
 
 
1.3.6.5. Category D: Validity evidence based on response 
processes 
 
Evidence of validity based on response processes considers the ways in which 
individuals respond when completing test questions. Therefore when trying to decide 
whether questions measuring a construct are valid, one needs to also consider whether 
answering the question generates tasks that require complex activities which actually 
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impede the measuring of that construct. Some questions may cause construct-
irrelevant variance due to the way that they are asked.[121] 
 
When constructing new questions to identify IPV they must be easily interpretable. 
Words that are ambiguous, incomprehensible or contain jargon terms only used by 
professional groups need to be eliminated. The reading level of the questions 
generally should be no higher than the reading age of a 12 year old.[103] The 
response alternatives should be precise especially with regards to time. Badly selected 
vague questions with poor wording cannot be overcome by complex statistical 
analysis. Validity evidence based on response processes becomes especially important 
when using questions in different cultural groups which may be less familiar with for 
example, a Likert type scale [122] or a “true / false” format. 
 
Likert scales have a number of response alternatives with interval properties. The 
participant has to rate them according to her degree of agreement or disagreement. 
Likert scales are thought to be difficult to negotiate for diverse patients with poor 
literacy skills,[122] decreasing the value of the validity evidence generated based on 
response processes. 
 
 
1.3.6.6. Category E: Validity evidence based on test content 
 
The content validation of the index questions measuring a construct is a systematic 
analysis of the appropriateness of the questions‟ content. The face validation is a 
subjective judgement to see whether on the face of it the questions appear to be 
assessing the same construct.[81] 
 
Content validation refers to more than just the mere content of questions in that it also 
concerns itself with the range of responses generated by the content of the questions. 
Hence the range of responses that are elicited should represent the complete domain 
that one is trying to measure. This involves carefully specifying the entirety of 
behaviours that can occur in that domain.[82] 
 
  
70 
Therefore questions that try to identify IPV should arise from a comprehensive 
definition of IPV so that they capture the different types of IPV. The WHO has 
globally defined intimate partner violence (IPV) as: 
“Any behaviour within an intimate relationship that causes physical, psychological, or 
sexual harm to those in a relationship; it includes: physical aggression, psychological 
abuse, forced intercourse and other forms of sexual coercion, various controlling 
behaviours.”[123] 
 
Hence a set of questions trying to identify IPV needs to include questions on physical, 
sexual and emotional IPV otherwise the questions cannot identify it. This flaw cannot 
be corrected by statistical manipulation. Each separate question should focus on one 
element of IPV only. One question cannot cover more than one type of IPV as this 
would result in the question being too complex and difficult to answer using the 
common “Yes / No” answer. Different patterns of IPV can occur so no assumptions 
should be made about whether physical, sexual or emotional IPV are either mutually 
inclusive or exclusive.[17] 
 
Fontes states that researchers may use definitions that do not exist in other 
cultures.[124] Lachs affirms that as there is no universally agreed case definition of 
IPV, one cannot calculate the sensitivity or specificity of IPV tools.[125] 
Undoubtedly IPV does mean different things to different women due to its opaque 
nature. This may be more accentuated in women from different ethnic groups (see 
section 1.5.1.) though may be just as evident in women from the same ethnic group. 
In clinical consultations it is the individual woman who decides whether to 
characterize her experiences as IPV. This interpretative process may be 
accommodated by the health care professional giving out key messages over time 
such as the actions by her partner, for example marital rape, are illegal; that there is no 
excuse for this behaviour and that this behaviour cannot be the woman‟s fault. I do 
not think that the woman‟s role in describing her own experience of IPV contradicts 
the importance of a global definition of IPV. 
 
It may be difficult to define IPV globally but the WHO definition (see above) is the 
closest to a universally agreed definition. Hence if a set of questions is going to be 
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used to identify IPV in a variety of settings it is important to use the WHO definition 
to assess content validation as opposed to colloquial definitions. 
 
Though IPV may be interpreted differently around the world, some women even 
construing it to be “normal,” international human rights law is very clear that states 
have a duty to prevent, prosecute and punish violence against women.[6] Using a 
human rights framework in which aspiration to health equality[126] and violence 
against women are human rights issues[127] leads to an appreciation that cultural 
relativism should not be used to diminish violence and its effects.[128], [129] 
Whereas the culture of a group is a constantly changing phenomenon[130] (see 
section 1.4.1.3.), the IPV definition arising from a human rights framework should be 
a constant. 
 
 
1.3.6.6.1.  Translation of questions 
 
Translation may significantly alter the meaning of questions unless attention is paid to 
reassessing the content validation of translated questions. The translation of questions 
to identify IPV also highlights the opacity of IPV as a construct. The content 
validitation of translated questions requires consideration of conceptual equivalence, 
item equivalence, semantic equivalence, operational equivalence, measurement 
equivalence and back-translation.[81] 
 
The first and most important step, yet also the most difficult to achieve is conceptual 
equivalence. This means establishing whether the persons in the two language groups 
which represent two cultural groups actually perceive the concept in the same way. 
This may be most difficult with aspects of emotional IPV.  
 
Item equivalence involves checking that specific questions are relevant and acceptable 
in the new language group. Semantic equivalence then checks if the meaning of each 
word is equivalent in the two language groups. For example, the direct translation of 
“I feel blue” from English to Spanish may not be semantically equivalent as there 
maybe no association of blueness with sadness in Spain. 
  
72 
After conceptual, item and semantic equivalence have been completed, one can 
proceed to the actual translation task. Ideally, there should be at least two separate 
translations preferably within two teams, translating into their native languages, using 
colloquial language that participants are more likely to be familiar with rather than the 
more formalised speech often used by and between professionals.[131] Independent 
teams who are preferably unaware of the research objectives and what the instrument 
is measuring, and have not seen the original English questions that were being 
translated should back-translate each question into English. Finally a separate team of 
translators should ideally look at the original and back-translated versions to resolve 
any outstanding differences.[103] 
 
Operational equivalence is considering whether the same questions, with the same 
instructions and the same method of administration (be it a self-completed / telephone 
/ mailed questionnaire, face-to-face interview, computer assisted administration) 
would function effectively in the new language group. For example, many first 
generation female Bangladeshi migrants to east London may not speak English, 
instead speaking Bengali but they would not necessarily be able to read Bengali. The 
literacy rate in Bangladesh is lower compared to the UK. Therefore they may find it 
difficult to answer a self completed translated questionnaire even though it is in 
Bengali. 
 
Once one has a translated version of the instrument one cannot assume that it has the 
same reliability and validity as the original version so these characteristics need to be 
reassessed in the new tool. One could then proceed to see if any cut-off scores used in 
the earlier tool are suitable in the new translated version. Once one has two versions 
of questions in two languages, the differences in the results (and even the similarities) 
need careful interpretation. Differences may not just be due to ethnic or cultural 
differences between two groups but also due to other factors. For example, socio-
economic differences would need to be carefully examined. Interpreting similarities 
or differences requires care and complex analysis.[103] 
 
Having examined the background to the measurement of validity, I now consider the 
background to the term ethnicity and how it has been used in IPV research. 
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1.4. Ethnicity 
 
Throughout this section on ethnicity, I will illustrate key issues by using IPV research 
studies which have used ethnicity data whilst considering how ethnicity may impact 
on IPV identification. In this section I will firstly explore the concept of ethnicity and 
then how ethnicity is actually utilised in health research studies. I use the phrase 
“health research” as an umbrella term which includes epidemiological, clinical, and 
health services research. Looking at how ethnicity is actually used in studies involves 
exploring ethnicity‟s close relationship with race. I will then explain why I have 
chosen to study ethnicity. I will focus on the rationale for and potential dangers of 
collecting ethnicity data in research studies before lastly presenting five criteria to 
assess the use of ethnicity data by papers. 
 
 
1.4.1. What is an ethnic group? 
 
Ethnicity is derived from the Greek work “ethnos” which means a nation, people or 
tribe. The Oxford Dictionary[90] contains a variety of definitions for the adjective 
ethnic including: 
“relating to race or culture (ethnic group); 
(of a social group) having a common national or cultural tradition.” 
 
Mares and colleagues,[132] stated that an ethnic group does not need to be stringently 
demarcated by specific cultural factors or characteristics but rather that the important 
feature of an ethnic group is that it is recognised by its own members and by others. 
Hastrup[133] said that 
“.. meaning of ethnicity cannot be sought out in a purely deductive manner,” 
– by others, be it one‟s patients or ethnicity experts – 
“it requires the cooperation of the people involved ... they themselves play the part of 
theoreticians in this field…” 
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This highlights the importance of self identity within the realm of ethnic 
classification. For ethnic classifications to be valid in studies they need to be self 
assigned as opposed to being determined by others.[134] 
 
Anthropologists have viewed ethnicity as a result of interaction, rather than 
representing the innate characteristics of a human group.[135, 136] Ethnicity means 
different
 
things in different contexts.[137] Cohen points out that ethnicity along with 
age, gender, class and other characteristics that individuals use to define them-selves 
all have an objective status derived from economic and social realities; and a 
subjective status with a symbolic quality. This therefore allows the simultaneous 
expression of both individual and collective identities.[138] 
 
An ethnic group has been defined by shared characteristics including cultural 
traditions, languages, religion, ancestral and geographical heritage.[134, 139] A 
comprehensive definition of an ethnic group is 
“a collectivity within a larger society having real or putative common ancestry, 
memories of a shared historical past, and a cultural focus on one or more symbolic 
elements defined as the epitome of their peoplehood.[140]” 
 
In the context of investigating questions designed to identify IPV, the foremost 
symbolic elements may be cultural beliefs about gender, family and what constitutes 
abuse. It is these cultural beliefs that impact on an individual‟s ethnic identity and 
ethnicity (see section 1.4.1.3.). 
 
 
1.4.1.1. Ethnicity’s relationship to race 
 
Despite the wide ranging debate on what constitutes an ethnic group, health research 
generally uses a narrow concept of ethnicity in studies.[137] Ethnicity is rarely based 
on any cultural factors or cultural beliefs. Previously in the UK, the country of birth 
was often used as a proxy measure for ethnicity. In the 21
st
 century, in increasingly 
diverse populations, country of birth has become a poor indicator of ethnicity. Instead 
now in Western Europe and the US, ethnicity is often based on apparent racial 
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categories, the majority of which represent the degree of melanisation of skin cells, 
i.e. skin colour. African-Americans equates to black, Asian to brown and white to 
white. I consider that the main justification for basing classification on euphemisms 
for skin colour (apart for the few conditions that are directly related to the degree of 
melanisation, for example melanoma, vitamin D deficiency) is that this could be used 
to investigate the effect of racism on health. Disappointingly researchers using these 
classification systems rarely mention racism whilst at the same time failing to reiterate 
that neither ethnic or racial groups relate to either biological or genetic 
differences.[141] 
 
Geneticists have clearly shown that the genetic differences between so-called races is 
less than the differences seen within these groups.[142] The principle that ethnicity 
and race are social constructs rather than biologically based ones is supported by a 
number of professional organisations, including the American Academy of 
Pediatrics,[143] the US Surgeon General,[144] the American Psychological 
Association,[145] the American Sociological Association [146] and the American 
Anthropological Association.[147] It has been said that the race concept has gradually 
changed, incorporating shared histories and social factors, hence merging with the 
concept of ethnicity.[148] 
 
However I consider that the current use of both ethnicity and race in health research, 
at the grassroots level reflected in academic papers does not represent a convergence 
of the two constructs. Even though there is little practical difference in the way that 
the two terms are currently used, this does not symbolize a union. Ethnicity has 
essentially evolved into becoming a politically correct way of saying race. Authors 
feel more comfortable and safe using the term ethnicity as opposed to race. 
Consequently, this has resulted in the burden of ethnicity classifications often being 
precisely the same as that for racial classifications. Ethnicity data is as vulnerable to 
discriminatory or prejudiced interpretation as is racial classification data to racist 
interpretation. Any research that contains ethnicity or race data is susceptible to 
stereotyping and discrimination. Baldwin agreed that ethnicity was similarly tainted to 
race, both ethnicity and race being derived partly from immigration and hence 
politically loaded terms as opposed to being neutral.[149] 
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1.4.1.2. The phrase “race / ethnicity” 
 
In health research literature, as well as the trend whereby ethnicity often simply 
replaces the word race, there is also currently the widespread use of the phrase “Race / 
ethnicity” – reflecting the synonymous use of race and ethnicity in practice.[134, 137, 
148, 150] The use of the phrase “Race / ethnicity” has been supported by some: 
 
“Race / ethnicity: in which race can be considered “the category to which others 
assign individuals on the basis of physical characteristics, such as skin color or hair 
type, & the generalizations & stereotypes made as a result” and ethnicity as “group 
mores & practices of one‟s culture of origin.”[145] 
 
I think that the use of race / ethnicity reflects the similarity of the current ethnic and 
racial classifications that are used, as discussed above. I have seen no clear 
justification for combining these two quite different concepts into one term. Instead, I 
consider that the existence of the phrase “race / ethnicity” results in continued use of 
terminology which can purport to be ethnicity though is based on race which in turn 
largely reflects skin colour. 
 
Despite the current similarity in how ethnicity and race are practically used in health 
research literature, they are fundamentally different. In the future, ethnicity may 
potentially throw light onto the complex issue of identity, unlike race. Ethnicity‟s 
strength is that when using it one can also include the factors that describe ethnicity. 
Therefore an understanding of ethnicity in health research still has the potential to be 
developed unlike race. Bhopal also stated that ethnicity is still under development 
whilst having the capability to combine cultural, social and biological features.[134] 
Oppenheimer concurred that though ethnicity has its own load of political, social and 
ideological meaning, being closely aligned to culture it is preferable to race.[151] 
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1.4.1.3.  Studying ethnicity 
 
The decision on whether ethnicity or race is studied should be determined by the 
specific research question that one is trying to answer. Investigating ethnicity is not 
always preferable to race. For example, it may be appropriate to investigate race, if 
the research question hinges on inequity driven by racial appearance. If the research 
question centres on behaviours, cultural beliefs and identity then it may be ethnicity 
which is more appropriate. 
 
In the context of investigating questions trying to identify IPV, I think that the cultural 
beliefs that impact on an individual‟s ethnic identity and ethnicity are central. Cultural 
beliefs are best uncovered by talking to individuals who are the experts on the cultural 
factors at play in their lives.[152] Cultural beliefs are likely to be particularly 
important when considering how individuals interpret IPV, in that cultural beliefs will 
impact on gender roles, expectations about family roles, what is considered to be 
abusive, how willing an individual is to disclose abuse and the reasons why they 
would consider disclosing abuse. The premise for my thesis is that cultural differences 
in attitudes towards IPV could affect disclosure in different ethnic groups which in 
turn could also affect how accurately some questions (according to their precise 
wording and order of words) identify IPV in different ethnic groups in a health 
setting. It is not only culture that may affect the questions used to identify IPV but 
also women‟s experience of IPV that may affect their culture. The culture of a group 
constantly changes as a result of the people in that group engaging and reinterpreting 
it. A postmodern perspective widely accepts the changeability of culture: “culture is 
not a static phenomenon; individuals interact with their culture so that the culture is 
constantly challenged and redefined.”[130] 
 
My thesis is concerned with the identification of IPV which may be impacted upon by 
cultural beliefs as well as cultural position (i.e. minority verses majority communities, 
oppressed groups verses oppressors - also see section 1.4.2.1.). Hence it seems 
appropriate that my thesis should focus on differences in ethnic groups as opposed to 
racial groups. Whilst reviewing previous literature (both in this background chapter 
and in my systematic review) I have used the ethnicity terms and factors used to 
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describe ethnicity reported in those studies. I now consider the rationale and dangers 
of collecting ethnicity data in general in health research. 
 
 
1.4.2. Rationale for collecting ethnicity data in health 
research 
 
The rationale for collecting ethnicity data in research studies is to expose health 
inequalities, improve health and to respond to increasing ethnic diversity. 
 
 
1.4.2.1. Exposing health inequalities 
 
The study of ethnicity can help to expose inequalities in both health and healthcare. 
Ethnicity as well as race, socioeconomic status, education level, health behaviours, 
gender, age and occupation are all well recognised epidemiological exposure 
variables.[134, 153] They can be used to subdivide populations, showing differences 
in disease experience. They all define a possible group identity, helping to make 
inequality more meaningful in a given population[154] as they are markers of 
underlying factors which are relatively more difficult to measure, such as how 
powerful an individual is and the power dynamics of relationships that they have with 
others around them (for example, intimate partners, extended family, neighbours, 
employers or the state). 
 
Epstein visualises ethnicity as well as race, age, gender, social class and sexual 
identity as “…intersecting attributes of identity, markers of difference, dimensions of 
social hierarchy and power…”.[140] Consideration of power relationships is 
particularly important when reflecting on IPV and how IPV maybe interpreted 
differently in specific ethnic groups. Power differences between the sexes may 
increase the likelihood of gendered violence whilst power differences between ethnic 
groups raise the possibility of cultural violence (including racism and discrimination). 
The power relationships between ethnic groups are often glossed over.[155] How 
violence operates to link the power relations of gender and ethnicity has been 
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considered by sociologists.[156] Collins describes that both hierarchies of gender and 
ethnicity as well as race, class, age, nation and sexuality are supported by violence. 
For example, gender hierarchies are supported by pornographic images of women, 
workplace sexual inequalities, widespread physical and sexual IPV. Collins advises 
that using a gender-only framework (or an ethnicity-only framework) restricts the 
understanding of an African-American woman‟s experiences with violence. In effect 
IPV‟s consequences and how a woman reacts to it cannot be neatly separated out from 
the other types of violence present in a woman‟s life. This is equally true for all 
women globally who exist within violent hierarchies of class, religion, immigration 
status, age and sexuality, not just gender and ethnicity.[156] 
 
 
1.4.2.2. Improving Health 
 
Collecting ethnicity data in health research can not only highlight inequalities but also 
potentially leads to insights into what accounts for differences, providing the 
possibility of solutions based on effective interventions. This process can improve the 
health of individuals in different ethnic groups and help overcome health 
inequalities.[137] 
 
With regards to IPV, it is not enough to know that there are ethnic differences in IPV. 
To improve health one would then want to disentangle the reasons for these 
differences in order to respond in a practical way, working towards decreasing IPV. 
Indeed Bhopal states that  
“The only ethical justification for collecting data by ethnicity and health is health 
improvement either directly or through research.”[134] 
 
Individuals are unlikely to consent to a study which uses their ethnicity data but is not 
ultimately trying to improve their group‟s health. Ethical robust research requires 
consenting participants. The aims for secondary analysis of ethnicity data need to be 
focussed on health improvement even more so as the use of anonymous data means 
that individuals may have not consented. 
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1.4.2.3. Responding to increasing ethnic diversity 
 
Collecting ethnicity data becomes increasingly important as worldwide the numbers 
of international migrants increases and there is increasing ethnic diversity. In the US 
46 million residents speak a different language from their primary care clinicians. 
Minority groups socially defined by “race” and “ethnicity” will be more than 50% of 
the population.[157] In England 12.5% of the population (6.4 million residents) is in 
an ethnic minority. In the UK, 7.6% of the population is from an ethnic minority 
group, representing an increase of over 44% over the preceding decade.[158] These 
migrants predominantly come from poor countries (in Africa, Asia, Central and South 
America) to rich affluent countries. 53% of new immigrants to European countries are 
women and 50% are women to North American countries.[148] Potential ethnic 
differences in the experience and nature of IPV are an important aspect of women‟s 
health that should not be ignored. 
 
In the UK, Europe and North America as populations diversify due to the immigration 
of people from low resource countries, the differences in health between ethnic groups 
becomes important in order to sustain a fair and just society. In the UK the notion of 
equitable access to services is firmly embedded in the founding principles of the NHS. 
An equitable service can only be provided by understanding the differences in 
patients, including those from different ethnic groups. In the UK the function of 
strong race relations legislation is to promote equality in a multi-ethnic society.[134] 
Enshrined within this is that a response is required when health inequalities are 
manifest. In the US, the “inclusion and difference paradigm” as described by Epstein, 
represents policy on including diverse groups in medical studies whilst measuring 
differences across those groups.[140] Having considered the rationale for collecting 
ethnicity data I now reflect on the dangers of collecting ethnicity data. 
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1.4.3. Dangers of collecting ethnicity data in health 
research 
 
The dangers of collecting ethnicity data in research studies include racism, arbitrary 
classification and inadequate analysis which I now expand upon. 
 
 
1.4.3.1. Racism 
 
The fundamental potential danger of collecting ethnicity data is that it, as with racial 
data, can be used to advocate racism. This has been very evident in the past but is still 
possible in the present, especially when there is no accompanying analysis or 
interpretation of ethnic differences within studies by researchers (see section 1.4.3.3). 
This leads the susceptible reader to the conclusion that biological differences account 
for social inequalities.[140] 
 
Historically racial classifications were thought by scientists to be firmly based on 
biological facts and were directly used to support racism, a belief in the superiority of 
a particular race with prejudice based on this. This resulted in antagonism and 
discrimination towards other human beings (said to belong to different races) with the 
underlying theory that human abilities are determined by race. There are numerous 
examples of this, perhaps the most well known being the West African slave trade. 
This involved approximately 12 million Africans being forcibly removed from their 
homelands, from 1500 to about 1900, in order to increase the wealth of Europeans. 
Another example is the extermination of Jews by the Nazis in the 20
th
 century.[159] 
Perhaps what is less well known is that medicine was not a passive bystander but 
played a very active role in composing and mitigating these racial hierarchies.[140, 
160] 
 
Advocating racism on the basis of scientific fact also persists in current times. For 
example, the recent widely publicised view of the eminent scientist, Nobel laureate, 
discoverer of DNA structure, James Watson that black people are less intelligent than 
white people[161] and the explosion of mainstream media interest about The Bell 
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Curve.[162] No TV channels gave airplay to other views, for example. that using IQs 
or “g” scores to rank individuals is a major misuse of science.[160] Scientific racism 
means the use of science to develop theories and propaganda that draw upon the 
biology of racial differences. This continues to be active today. Racism is a present 
day reality throughout the world and not just a historical fact.[163] 
 
 
1.4.3.2. Arbitrary classification 
 
When classification based on ethnicity data appears in academic journals it appears to 
have scientific validity. However classification based on ethnicity is subjective, 
context-specific, purpose-driven and imprecise.[134] It results in idiosyncrasies such 
as individuals classified as being Hispanic in US studies simultaneously being 
categorised as white in south American studies. This context specificity of ethnicity is 
partly a strength which in this example successfully captures cultural positions. 
However in other more complex examples ethnicity is likely to be too limited to 
capture all of the nuances and subtleties of cultural position.[164] 
 
Researchers also use census ethnicity categories though these have been developed for 
administrative reasons. Bhopal stated that ethnicity was not measurable with accuracy
 
or validity[153] and that the classification used for the 1991 UK census was arbitrary. 
He said that the UK census only worked as the population were willing to answer it, 
partly as it had been developed with input from ethnic minority organisations. 
 
Guidance on the use of ethnicity in health research published in the British Medical 
Journal (BMJ) and the Journal of the American Medical Association (JAMA) both 
emphasise the importance of the terms used to describe ethnicity.[137, 165] The BMJ 
guidance stressed that the terms used should be descriptive showing how groups were 
defined with the logic underlying ethnic groupings and their allocation included in the 
Methods section.[166] Similarly the JAMA guidance highlighted defining categories 
precisely and being able to state how persons are allocated to these categories.[137] 
These measures encourage transparency about the arbitrary nature of ethnicity 
classification systems used by a paper. 
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1.4.3.3. Inadequate analysis 
 
When ethnicity data appears in papers there is often no analysis by ethnic subgroups. 
Epstein states that there should be clarity about why a researcher assumes that 
ethnicity (or race, sex, gender and / or age) are medically meaningful identity 
attributes in a particular subject area.[140] Often this reasoning is ignored in papers 
and furthermore what accounts for any revealed ethnic differences is not always 
addressed. For example, one IPV study, detected a significant difference in the 
ethnicity of IPV cases compared to controls, along with a number of socio-economic 
differences.[167] There was no further analysis or discussion about this result. 
Another IPV study found that African-Americans in Newark, US were significantly 
more likely to be coded as an IPV visit (odds ratio 1.9) when attending the Emergency 
Department.[168] Again there was no further discussion about what may account for 
this result. There are exceptions to these studies, with examples of thoughtful data 
analysis to account for ethnic differences. For example, a study skilfully investigated 
mothers‟ health behaviours by unpacking ethnicity effectively.[169] Thus 
acculturation indicators (generational status, language spoken at home, length of 
residency in UK) were also examined when looking at mothers from ethnic 
minorities. Harmful maternal health behaviours were shown to rise as length of 
residency in the UK increased. Data is vulnerable to xenophobic interpretation when 
there is limited analysis. In the first two studies, headline results may convey that 
some ethnic groups are biologically more violent and in the second that pregnant 
Asian mothers do not need to be asked about drinking or smoking. As with all other 
research, researchers looking at ethnic differences need to have focussed research 
questions which can be addressed by the data collected and data collection needs to 
include potentially confounding factors that ethnicity may be a proxy for. This is 
perhaps more important when ethnicity is involved because of the potential for 
misinterpretation. 
 
In family violence research it has been suggested that eco-cultural factors including 
economic marginality, salience of religion, social support, domestic and family 
workload need to be separated out from ethnicity when it is being investigated.[148] 
These eco-cultural confounding factors allow one to understand what may account for 
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apparent ethnic differences that may be seen in family violence. They are consistent 
with the contributing factors put forward by the Ecological Model of IPV (see section 
1.1.). In IPV identification, ethnicity may also be confounded by socioeconomic 
status. For example, a higher IPV prevalence in a particular ethnic group may be 
related to the group‟s lower socioeconomic status. This would potentially increase the 
PPV of index questions in this ethnic group which could actually be due to a 
difference in socioeconomic status rather than an ethnic difference per se. 
 
The British Medical Journal[165] and the Journal of the American Medical 
Association[137] guidance on the use of ethnicity in health research both include that 
ethnicity may be confounded by socioeconomic status. The need to adjust either for 
social class or socioeconomic status has been depicted as “a necessary first step” in 
investigating ethnic differences.[170] Yet socioeconomic
 
status as a confounder is 
often neglected in comparisons between ethnic groups[153] reflecting inadequate 
analysis. 
 
 
1.4.4. Five criteria to assess the use of ethnicity data by papers 
 
I used published guidance on the use of ethnicity in health research from the British 
Medical Journal,[165, 166] the Journal of the American Medical Association[137] 
and more specific guidance related to IPV[148] to generate five criteria which 
indicate how effectively papers handle ethnicity data. This is one way of appraising 
the quality of a paper. My five criteria encompass what I believe is the minimum that 
investigators should address if they have chosen to collect ethnicity data in their 
research. I produced the five criteria by examining the common themes arising from 
this published guidance whilst endeavouring to isolate the most important issues. See 
Box 1, on page 85, for my five criteria. 
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Box 1:  
Five criterion checklist (DECSS) for quality appraisal of the use of ethnicity data 
 
 
These five criteria take into account the rationale for collecting ethnicity data (see 
section 1.4.2.) whilst trying to minimise the dangers of collecting ethnicity data (see 
section 1.4.3.). Consequently these criteria scrutinise what and how ethnicity terms 
are used in papers. The importance of justifying the classification used (for example 
by having an underlying hypothesis) and self-assignment is emphasised. If ethnic 
differences are being investigated, the need to consider socioeconomic status as a 
potential confounding factor is highlighted. For further details about these criteria see 
Method, section 2.2.5. 
 
Having described the background to the meaning of ethnicity, I now consider IPV 
research that has used ethnicity data. This is followed by a description of the clinical 
problem which I address with my research questions. My principal research question 
and a related second research question are presented, followed by my study aims and 
a thesis outline. 
 
1. D: Is ethnicity described? 
2. E: What are the terms used to describe ethnicity? 
3. C: Is the classification system using ethnicity justified? 
4. S: Is ethnicity self-assigned? 
5. S: If the study analyses differences in ethnic groups are socio-      
economic factors considered or controlled for? 
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1.5. IPV Research and Ethnicity 
 
IPV prevalence studies from around the world show that IPV is common in many 
different ethnic groups.[6, 8, 123, 171-176] Studies from the US and UK have made 
within-study ethnic comparisons. These generally have not found differences between 
ethnic groups with respect to IPV prevalence, pattern or severity in abused 
women.[171, 172, 174, 175, 177] Exceptions to this include two large studies, (one 
with a study population of 16,000) which found apparent ethnic differences in IPV 
prevalence in the US.[1, 178] On analysis these ethnic differences were accounted for 
by lower income[1] and lower education levels.[178] Other studies which have 
showed ethnic differences in IPV in the US have not analysed or discussed this 
variation any further.[167, 179] Campbell and colleagues[167] using a case control 
study showed that the percentage of IPV cases that were African-American was 
greater than white. Dearwater and colleagues[179] using logistic regression analysis 
showed that African-American ethnicity was an independent risk factor for lifetime 
emotional or physical abuse. 
 
Factors which have been suggested as accounting for variation in IPV within the same 
ethnic group are lower income in black women,[180] perceived racial discrimination 
in black women in New York[181] and immigrant related factors (social isolation, 
lack of awareness about IPV services, immigration policies preventing women on 
spousal visas from working and emotional abuse from in-laws) in south Asian female 
immigrants in Greater Boston.[182-184] The effects of acculturation (generational 
status reflected by country of birth and language) were not consistent in either the 
same or different ethnic groups.[173, 182, 185-188] 
 
The large multi-country WHO study was powerful and found globally that there were 
wide differences in prevalence of IPV, patterns of IPV and attitudes towards IPV both 
between and within countries. This landmark study directly measured the extent of 
IPV experienced by 24,000 women, from 15 sites in 10 countries. It used cross-
sectional population-based household surveys which allowed comparison and analysis 
across different settings, ensuring that variations mostly signified real differences – 
unlike earlier work.[6] The countries studied included Bangladesh (with urban and 
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rural study sites), three African nations and Serbia – all of which have migration to 
urban first world countries. There was awareness that when IPV is measured in these 
very different cultures that disclosure would always be affected by cultural beliefs and 
biases. The standardised methodology, measuring IPV cross-culturally and using 
conservative definitions of violence helped to ensure that real differences were 
measured. 
 
The WHO study found that the prevalence of lifetime physical violence and sexual 
violence by an intimate partner among ever-partnered women varied from 15% in 
Japan to 71% in Ethiopia. This wide variation existed not only from country to 
country but also between urban and rural provincial settings within countries. For 
example the percentage of women affected from rural Bangladesh was 62% versus 
54% from urban Bangladesh. In most settings, sexual IPV was less frequent than 
physical IPV except in provincial Bangladesh, Ethiopia and urban Thailand where it 
was more frequent. The differences between settings were not accounted for by 
socioeconomic factors alone though age, marital status and education level did cause 
some variation in IPV prevalence. 
 
The wide contrasts seen in women‟s attitudes towards IPV suggested that there were 
cultural differences between the study populations sampled. These were most marked 
between the urban, industrialized settings and the rural, traditional ones. In rural 
Bangladesh 80% of women agreed that wife beating was justified for certain reasons; 
with ~15% believing that a woman did not have the right to refuse to have sex with 
her partner under any circumstances, even if he mistreated her. Women in poorer 
countries were more likely to think that violence was justified, with the highest rates 
being in more rural traditional communities where the problem remained largely 
hidden. Half of the women surveyed had never spoken of their situation to anyone. 
Some said they did not report the violence because they considered it normal. Some 
even said their husbands were justified in beating them, illustrating an impact of male 
domination. 
 
Another multi-country study has also demonstrated a wide variation in women‟s 
attitudes towards violence.[189] In India, 70% of women believed that wife beating 
was justified for at least one reason whilst in the Dominican Republic this figure was 
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11%. I think that it is possible that some of the attitudes seen in poorer developing 
countries persist in diaspora populations who have moved to richer industrialised 
nations. This may affect how individuals respond to questions asking them about IPV 
as well as how they define IPV. 
 
Strong beliefs about the importance of male domination along with the woman‟s 
responsibility to keep the family together and the centrality of the family have 
certainly also been expressed by African-American women,[190] Hispanic Mexican-
American women, Anglo-American women,[191] Japanese-American women in the 
US[192] as well as Japanese women in Japan,[193] south Asian women [194] and 
Jewish Israeli women.[195] These beliefs about male domination have been presented 
in all these individual studies bar one as specific cultural beliefs exclusive to that 
particular ethnic group. I think that this is an example of the “cultural deviant 
perspective” in which there is an overemphasis on the role of cultural values in 
propagating IPV in different ethnic groups.[196] Others have also pointed out that 
culture should not be held to account for all the variation seen in patients.[152] 
Almost universal states of male domination and family centrality should not be 
attributed only to certain cultures. 
 
I think that these studies collectively support the universality of the gender power 
imbalance rather than gender power imbalance being a cultural belief exclusive to a 
group as suggested by the authors of many of these individual papers. Recalling the 
universality of the imbalance in gender power helps to guard against cross-cultural 
hypocrisy over gender practices.[197] It is important that gender based violence in 
majority communities is not hidden away[128] whilst being exposed in minority 
groups. 
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1.5.1.  Research questions 
 
The authors of the two studies examining Japanese-American women and south Asian 
women in Boston, proposed that there were ethnic differences in attitudes towards 
IPV.[183, 188] Similarly Torres and colleagues[191] showed that despite there being 
no significant difference in the severity or frequency of wife abuse between Mexican-
American and Anglo-American women that there were differences in what was 
perceived to be abusive and the likelihood of reporting abuse. Anglo-Americans were 
more likely to label specific behaviours (for example being punched, slapped or 
pushed) as abuse than Mexican-American women. Or put another way Mexican-
American women if asked whether they were being abused were less likely to say yes 
even if they were experiencing some of the above actions from their partner. This 
clearly shows that the precise wording of questions trying to identify IPV in different 
ethnic groups in a health setting could have a drastic effect on the identification rate of 
IPV. Close attention needs to be paid to the content validation of questions trying to 
identify IPV in health care settings. So in this example, it would be better to ask these 
women about specific behaviours or impacts of IPV rather than asking “Have you 
been abused?” 
 
There is a large volume of literature describing questions that can be used to identify 
IPV in both clinical and research settings. Whether any studies address how questions 
trying to identify IPV function in individual ethnic groups is unclear. Ethnic 
differences in the ability of questions to identify IPV are alluded to in the literature 
but it is uncertain whether this has been methodically investigated. Hence it has been 
reported that the utility of validated tools to detect abuse in diverse populations is 
unknown,[198] with self report surveys mostly validated among white 
populations.[196] Sorenson concurs that survey instruments for IPV which have been 
developed and used with “Anglos” have then been directly used in other ethnic groups 
[199] without assessing whether it is valid to do so. Therefore the clinical problem for 
health care professionals and researchers of IPV is are the questions that they use to 
identify IPV valid in women from different ethnic groups. I address this problem with 
my two research questions. 
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My principal research question is: 
 What is the evidence for the validity of questions trying to identify IPV in 
specific ethnic groups? 
Related to this is my second research question: 
 Does the evidence for the validity of questions trying to identify IPV vary 
between different ethnic groups? 
 
 
1.5.2.  Aims and objectives 
 
Intimate partner violence (IPV), including physical, sexual and emotional violence, 
causes short and long term ill-health.[15] Brief questions that can identify women 
from different populations experiencing IPV who present in clinical settings are a pre-
requisite for an appropriate response from health services to this substantial public 
health problem.[200] 
 
My principle research aim is to examine the evidence for the validity of questions 
trying to identify IPV in different ethnic groups. My second aim is to determine 
whether these questions‟ validity varies between ethnic groups. 
 
My research objectives are to firstly systematically search the literature for index 
questions for the identification of IPV in different ethnic groups and assess their 
evidence of validity. My second objective is to analyse the data from a cross-sectional 
survey of four questions (HARK) identifying IPV in a primary care study 
population.[200] This is to generate diagnostic indices for identifying IPV in three 
ethnic groups for the four HARK questions; and then to generate diagnostic indices 
for the dimensions of IPV (physical and emotional abuse) in three ethnic groups for 
individual HARK questions. 
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1.5.3.  Outline of the thesis 
 
Chapter 1 has presented the case for IPV being a priority that should be addressed by 
primary care. This background chapter has also covered the central theoretical 
concepts that underpin my thesis. These include the background to measuring validity 
and the meaning of ethnicity. There has been consideration about the different 
methods to measure the validity of questions trying to identify IPV. There has also 
been reflection on the rationale as well as the dangers of collecting ethnicity data in 
health research. IPV research that has used ethnicity data has been presented. This 
subsequently has led to the articulation of my principal research question and my 
related secondary research question. 
 
Chapter 2 describes the methods used to answer my two research questions. This 
includes the systematic review used to identify relevant research papers as well as my 
secondary analysis of data generated by a cross sectional survey. 
 
Chapter 3 presents the results of the systematic review and my secondary data  
analysis. The systematic review‟s results are presented in a series of tables with 
accompanying narrative results. The quality of the methodology is appraised using 
QUADAS, a 14 item tool for Quality Assessment of Diagnostic Accuracy Studies. 
The quality of the use of ethnicity data is appraised using five criteria generated from 
existing published guidance. The narrative account complements the tabulated results 
by justifying decisions made about the QUADAS criteria and containing further 
information on how ethnicity data were used by primary studies. The results of my 
secondary data analysis are presented predominantly in tables with complementary 
receiver operator characteristic curves and a brief commentary. 
 
Chapter 4 first summarises the answers to my research questions and then considers 
why these results are important by considering them in the context of other reviews 
and clinical practice. Following this there is evaluation of the quality appraisal of my 
methodology and the quality appraisal of how ethnicity data is used in the systematic 
review studies and my secondary data analysis. The limitations of QUADAS as a 
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quality appraisal tool are discussed. The overall strengths and limitations of my thesis 
are examined. 
 
Chapter 5 presents my conclusions, followed by recommendations for future research 
in this field. 
 
Thus in this background chapter, I have justified the case for IPV to be a priority in 
primary care, considered how to measure validity, reflected on the meaning of 
ethnicity and presented my research questions, aims, objectives and thesis outline. In 
my next chapter I will describe the methods used in my research. 
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Chapter 2: Methods 
 
 
2.1.  Overview 
 
I used a systematic review and a cross sectional survey to evaluate the items used in 
tools to identify IPV in specific ethnic groups in order to answer my principal 
research question and my related secondary research question: 
 What is the evidence for the validity of questions trying to identify IPV in 
specific ethnic groups? 
 Does the evidence for the validity of questions trying to identify IPV vary 
between different ethnic groups? 
 
Both of these research questions were addressed using both of the methods – the 
systematic review and my secondary data analysis of the cross sectional survey. The 
cross-sectional survey originally estimated the diagnostic accuracy of HARK (four 
questions trying to identify IPV) in a study population of varied ethnicity.[200] 
 
In this chapter I describe both of these two methods. The use of two different 
approaches to answer the same two research questions is a deliberate strategy that I 
have employed to try to improve the quality of the answers generated. The research 
answers will be more robust if they embody converging results from independent 
methods. Using more than one method is thought to lead to a greater understanding of 
a subject than if a single method is used whilst “challenging conventional 
thinking…offering multidimensional insights.”[201] 
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2.2.  Systematic review 
 
The aim of the systematic review was to find, evaluate and synthesise research 
looking at questions used to identify IPV and to consider this research‟s relevance to 
identifying IPV in different ethnic groups. 
 
There have been many studies validating questions to identify IPV which often collect 
ethnicity data. It is uncertain whether ethnic differences in the ability of questions to 
identify IPV have been examined. Systematically reviewing these research papers 
may help to establish whether evidence of validity exists for questions trying to 
identify IPV in specific ethnic groups, the quality of this validity evidence and 
whether this evidence varies between different ethnic groups. 
 
 
2.2.1.  Data sources and search strategy 
 
I searched nine electronic databases for relevant papers which tried to assess the 
validity of questions to identify IPV. The electronic databases were all searched from 
their individual respective start dates until 31
st
 of December 2007. 
 
The nine electronic databases: Cochrane Collaboration central register 
(CENTRAL/CCTR), Medline, Cumulative Index to Nursing and Allied Health 
Literature (CINAHL), British Nursing Index (BNID), Embase, National Research 
Register (NRR), Health Management Information Consortium (HMIC), Midwives 
Information and Resource Service (MIDIRS), NHS Economic Evaluation and 
Database of Abstracts of Reviews for Effectiveness (DARE). 
 
I found eligible studies using pre-defined search strategies which had previously been 
used in a related systematic review.[7] These predefined search strategies used a 
mixture of content terms and test types. See Appendix C for search strings. Primary 
studies describing validation of questions trying to identify IPV were sought. 
Backward and forward citation tracking were used and examination of papers in 
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references of included papers to identify further studies. The first or corresponding 
authors of included papers were contacted to try to identify further relevant studies. 
The authors of the four papers which were found in the last updated search covering 
the period from December 2006 to December 2007 were not contacted due to time 
limitations apparent at that stage. International researchers of IPV were contacted 
using partner violence organisations and research networks in the UK, Europe, US 
and Australia in order to identify relevant papers. There was no hand searching of 
journals. 
 
 
2.2.2. Study selection 
 
The inclusion criteria were: 
 The study participants had to be aged over 15 years. 
 The study design had to include validation of the items in the IPV 
identification tool, compared to another tool. 
 The comparator tool was either a standard reference criterion or other test 
intended to measure a construct which was similar or related to IPV. There 
was no limit on the number of questions that the comparator tool contained. 
 The index IPV tool being evaluated had to contain less then eleven questions 
and so be short enough to be potentially used in routine ten minute primary 
care consultations as part of the clinical history taken by clinicians. 
 The outcome measures needed to include either indices of diagnostic accuracy 
(i.e. sensitivity, specificity, PPV, NPV, LR, PTO or ROC curves) or 
correlation coefficients (representing the relationship between index questions 
and comparator tools) or reliability measures of the index questions. 
 The study setting could be in or outside a health care setting. There were no 
restrictions on the geographical or national setting. 
 Studies published in peer-reviewed journals or in published books. 
 
The exclusion criteria were: 
 Studies in which the sole participants were male survivors of partner abuse of 
any age. 
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 Studies which involved the survivors of abuse committed by other family 
members (such as in-laws), studies reporting joint treatments, such as couple 
or family therapy (even if the therapy was administered separately to women) 
and community or societal interventions conducted with the aim of increasing 
public awareness of the problem of partner abuse. 
 Papers published in non-European languages. 
 Studies that used non standardised interviews as a comparator with no known 
sensitivity, specificity or reliability at identifying IPV. 
 
 
2.2.3.  Data extraction 
 
All the eligible papers were read with relevant data recorded on to electronic data 
collection forms, (see Appendix D). Summary data were entered into summary tables 
(see Results, tables 1 to 6, pages 110 to 133). 
 
 
2.2.4.  Analysis of primary data extracted 
 
For each set of index IPV questions being evaluated, evidence of validity was 
collected including any diagnostic accuracy indices, correlation coefficients and 
reliability measures. I also examined the validity evidence based on response 
processes of the index questions and the content validation of the index questions. 
This was followed by synthesis and interpretation of the data collected. 
 
I considered combining the results from studies about the same index questions in 
specific ethnic groups by pooling data if primary studies contained the same outcome 
measures for the same index questions. However this was not possible as primary 
studies did not contain the same index questions for specific ethnic groups with the 
same outcome measures. 
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2.2.5.  Quality appraisal 
 
The quality of studies was appraised using the 14-item Quality Assessment of 
Diagnostic Accuracy Studies (QUADAS) [202-204] and by assessing the 
appropriateness of authors‟ use of ethnicity data, using published guidance on the use 
of ethnicity in health research.[137, 148, 165, 166] 
 
The QUADAS tool has been specifically devised to be used in systematic reviews to 
assess the quality of primary studies of diagnostic accuracy.[204] Hence it was 
thought to be appropriate to use to appraise the studies in this systematic review of 
questions identifying IPV in specific ethnic groups. I was unable to find any published 
tools to assess the quality of studies which used the validation paradigm. The 
validation paradigm presumes that there is no existing gold standard which can 
identify IPV (see section 1.3.3.). 
 
QUADAS rates studies for bias (8 items), variability (1 item), and reporting (5 items). 
This includes examining patient spectrum, selection criteria, reference standard, 
partial verification, differential verification, incorporation, test execution, blind 
analysis, interpretation, indeterminate results and study withdrawals. See table 5 for 
the complete QUADAS criteria. The QUADAS outputs are descriptive results relating 
to the potential sources of bias. There is no scoring system and no generation of a 
single score.[205] I used QUADAS to assess within-study bias, looking at the level of 
methodological quality of each primary study. 
 
How studies used ethnicity data (i.e. what ethnicity terms were used, how these 
ethnicity terms were used and whether confounding was considered) was assessed by 
applying criteria which I devised but which originated from published guidance on the 
use of ethnicity in health research.[137, 165, 166, Malley-Morrison, 2007 #440] See 
section 1.4.4. My criteria are listed on page 98. 
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Five criterion checklist (DECSS) for quality appraisal of the use of ethnicity data 
 
The first two criteria try to achieve clarity on whether ethnicity is described and how 
it is described. They are checking whether papers are being clear about the arbitrary 
nature of ethnicity classification. The third criterion on justifying the classification 
system used (for example by having an underlying hypothesis) is to assess whether 
researchers have been clear about why ethnicity data has been collected. If ethnicity is 
thought to be an important factor, there should be explanation about why this is the 
case. Alternatively the justification for the ethnicity classification system used may be 
to assess whether the study population is representative of the actual population. The 
fourth criterion highlights the importance of self-assignment in order for ethnic 
classifications to have any validity. The final criterion is to ensure that if ethnic 
differences are considered that there is adequate basic analysis of ethnicity data. 
Studies that characterise the ethnicity of participants but not their socioeconomic 
status are at risk of confounding ethnicity with socioeconomic status. 
 
 
 
 
 
 
 
 
 
 
 
1. D: Is ethnicity described? 
2. E: What are the terms used to describe ethnicity? 
3.   C: Is the classification system using ethnicity justified? 
4. S: Is ethnicity self-assigned? 
5. S: If the study analyses differences in ethnic groups are socio-      
economic factors considered or controlled for? 
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2.3.  Secondary data analysis 
 
The aim of my secondary data analysis of a cross-sectional survey was to investigate 
how four questions used to identify IPV (HARK), performed in different ethnic 
groups. The cross sectional survey sampled women waiting to be seen by a doctor or 
nurse, sitting in general practice waiting rooms. This survey‟s original study aim was 
to validate the use of HARK in primary care. Ethnicity data was collected to see if the 
study population was representative of the local population.[200] For a copy of this 
published paper, see Appendix B. The potential value of pre-existing data has been 
recognised.[206] My exploratory secondary data analysis of the HARK study allows 
the diagnostic accuracy of the four HARK questions to be directly calculated in 
specific ethnic groups and then compared to see if there are any differences which 
could potentially be clinically important, for example if a particular question did not 
identify IPV in a specific ethnic group. 
 
Hence my secondary data analysis investigated: 
 the four HARK questions‟ ability to identify IPV in the different ethnic groups 
and whether this varied in the different ethnic groups 
 the individual HARK questions‟ ability to identify IPV in the different ethnic 
groups and whether this varied in the different ethnic groups 
 the individual HARK questions‟ ability to identify specific dimensions of IPV 
(emotional IPV and physical IPV as defined by the CAS) in the different 
ethnic groups and whether this varied in the different ethnic groups 
 
The HARK study data were collected from May 2003 to October 2003. The HARK 
study population was sampled from all women sitting in selected GP waiting rooms 
over this time period. The fifty-one general practices in Newham, a multi-ethnic inner 
city area of London, were stratified according to the number of doctors and the 
proportion of south Asian names on the practice register.[207] Equal numbers of 
practices were selected from each stratification group using a randomisation 
procedure within a statistical software package for social sciences (SPSS version 12). 
This was in an attempt to ensure that the practice population reflected the local area 
population. 
 100 
Out of all the women sitting in the GP waiting rooms, seven hundred and thirty seven 
women did not meet the inclusion criteria. Fourteen women were not approached 
because there were too many women in the waiting room for all the women to be 
approached. Two hundred and three women said that they would participate in the 
study but then did not come back following their clinical consultation. One hundred 
and eighty six women declined participation in the waiting room, only knowing that 
the survey was about women‟s health. Eleven women declined consent in the private 
room, knowing that the study was about IPV. In total 232 women agreed to participate 
and completed the survey. The response rate of 54% (232 / (232 + 186 + 11) was 
adjusted for the women who did not come back following their clinical consultations 
(see figure 6, page 101). The unadjusted response rate was 36%. This included in the 
denominator the women who were not approached and women who said that they 
would participate in the study but then did not come back following their clinical 
consultation. 
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Potentially 
eligible women 
1,383 
HARK completed 
232 
Abnormal result, 
HARK≥1 = 51 
Normal result, 
HARK<1 = 181 
n= 
Reference standard (CAS) completed 
51 
Reference standard (CAS) completed 
181 
IPV present 
41 
IPV present 
9 
IPV absent 
172 
IPV absent 
10 
Too busy to be 
approached 14 
Did not come back 
203 
Declined participation 
in waiting room 186 
Consent declined 
in private room 11 
Inclusion criteria 
not met 737 
Figure 6: Flow diagram of recruitment of participants to the study 
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The 232 women included in the current analyses were more than 17 years old and in 
the last year had been in an intimate relationship. The research protocol for the study 
was approved by The East London and City ethics committee. Further details of the 
method for this cross sectional survey, including the data collection and the data 
analysis are described elsewhere.[200] This published paper is reprinted in Appendix 
B. It should be noted that more in depth coverage of how the HARK questions were 
developed (for example details of the pilot study) are contained in my MSc thesis.[95] 
These details have been deliberately omitted from my current work, avoiding 
repetition. 
 
 
2.3.1.  Sample size 
 
The HARK study was originally powered so that the sample size used demonstrated 
an acceptable level of sensitivity for the four HARK questions.[200] This further 
secondary exploratory analysis was underpowered to detect statistically significant 
ethnic differences in the diagnostic accuracy of HARK. I amalgamated data into 
larger groups in an attempt to increase the power to make comparisons between 
groups. Black British, African and Caribbean were combined to form an African-
Caribbean group. Indian, Pakistani, Bangladeshi and Sri Lankan data were combined 
to form a south Asian group. White British, white Irish and white other were 
combined to form a white group. My logic underlying these ethnic groupings was that 
women within each amalgamated group (African-Caribbean, south Asian and white) 
may share cultural beliefs (about gender roles, expectations about family roles, what 
is considered to be abusive, willingness to disclose abuse and reasons for disclosing 
abuse – see Background, section 1.4.1.3.) affecting how they respond to questions 
asking about IPV. 
 
A power calculation showed that with the sample sizes of my three amalgamated 
groups my analysis had a 80% power to detect a 17% difference in PPV between the 
African-Caribbean and white groups (79% to 96%); and a 80% power to detect a 19% 
difference in PPV between the south Asian and white groups (79% to 98%). 
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My use of 95% confidence intervals allows the level of precision of the results to be 
defined. Inspecting the limits of the 95% confidence limits of my results enables the 
planning of a future larger authoritative study into the ethnic differences in the 
validity of questions identifying IPV. 
 
 
2.3.2.  Analysis 
 
My secondary data analysis examined the combined four HARK questions‟ ability as 
well as the individual HARK questions‟ ability to identify IPV and its dimensions, in 
the different ethnic groups and then whether this varied in the different ethnic groups. 
Statistical analyses of my data, including generating ROC curves, were conducted 
using STATA, a statistical software package. 
 
 
2.3.2.1.  HARK’s ability to identify IPV in different ethnic groups 
 
The rate of current IPV with 95% confidence intervals, within the last twelve months 
was calculated for the CAS (using the cut off score of ≥ 3) within the three main 
aggregated ethnic groups: i. African-Caribbean (black British, African or Caribbean) 
ii. south Asian (Indian, Pakistani, Bangladeshi or Sri Lankan) and iii. white (white 
British, white Irish or white other). For each of these three main ethnic groups, the 
rates of IPV within the last twelve months were also calculated with 95% confidence 
intervals for the HARK, at different cut off scores (for example, HARK cut off score 
≥ 2, means a HARK score of either 2, 3 or 4).  
 
Each woman was identified as being positive or negative for IPV for each HARK cut 
off score and for the CAS cut off score of ≥3. I then calculated within each ethnic 
group HARK‟s sensitivity, specificity, PPV, NPV, LR (all with 95% confidence 
intervals) and post-test odds (= pre-test odds x LR) at different HARK cut off 
scores.[91] The change from the pre- to post-test probability of IPV that occurred 
using different HARK cut off scores was then calculated. 
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For each ethnic group, a ROC curve was constructed by plotting the sensitivity of 
each different HARK cut off against the false positive rate (= 100 – specificity) at the 
different HARK cut offs. This was used to determine an optimal cut off HARK score 
and the instrument‟s overall sensitivity and specificity in each ethnic group. In each 
ethnic group at the optimal HARK score, the estimates for each of the diagnostic 
indices and their corresponding 95% confidence intervals were inspected to check 
whether any were not overlapping, representing statistically significant differences. 
 
 
2.3.2.2.  Each individual HARK question’s ability to identify IPV 
in different ethnic groups 
 
For each of the three main ethnic groups, each woman was identified as being positive 
or negative for IPV, according to whether each individual HARK question was 
positive or negative, as well as for the CAS cut off score of ≥3. 
 
I then calculated within each ethnic group each individual HARK question‟s 
sensitivity, specificity, PPV, NPV, LR (all with 95% confidence intervals) and post-
test odds (= pre-test odds x LR) for identifying IPV. The difference between the pre-
test probability and the post-test probability of IPV was also calculated. This allowed 
us to examine for example, whether being humiliated (“H”) was more predictive of 
IPV in the African-Caribbean group as opposed to the south Asian group. For each 
individual HARK question, the estimates for the diagnostic indices and their 
corresponding 95% confidence intervals were inspected to check whether any were 
not overlapping, representing statistically significant differences. 
 
 
2.3.2.3.  Each individual HARK question’s ability to identify 
dimensions of IPV (emotional and physical IPV) in 
different ethnic groups 
 
Furthermore, for each of the three main ethnic groups, each woman was identified as 
being positive or negative for emotional IPV (according to whether emotional IPV 
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was present, as defined by whether the score for the CAS emotional abuse score was 
≥ 3) and physical IPV (as defined by whether the score for the CAS physical abuse 
score was ≥ 1). 
 
 
I then calculated within each ethnic group each individual HARK question‟s 
sensitivity, specificity, PPV, NPV, LR (with 95% confidence intervals) and post-test 
odds (= pre-test odds x LR) for identifying emotional and physical IPV, two 
dimensions of IPV. Additionally the difference between the pre-test probabilities and 
the post-test probabilities of emotional and physical IPV when identified by individual 
HARK questions were calculated. This allowed us to examine for example, whether 
being humiliated (“H”) or being afraid (“A”) was more predictive of emotional IPV in 
the African-Caribbean group as opposed to the south Asian group. For each individual 
HARK question used to identify either emotional or physical IPV, the estimates for 
the diagnostic indices and their corresponding 95% confidence intervals were 
inspected to check whether any were not overlapping, representing statistically 
significant differences. 
 
Having described the methods used in my research, in the next chapter I will present 
my results. 
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Chapter 3: Results 
 
 
3.1. Overview 
 
This results chapter will present the results of the systematic review followed by the 
results of my secondary data analysis of a cross-sectional survey. The cross-sectional 
survey used four questions (HARK) to identify IPV in a primary care sample of 
women. The systematic review‟s results have been presented in a series of tables with 
an accompanying narration. The secondary data analysis results are presented in 
tables of diagnostic indices with 95% confidence intervals and figures of receiver 
operator characteristic curves with a brief commentary. 
 
Both the results of the systematic review and the secondary data analysis are 
organised in order to try to answer my principal research question (what is the 
evidence for the validity of questions trying to identify IPV in specific ethnic groups?) 
and my related secondary research question (does the evidence for the validity of 
questions trying to identify IPV vary between different ethnic groups?). 
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3.2.  Systematic review results 
 
The chief findings of the systematic review are presented in a series of tables with 
accompanying narrative results. Table 1 shows a summary of the results of the twenty 
studies in the systematic review. Table 2 contains further details about the 
characteristics of each study (for example study design and study population 
description). Table 3 shows the correlation measures used for criterion correlation 
validity and convergent validity with their interpretation by papers. Table 4 shows the 
correlation measures used for internal consistency reliability with their interpretation 
by papers. Table 5 summarises the QUADAS quality items for each study. Table 6 
summarises the criteria assessing the use of ethnicity data for each study. Following 
these tables, the narrative results include a brief overview for each study. The 
narrative results provide material which is additional to the tabular results. Thus there 
is explanation about the rationale for potentially contentious judgements made with 
respect to the QUADAS criteria (see table 5) and information, in addition to table 6, 
about how ethnicity data was used by studies. The tables should be read alongside the 
narrative results. To accommodate this, the overall summary of the results shown in 
table 1 is presented in a laminated version and placed in the front sleeve of this thesis 
so that it can be easily referred to when reading the narrative results. 
 
This systematic review identified 20 validation studies reported in 20 papers assessing 
17 sets of questions trying to identify IPV.[198, 200, 208-225] These sets contained a 
total of 76 questions trying to identify IPV. These studies involved validation in 
11,648 participants. The publication dates ranged from 1992 to 2007. A flow diagram 
showing the numbers of studies retrieved at each stage of the systematic review is 
shown in figure 7, on page 109. In total 147 full papers were read. 127 studies were 
excluded after applying the exclusion criteria. 20 studies were included which 
fulfilled the inclusion criteria. 
 
Out of the 20 studies, 11 studies explicitly used the classical diagnostic accuracy 
paradigm, generating diagnostic accuracy data.[198, 200, 208-216] Five of these 
studies contained only diagnostic accuracy data.[200, 208-211] Eight studies used 
methods from the validation paradigm as well as the diagnostic accuracy 
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method.[198, 212-218] Two of these studies reported the figures which allowed the 
computation of diagnostic accuracy results.[217, 218] 
 
Out of the 20 studies, 14 studies used the validation paradigm, including the eight 
above that also contained diagnostic accuracy data.[198, 212-224] Eight studies out of 
the 20 contained eleven estimates of internal consistency reliability for eight sets of 
questions trying to identify IPV.[198, 214-216, 219-222] Six studies focussed solely 
on the validation paradigm.[219-224] Four of them used a variety of methods, 
including convergent validity, known group comparisons and internal consistency 
reliability.[219-222] Two used only a convergent validity method.[223, 224] The 
remaining one study used neither of the research paradigms.[225] 
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Table 1: Summary results of 20 studies in systematic review 
 
 
Study Index 
Questions 
Evaluated 
Comparator 
Tool 
Measures of Validity 
Diagnostic accuracy indices Criterion or Convergent 
validity (correlation or 
%) 
Internal  
consistency  
reliability 
Response  
processes  
validity 
Content  
validation Prevalence 
of IPV (%) 
Sen 
(%) 
Spec 
(%) 
PP
V 
(%) 
NPV 
(%) 
LR+ PPV – 
prevalence 
Five diagnostic accuracy studies 
Peralta & 
Fleming 
(2003) 
1 question 
“Do you feel 
safe at 
home?” 
6 question 
Modified 
Conflict 
Tactics Scale 
(6item 
mCTS) 
6 item mCTS 
for any type 
of violence 
(period 90 
days) 44 
9 96 63 57 3 19 Not stated Not stated Good – 
simple 
scoring 
system 
- 
Paranjape, 
Rask, & 
Liebschutz 
(2006) 
3 question 
Slapped, 
Threatened or 
Thrown 
(STaT) 
30 question 
Index of 
Spouse Abuse 
(ISA) 
ISA  
Most recent 
relationship: 
33 
Current IPV 
15 
If STaT ≥ 1 (set criterion for a positive) vs ISA Not stated Not stated Good – 
simple 
scoring 
system 
Decreased – no 
sexual IPV 
question 
95 37 42 94  9 
If STaT ≥ 2 vs ISA 
85 54 48 88  15 
If STaT = 3 vs ISA 
62 66 47 78  14 
Feldhaus, 
Kozioi-
McLain, 
Amsbury, 
Norton, 
Lowenstein 
& Abbott 
(1997) 
3 question 
Partner 
Violence 
screen (PVS) 
30 question 
ISA 
16 questions: 
16 item 
mCTS 
ISA: 
24 
 
16 item 
mCTS: 
27 
PVS vs ISA Not stated Not stated - Decreased – no 
sexual IPV 
question 
65 80 51 88 3 27 
PVS vs 16 item mCTS 
71 84 63 89 5 36 
MacMillan, 
Wathen, 
Jamieson, 
Boyle, 
McNutt, 
Woster, Lent 
& Webb 
(2006) 
3 question 
PVS 
8 question 
Woman 
Abuse 
Screening 
Tool 
(WAST) 
30 question 
Composite 
Abuse Scale 
(CAS) 
CAS ≥ 7: 
10 
PVS vs CAS Not stated Not stated - 
For 
WAST: 
Decreased 
– uses term 
abuse and 
likert type 
scale 
For PVS: 
Decreased – no 
sexual IPV 
question 
 
For WAST: see 
Brown 2000 study 
49 94 47 94  37 
WAST vs CAS 
47 96 55 94  45 
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Sohal, 
Eldridge & 
Feder (2007) 
4 question 
Humiliation, 
Afraid, Rape, 
Kick(HARK) 
30 question 
Composite 
Abuse Scale 
(CAS) 
CAS ≥ 3:  
23 
HARK ≥ 1((optimal cut off, maximising true 
positives whilst minimising false positives) vs CAS 
Not stated Not stated Good, 
simple 
scoring 
system 
Good – discrete 
questions on 
physical, sexual & 
emotional IPV 
81 95 83 94 16 60 
Eight studies using diagnostic accuracy and validation paradigm methods 
Tiwari, Fong, 
Chan, Leung, 
Parker & Ho 
(2007) 
3 individual 
questions 
derived from 
the Chinese 
Abuse 
Assessment 
Screen 
(AAS) 
3 subscales of 
physical, 
emotional & 
sexual IPV of  
39 question 
revised  
Chinese CTS 
(CTS2) 
CTS2 for: 
Physical 
IPV: 12 
Emotional 
IPV: 57 
Sexual IPV: 
9 
For physical IPV: 1 question AAS vs CTS2 
physical violence subscale 
Kappa, 1 question AASs 
vs CTS2 subscales: 
Physical IPV 0.56 
Emotional IPV 0.52 
Sexual IPV 0.47 
Not stated  Verified by IPV 
researchers - 3 
nurses, 2 drs, 1 
clinical 
psychologist & 1 
social worker 
45 99 87 93 51 75 
For emotional IPV: 1 question AAS vs CTS2 
emotional aggression subscale 
66 89 89 66 6 32 
For sexual IPV: 1 question AAS vs CTS2 sexual 
coercion subscale 
36 99 80 94 43 71 
Reichenheim 
& Moraes 
(2003) 
1 question: 
Portuguese 
AAS‟s 
anchor 
question on 
physical IPV 
during 
pregnancy 
12 question 
physical 
violence scale 
of modified 
revised 
Portuguese 
CTS2 (12 
item mCTS2) 
12 item 
mCTS2 for  
Minor 
physical IPV 
18%  
Major 
physical IPV 
8% 
Overall – 
19%  
For minor physical IPV: 1 question AAS vs 5 items 
mCTS2 
Point biserial correlation, 
1 question AAS vs 12 
item mCTS2: 0.68 
Not stated  Decreased – single 
question does not 
consider sexual or 
emotional IPV 
32 99 88 13 32 70 
For severe physical IPV: 1 question AAS vs 7 
items mCTS2 
61 98 70 0 28 62 
For both minor & severe physical IPV: 1 question 
AAS vs 12 items mCTS2 
32 99 90 14 40 71 
Ernst, Weiss, 
Cham, Hall 
& Nick 
(2004) 
4 question 
Ongoing 
Violence 
Assessment 
Tool (OVAT) 
30 question 
Index of 
Spouse Abuse 
(ISA) 
ISA: 20% OVAT vs ISA Kappa,  
OVAT vs ISA: 
0.58 
Cronbach‟s 
alpha 0.6 
Inter-item 
correlation 
0.38 
Decreased 
– uses a 
Likert 
scale for 1 
question 
Decreased – does 
not explicitly 
consider sexual 
IPV 
86 83 56 96 5 36 
Chen, Rovi, 
Vega, Jacobs 
& Johnson 
(2005) 
4 question 
English HITS 
(E.HITS) 
4 question 
Spanish 
HITS 
(S.HITS) 
11 question 
ISA- Physical 
(ISA-P), 
8 question 
WAST; 
English & 
Spanish 
forms  
ISA-P: 
5% 
 
WAST: 
10% 
 
English HITS > 10.5 vs English ISA-P E.HITS vs E.ISA-P 0.76 Cronbach‟s 
alpha for: 
E.HITS 0.76 
S.HITS 0.61 
Decreased 
– uses a 
Likert 
scale 
Decreased -  does 
not explicitly 
consider sexual 
IPV 
86 99 86 99 91 ~81 E.HITS vs E.WAST 0.75 
Spanish HITS > 5.5 vs Spanish WAST S.HITS vs S.ISA-P 0.81 
100 86 45 100 7 ~35 S.HITS vs S.WAST 0.78 
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Sherin, 
Sinacore, Li, 
Zitter & 
Shakil (1998) 
4 question 
English HITS 
15 question 
modified CTS 
(15 item 
mCTS)  
 Phase 2, in known group comparison: 
HITS > 10.5* vs 15 item mCTS 
Phase 1: 
HITS vs 15 item mCTS 
0.85 
Phase 1: 
Cronbach‟s 
alpha 0.80 
Decreased 
– as above 
Decreased – as 
above** 
96 91 87 97 - - 
Zink, Levin, 
Putnam & 
Beckstrom 
(2007) 
5 non-graphic 
questions 
39 question 
revised CTS 
(CTS2) 
CTS2: 11% Question 1. (“how do you and your partner work 
out arguments”) vs CTS2 
Not stated Cronbach‟s 
alpha for the 
5 questions 
0.46 
Decreased 
– uses a 
Likert type 
scale 
Decreased – does 
not explicitly ask 
about physical or 
sexual IPV (as 
non-graphic) 
25 98 58 91  47 
Questions 1. 3. & 4. vs CTS2 
45 95 51 93  40 
Bonomi, 
Thompson, 
Anderson, 
Rivara, Holt, 
Carrell & 
Martin 
(2006) 
5 question 
Behavioural 
Risk factor 
Surveillance 
Survey 
(BRFSS) 
10 question 
Women‟s 
experience 
with battering 
scale (WEB) 
WEB 
(IPV of any 
type, in most 
recent 
relationship): 
7% 
BRFSS vs WEB: BRFSS+/WEB+ 5% Not stated Good, 
simple 
scoring 
system  
Satisfactory – 
items on physical, 
sexual and 
emotional IPV 
BRFSS+/WEB- 9% 
72 90 34 98 7 27 BRFSS-/WEB+ 2% 
BRFSS-/WEB- 83% 
Coker, Pope, 
Smith, 
Sanderson & 
Hussey 
(2001) 
10 question 
Women‟s 
Experience 
with 
Battering 
Scale (WEB) 
15 question 
modified 
Index of 
Spouse 
Abuse- 
Physical (15 
item mISA-P) 
15 item 
mISA-P 11% 
WEB vs 15 item mISA-P: WEB+/mISA-P+ 9% Not stated Decreased 
– uses a 
Likert 
scoring 
method for 
all 10 
questions 
Measures impact 
(disempowerment) 
not specific 
behaviours 
WEB+/mISA-P- 8% 
WEB-/mISA-P+ 1% 
86 91 52 98 10 41 WEB-/mISA-P- 82% 
Pearson correlation  
coefficient, continuous 
WEB vs 15 item mISA-P 
r = 0.67 
Kappa, dichotomised  
WEB vs 15 item mISA-P: 
0.6 
Six studies using validation paradigm methods only 
Brown, Lent, 
Brett, Sas & 
Pederson 
(1996) 
7 question 
WAST 
2 question 
WAST-Short 
Abuse Risk 
Inventory 
(ARI) 
 In known group comparison, significant difference 
between abused and non-abused women on total 
WAST score: 18 vs 9 respectively, p<0.001 
Total 7 question WAST 
score vs total ARI, r=0.96 
 
Individual WAST 
questions vs ARI, 
Spearman correlation 
coefficients, r = 0.80 to 
0.85 
Cronbach‟s 
alpha 0.95 
Corrected 
item total 
correlations, 
r = 0.81 to 
0.89 
Decreased 
– uses a 
likert type 
scale 
Decreased -  does 
not explicitly 
consider sexual 
IPV In known group comparison: WAST-Short ≥ 1 vs 
ARI*** 
92 100     
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Brown, Lent, 
Schmidt & 
Sas (2000) 
8 question 
WAST 
Abuse Risk 
Inventory 
(ARI) 
       Pearson correlation 
coefficient, WAST vs 
ARI: r= 0.69, p=0.01 
Cronbach‟s 
alpha 0.75 
Decreased 
– uses term 
abuse and 
likert type 
scale 
Includes questions 
on physical, sexual 
& emotional IPV 
with impact 
questions 
Brown, 
Schmidt, 
Lent, Sas & 
Lemelin 
(2001) 
8 question 
French 
WAST 
2 question 
French 
WAST-Short 
Abuse Risk 
Inventory 
(ARI) 
Not stated In known group comparison: French WAST-Short 
≥ 1 vs ARI 
Total French WAST 
score vs Total ARI score: 
r=0.96 
 
Individual French WAST 
questions vs ARI, r= 0.75 
to 0.93 
Cronbach‟s 
alpha for 8 
question 
French 
WAST 0.95 
Decreased  
- both use 
likert type 
scale 
 
79 100     
Chen, Rovi, 
Washington, 
Jacobs, 
Vega, Pan & 
Johnson 
(2007) 
2 question 
WAST-Short 
4 question 
HITS 
8 question 
Woman 
Abuse 
Screening 
Tool (WAST) 
       Total English WAST-
Short score vs total 8 
question WAST score, 
0.81, p<0.001 
Total HITS score vs total 
8 question WAST score, 
0.77, p<0.001 
Cronbach‟s 
alpha for: 
WAST-
Short 0.8 
HITS 0.79 
Decreased 
-both use 
likert type 
scale 
Decreased – 
neither explicitly 
consider sexual 
IPV 
Sagrestano, 
Rodriguez, 
Carroll, 
Bieniarz, 
Greenberg, 
Castro & 
Nuwayhid 
(2002) 
2 questions in 
Perinatal 
Self-
Administered 
Inventory 
(PSAI) 
English & 
Spanish 
versions 
CTS subscale 
on verbal 
aggression 
(7items) and 
physical 
violence (9 
items) 
English & 
Spanish 
versions 
In past year: 
according to 
CTS verbal 
aggression 
84%, 
physical 
violence 
17% 
      First PSAI question vs 
verbal aggression 
subscale of CTS, r=0.10 
Second PSAI question vs 
verbal aggression 
subscale of CTS, r=0.03 
Second PSAI question vs 
physical subscale of CTS, 
r=- 0.05 
Not stated Decreased 
– due to 
complexity 
of 2 
questions 
(see text) 
Decreased - do not 
explicitly consider 
sexual IPV 
 
Spanish versions 
of index questions, 
back translation 
used 
McFarlane, 
Parker, 
Soeken, & 
Bullock 
(1992) 
3 question 
AAS 
English & 
Spanish 
versions 
30 question 
ISA 
English & 
Spanish 
versions 
-       Those positively 
identified for IPV on the 
3 question AAS also 
scored significantly 
higher on the ISA (no 
figures presented) 
Not stated  Decreased – no 
question on 
emotional IPV. 
No details on 
validation of 
Spanish versions 
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*: An optimal data analysis computer program established that a cut off score of 10.5 on the HITS reliably differentiated respondents into two 
groups. 
**: Focus group decided HITS should focus on physical & verbal IPV – though titled as a “Domestic violence screening tool.” 
***: WAST-Short ≥1: a score of one was assigned to the most extreme positive responses (e.g. “a lot of tension”) and a score of zero to other 
response options.
One study using method from neither paradigm 
Connelly, 
Newton, 
Landsverk & 
Aarons 
(2000) 
Single 
question in 
hospital 
admission 
protocol 
CTS subscale 
on physical 
violence (9 
items) 
9 item CTS: 
19% 
 
Single 
question: 4%  
      Not stated Not stated  - 
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Table 2: Summary characteristics of 20 studies in systematic review 
 
Study details Study design Number of participants Participants 
Peralta & Fleming (2003)  Index Question: 1 question: “Do you feel safe at home? Eligible: Not stated Age (mean, SD, range): Mean and SD not 
stated; range 18-36 
Comparator Tool: 6 questions Modified Conflict Tactics Scale 
(6 item mCTS) - for physical & / or psychological IPV 
Declining: 12% Ethnicity: White 61%, Black 26%, Other 13% 
Inclusion criteria: All women within the waiting room of the 
urban family practice clinic in Madison, Wisconsin who were 
English-speaking between the age of 18-36 years 
Exclusion criteria: Non-English speakers Recruited: 399 Socio-economic status indicators: 
More than high school education: 81% 
Marital status: 
41% abused women married, 
58% of non-abused women married  
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: USA, urban family practice clinic 
    
Paranjape, Rask, & Liebschutz 
(2006) 
Index Questions: 3 questions: Slapped, Threatened or Thrown Eligible: 324 Age (mean, SD, range): 38, 10, not stated 
Comparator Tool: 30 questions Index of Spouse Abuse (ISA) Declining: 84 Ethnicity: African American 91% 
Inclusion criteria: Women between 18 - 65 years of age, 
English speaking, and seen a medical provider within the centre 
on that day 
Exclusion criteria: Patients who could not be interviewed alone Recruited: 240 Socio-economic status indicators: 
Median monthly income- $800 
Educational level, marital status, housing 
status, employment and insurance status was 
collected according to whether participants 
where positive or negative for IPV. No 
significant difference seen between 2 groups 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: USA, urgent care centre in an inner city hospital which 
provides primary care to an impoverished and mostly uninsured 
population 
    
Feldhaus, Kozioi-McLain, 
Amsbury, Norton, Lowenstein & 
Abbott (1997) 
Index Questions: 3 questions: Partner Violence screen (PVS) Eligible: 426 Age (mean, SD, range): 36, 16, not stated 
Comparator Tool: 30 questions Index of Spouse Abuse (ISA) 
16 questions Modified Conflict Tactics Scale (16 item mCTS) 
Declining: 47, 57 missed 
due to heavy volume of 
patients 
Ethnicity: White 45%, Hispanic 30%, Black 
19%, Other 6% 
Inclusion criteria: Non-critical, English speaking women 
presenting to one of 2 urban ED departments 
Exclusion criteria: Under the age of 18, had an altered mental 
status or primary psychiatric disorder 
Recruited: 322 Socio-economic status indicators: 
Household income <$15,000- 64%  
Educational level and insurance status Sample: Abused and non-abused women 
Type of study: Validation study 
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 Setting: USA, two urban, hospital-based A&E departments   
    
MacMillan, Wathen, Jamieson, 
Boyle, McNutt, Woster, Lent & 
Webb (2006)  
Index Questions: 3 questions: Partner Violence Screen (PVS) 
8 questions: Woman Abuse Screening Tool (WAST) 
Eligible: 2602 Age (mean, SD, range): 37, 12, not stated 
Comparator Tool: 30 question Composite Abuse Scale (CAS) Declining: 141 Ethnicity: Born in Canada- 87% 
Inclusion criteria: All women presenting for an appointment at 
the included sites (EDs, family practices or women‟s health 
clinics), aged 18-64 years, at a site for their own health care 
visit, able to separate themselves from individuals who 
accompanied them, able to speak and read English, were not too 
ill to participate and could provide informed consent. 
Exclusion criteria: Not stated Recruited: 2461  Socio-economic status indicators: 
<$24,000- 18% 
Woman was the main source of income wages 
or salary- 58% 
Educational level, marital status and children 
living at home 
Sample: Abused and non-abused women 
Type of study: Validation study- primary aim was to test 
presentation effects of tools  
Setting: Canada, Ontario. 2x ED, 2x Family practices, 2x 
Women‟s health clinics 
    
Sohal, Eldridge & Feder (2007) 
 
 
 
 
 
 
 
Index Questions: 4 questions: Humiliation, Afraid, Rape, Kick 
(HARK) 
Eligible: 429 Age (mean, SD, range): 35, 11.95, 18 - 70 
Comparator Tool: 30 question Composite Abuse Scale (CAS) Declining: 197 
(14 missed due to heavy 
volume of patients) 
Ethnicity: White British 40%, Black British, 
African or Caribbean 25%, Indian, Pakistani or 
Bangladeshi 18% 
Inclusion criteria: Women aged more than 17 years waiting to 
see a doctor or nurse, who had been in an intimate relationship 
in the last year. 
Exclusion criteria: Women who were accompanied by children 
over four years of age or another adult, too unwell to complete 
the questionnaires, unable to understand English or unable to 
give informed consent.  
Recruited: 232 Socio-economic status indicators: 
51% in paid job, 53% owned house or flat  
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: UK, 12 general practices in a multi-ethnic inner city 
area of London 
    
Tiwari, Fong, Chan, Leung, Parker 
& Ho (2007) 
Index Questions: 3 individual questions derived from the 
Chinese Abuse Assessment Screen (AAS) 
Eligible: 257 Age (mean, SD, range): 36, 8, not stated 
Comparator Tool: 3 subscales of physical, emotional & sexual 
IPV of the 39 question Chinese revised Conflict Tactics Screen 
(CTS2) 
Declining: 0 Ethnicity: 
All Chinese 
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Inclusion criteria: Not stated 
Exclusion criteria: Not stated Recruited: 
100 pregnant women and 
157 non-pregnant women. 
Socio-economic status indicators: 
91% married women 
44% monthly family incomes lower than the 
official median of HK$11,000 (about 
US$1,375) 
35% less than 10 yrs of schooling 
Sample: Abused and non-abused pregnant and non-pregnant 
women 
Type of study: Validation study 
Setting: Hong Kong, antenatal clinic of a public hospital and a 
community centre 
    
Reichenheim & Moraes (2003) Index Questions: 1 question Portuguese Abuse Assessment 
Screen‟s (AAS) anchor question on physical IPV during 
pregnancy  
Eligible: 3800 Age (mean, SD, range): 24, 6, range not stated 
Comparator Tool: 12 question physical violence scale of 
modified revised Portuguese Conflict Tactics Screen (12 item 
mCTS2) 
Declining: 3 Ethnicity: All Brazilian, Portuguese speaking 
Inclusion criteria: Given birth within 24 hours; interviews 
conducted in first 48 hours postpartum. Included all premature 
births within six month period 
Exclusion criteria: Diabetes mellitus, systematic arterial 
hypertension, given birth to neonates with severe congenital 
malformations, infections associated with prematurity, or twins. 
Not in steady relationships involving current or former partners 
Recruited: 748 Socio-economic status indicators: 
Median monthly income per capita of US$97 
(95%CI 26 to 346) 
57% attended less than 8 yrs of school 
75% either married or living with a partner at 
the time 
6 prenatal visits on average 
Sample: Abused and non-abused post-natal women 
Type of study: Validation study 
Setting: Brazil, Rio de Janeiro. Three public sector maternity 
wards  
    
Ernst, Weiss, Cham, Hall & Nick 
(2004) 
Index Questions: 4 question Ongoing Violence Assessment 
Tool (OVAT) 
Eligible: 362 Age (mean, SD, range): 34, 10, range not 
stated 
Comparator Tool: 30 question Index of Spouse Abuse (ISA) Declining: 46 (10 did not 
complete forms) 
Ethnicity: Caucasian 49%, African American 
16%, Hispanic 20%, Asian or other 15%  Inclusion criteria: English speaking patients entering ED 
department  
Exclusion criteria: Under the age of 18, had no current partner, 
had an altered mental state, had an underlying psychiatric 
diagnosis, were too ill to participate or drug or alcohol 
intoxicated 
Recruited: 212 women & 
94 men. 
Socio-economic status indicators: 
41% married, 57% not married, 2% not stated 
66% with children, 33% without children, 1% 
not stated 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: USA, A&E department 
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Chen, Rovi, Vega, Jacobs & 
Johnson (2005) 
Index Questions: 4 questions - Hurts, Insults, Threatens and 
Screams (HITS). English & Spanish versions 
Eligible: 386 Age (mean, SD, range): 36, SD & range not 
stated 
Comparator Tool: 11 question Index of Spouse Abuse- 
Physical dimension (ISA-P)  
8 question Woman Abuse Screening Tool (WAST)  
English & Spanish versions 
Declining: 128 refused,  
56 did not complete 
questionnaire due to long 
waiting period for a private 
room 
Ethnicity: Hispanic 72%, non-Hispanic White 
20%, non-Hispanic Black 6%, non-Hispanic 
Other 1%.  
Country of origin for Hispanics: 
39% Cuban / Cuban American, 35% Puerto 
Rican, 11% Dominican, 5% Mexican / 
Mexican American, 10% other Latin American 
44% completed interviews in Spanish 
Inclusion criteria: Women attending an urban family practice 
site who were 18 years or older and were currently involved in 
an ongoing relationship 
Exclusion criteria: Not stated Recruited: 202  Socio-economic status indicators: 
Total mean income $10,757 
For English speaking $14,142 
For Spanish speaking $6,461 
Significant differences between those who 
carried out the study in English & those in 
Spanish, including between Hispanics. 
No significant differences between Hispanics 
and non-Hispanics 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: USA, urban family practice site 
    
Sherin, Sinacore, Li, Zitter & 
Shakil (1998) 
Index Questions: 4 questions - Hurts, Insults, Threatens and 
Screams (HITS) 
Eligible: Not stated Age (mean, SD, range): Not stated 
Comparator Tool: 15 question modified Conflict Tactics Scale 
(15 item mCTS) – verbal & physical aggression items 
Declining: Not stated Ethnicity: Not stated 
Inclusion criteria: Phase 1- Patients at Family Practice Centre, 
aged 21 or over and lived with the same partner for at least 12 
months. Phase 2 - Self-identified women who had experienced 
IPV, recruited via a crisis shelter or an emergency room 
 
Exclusion criteria: Not stated Recruited: Phase 1: 160 
women recruited from 
general practice; 
Phase 2: 99 self-identified 
survivors of partner 
violence, (54 via shelter; 45 
via emergency room) 
Socio-economic status indicators: 
Not stated Sample: Abused and non-abused women; in phase 2 a known 
group comparison 
Type of study: Validation study & known group comparison 
Setting: USA. Phase 1 - Family practice. Phase 2 - IPV crisis 
shelter and an emergency room 
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Zink, Levin, Putnam & Beckstrom 
(2007) 
 
 
 
 
 
 
 
 
 
 
 
Index Questions: 5 non-graphic questions that can be used 
when children are present 
Eligible: 450 Age (mean, SD, range): Not stated 
Comparator Tool: 39 question revised Conflict Tactic Scale 
(CTS2)  
Declining: 50 refused 
participation, 7 data not 
analysed (5 answered every 
question with 0) 
Ethnicity: African American 51%, White 49% 
Inclusion criteria: English speaking mothers, in a relationship 
with a steady partner for at least 1 year and with at least 1 child 
between 3 & 12 yrs of age. 
Exclusion criteria: Not stated Recruited: 393 Socio-economic status indicators: 
Income $40,000/yr 31%, $20,000-$40,000/yr 
34%, <$20,000 34% 
>12th grade 40%, ≤ 12th grade 60% 
Married 81%, Single 13%, Separated / divorced 
6% 
Sample: Abused and non-abused women 
Type of study: Validation study  
Setting: USA, Cincinnati, Ohio. 5 paediatric and family 
medicine practices. 
    
Bonomi, Thompson, Anderson, 
Rivara, Holt, Carrell & Martin 
(2006) 
 
 
 
Index Questions: 5 behavioural tactic abuse questions - 
Behavioural Risk factor Surveillance Survey (BRFSS) 
Eligible: 2,504 Age (mean, SD, range): 
46, 12, range not stated 
Comparator Tool: 10 impact questions - Women‟s Experience 
with Battering scale (WEB) 
Declining: 0 Ethnicity: White 83%, Hispanic 4%, No 
information on 13% 
Inclusion criteria: Women enrolled for at least 3 years in a 
Group Health Cooperative, aged between 18-64 years  
Exclusion criteria: Women who have never had an intimate 
partner or who resided outside of Washington State 
Recruited: 2,504 Socio-economic status indicators: 
>$75,000 - 34%, $50,000- $75,000- 27%, 
$25,000- $50,000- 28%, <$25,000- 11% 
 
81% employed, 87% completed some college 
or more 
65% married, 34% children in home 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: USA, Washington State. Telephone survey of randomly 
selected women 
    
Coker, Pope, Smith, Sanderson & 
Hussey (2001) 
Index Questions: 10 impact questions - Women‟s Experience 
with Battering scale (WEB) 
Eligible: 1503 Age (mean, SD, range): 38, 11, range not 
stated 
Comparator Tool: 15 question modified Index of Spouse 
Abuse- Physical (15 item mISA-P) 
Declining: 174 refused, 
97 did not complete health 
assessment interview, 
80 had missing data on 
several response variables 
Ethnicity: African American 62%, White 38% 
Inclusion criteria: Women seeking medical care in a family 
practice clinic, aged between 18 and 65, were insured by a 
managed care organisation and/or Medicaid and ever been in an 
intimate, sexual relationship with a man for a least 3 months 
Exclusion criteria: Women whose partners would not leave 
them alone were not recruited 
Recruited: 1152 Socio-economic status indicators: 
78% insured by a managed care provider, 22% 
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Sample: Abused and non-abused women insured by Medicaid 
33% college graduates, 56% high school 
graduate or some college, 11% less than high 
school 
86% were currently employed 
39% married, 35% single, 21% divorced / 
separated, 5% widowed 
Type of study: Validation study 
Setting: USA, two university associated family practice clinics 
    
Brown, Lent, Brett, Sas & 
Pederson (1996) 
 
 
 
 
 
 
 
 
 
Index Questions: 7 questions Woman Abuse Screening Tool (7 
item WAST) 
2 question WAST-Short (= 2 questions from the 7 item WAST 
that women were most comfortable with) 
Eligible: Out of 
comparison group: 38 
women approached 
In abuse group: unknown 
Age (mean, SD, range): 
Abused: 32, SD not stated, 18 – 57, 
Non-abused: 42, SD not stated, 25 - 61 
Comparator Tool: Abuse Risk Inventory (ARI) Declining: Out of 
comparison group 11 
refused, 2 did not appear for 
interview and 1 during 
interview was “identified as 
having experienced abuse 
in her current relationship; 
her data was not included in 
the analysis.” 
In abuse group: unknown 
Ethnicity: Not stated 
Inclusion criteria: Women staying at local shelter due to abuse 
by male partners 
Exclusion criteria: All comparison groups subjects were asked 
not to participate if they had a history of spousal abuse 
Recruited: 48 (24 abused, 
24 non-abused) 
Socio-economic status indicators: 
                          Abused           Non-abused 
Employed:         25%                 100% 
> Can$30,000:   33%                  100% 
Married:            12%                  79% 
Separated /  
Divorced           50%                  4% 
Single                38%                  17%  
College / University  
Education:         22%                  74% 
Sample: Known group analysis using intentionally selected 
women representing 2 extreme groups of abused women at a 
local shelter and non-abused women, recruited from the 
principal investigator‟s professional contacts 
Type of study: Validation study, using a known group 
comparison 
Setting: Canada, Western Ontario. At women‟s shelter 
Brown, Lent, Schmidt & Sas 
(2000) 
Index Questions: 8 questions Woman Abuse Screening Tool 
(WAST) 
Eligible: 399 patients;  
44 physicians 
Age (mean, SD, range): 46; SD not stated; 
18-86 
Comparator Tool: Abuse Risk Inventory (ARI) Declining: 92 patients; 24 
physicians 
Ethnicity: White 98% 
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Inclusion criteria: Using a stratified random sampling 
frame, 20 physicians needed to be selected from 400 in 
London, Ontario, Canada 
-) Women needed to be 18 or older, attending for a 
periodic health examination, for prenatal care or acute 
symptoms of illness, be English speaking, unaccompanied 
by another person, currently involved in an intimate 
relationship (married or common law) and they had to 
consider the attending physician their primary care 
physician. 
Exclusion criteria: Not stated Recruited: 307 patients; 
20 physicians 
Socio-economic status indicators: Employed 
59% 
Income >$30,000 - 59% 
Married or in common law relationship 
88% 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: Canada, South Western Ontario, Family practices 
– urban and rural 
    
Brown, Schmidt, Lent, Sas & 
Lemelin (2001) 
Index Questions: 8 questions French Woman Abuse Screening 
Tool (WAST) 
2 question French WAST-Short 
Eligible: Not stated Age (mean, SD, range): SD not stated 
Mean:-  Abused            Non-abused 
               38                      36 
Range:- 27-54                 17-58 
Comparator Tool: Abuse Risk Inventory (ARI) Declining: Not stated Ethnicity: French speaking women 
Inclusion criteria: 18 years of age (not adhered to) 
In a couple relationship for the last 12 months 
Exclusion criteria: Not stated Recruited: 
46 
25 abused 
21 non-abused 
Socio-economic status indicators: 
                      Abused           Non-abused 
Employed:    9%                    92% 
Can$30,000: 15%                   95% 
Married:       32%                   81% 
Sample: Abused and non-abused women 
Type of study: Validation study, using a known group 
comparison 
Setting: Canada, Ontario & Quebec - refuge and private 
homes 
    
Chen, Rovi, Washington, Jacobs, 
Vega & Pan (2007) 
Index Questions: 2 question English WAST-Short 
4 question - Hurts, Insults, Threatens and Screams (HITS). 
English version 
Eligible: 730  Age (mean, SD, range): 36, SD & range not 
stated 
Comparator Tool: 8 question English Woman Abuse Declining: 200 refused to Ethnicity: African-American 71%, Hispanic 
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Screening Tool (WAST) participate, 7 did not 
complete the questionnaire 
because of the waiting time 
for a private room 
14%, White 12%, Other 4% 
Inclusion criteria: aged 18 years or older, currently involved 
with a partner 
Exclusion criteria: “” Recruited: 523 Socio-economic status indicators: 
29% completed college 
Mean income $20,423 
73% employed, including part time work 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting:  – 4 urban family medicine practices 
    
Sagrestano, Rodriguez, Carroll, 
Bieniarz, Greenberg, Castro & 
Nuwayhid (2002) 
Index Questions: 2 questions on IPV within the Perinatal Self-
Administered Inventory (PSAI) 
Eligible: 196 Age (mean, SD, range): 25.7, 6.0, 14-41 
Comparator Tool: Seven questions on verbal aggression & 
nine on physical violence from the Conflict Tactics Scale 
(CTS) 
Declining: 0 Ethnicity: African American 48%, 
Hispanic 46%, White or other 6% 
 
25% (n=42) completed survey in Spanish Inclusion criteria: Women in a waiting room of a women‟s 
care centre scheduled for routine, antenatal care 
Exclusion criteria: Less than 20 weeks pregnant; were 
accompanied by small children who could not leave the 
waiting room with another relative; did not speak English 
or Spanish 
Recruited: 196, but only 
166 entered into analysis 
Socio-economic status indicators: 
Median annual income was $10,000 to 
$20,000 
49.4% earned less than$10,000 
Sample: Abused and non-abused women 
Type of study: Validation study 
Setting: Mid-Western USA, university affiliated women‟s 
care centre 
    
McFarlane, Parker, Soeken, & 
Bullock (1992) 
Index Questions: 3 question Abuse Assessment Screen AAS Eligible: 691 Age (mean, SD, range): Age ranged from 13 
to 30+ years (13 to 19 years- 31%, 20 to 29 
years- 57%, >30 years- 12%); -, - 
Comparator Tool: 30 question Index of Spouse Abuse 
(ISA) 
Declining: 0 Ethnicity: Black- 39%, Hispanic- 34% 
(most Mexican American), White- 27% 
Survey completed in English and Spanish 
– numbers in each language group not 
known 
Inclusion criteria: Attending one of two prenatal clinics 
Exclusion criteria: Not stated Recruited: 691 Socio-economic status indicators: 
95% below poverty level (not defined) Sample: Abused and non-abused women 
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Type of study: Validation study 35% married 
Setting: US, Texas, Houston & Baltimore; two prenatal 
clinics 
    
Connelly, Newton, Landsverk 
& Aarons (2000) 
Index Questions: 1 question: “Are you in a relationship in 
which you have been threatened, scared or hurt by 
someone?” If yes, whom? (Part of hospital admission 
protocol) 
Eligible: Not stated Age (mean, SD, range): 
23, 6.2, 14-42 
46% were 21 years or younger 
Comparator Tool: 9 question physical subscale of the 
Conflict Tactics Scale (CTS) 
Declining: Not stated Ethnicity: 
Hispanic 40% 
Caucasian 27% 
African American 23% 
Asian, Pacific Islander, Native 
American/other- 9% 
Inclusion criteria: Mothers giving birth between Feb 1996 
and Mar 1997 who participated in a randomised clinical 
trial of paraprofessional home visitation services. High 
risk mothers were identified 24 hours after birth using 15- 
item screen. Participants had to be English or Spanish 
Speaking, not active to child protective services and 
referenced “baby‟s father” for the CTS. 
Exclusion criteria: Not stated Recruited: 436 Socio-economic status indicators: 
53% not completed high school 
21% only completed high school 
84% not married 
53% reported father of the baby lived in 
the home 
Sample: Abused and non-abused high risk post partum mothers 
Type of study: Validation study, part of larger trial 
Setting: San Diego, US. Unclear whether all questions 
administered at hospital or home 
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Table 3: Correlation measures and their interpretation (for criterion 
correlation validity, convergent validity and association between 
index scores & external variables) 
STUDIES REFERENCE 
STANDARD
 
CORRELATION 
COEFFICIENT 
ACTUAL VALUE PAPER‟S 
INTERPRET
-ATION 
Tiwari et al, 2007 
3 individual questions 
derived from the Chinese 
AAS Qs 
Yes Kappa coefficient Physical IPV 0.56 
Emotional IPV 0.52 
Sexual IPV 0.47 
Fair 
agreement 
Reicheheim et al, 2004 
Portuguese anchor AAS Q. 
Yes Point biserial 
correlation 
0.68 High 
Ernst et al, 2004 
OVAT 
Yes Kappa statistic 0.58 - 
Chen et al, 2005 
English HITS vs English 
ISA-P 
English HITS vs English 
WAST 
Spanish HITS vs Spanish 
ISA-P 
Spanish HITS vs Spanish 
WAST 
Not stated -  
0.76 
 
0.76 
 
0.81 
 
0.78 
- 
Sherin et al, 1998 
HITS 
Not stated - 0.85 - 
Bonomi et al, 2006 
BRFSS 
No Numbers & 
percentages of 
women 
overlapping 
between BRFSS 
and WEB 
BRFSS+/WEB+ 
126=5% 
BRFSS+/WEB- 
240=9% 
BRFSS-/WEB+ 
48=2% 
BRFSS-/WEB-
2085=83% 
- 
Coker et al, 2001 
WEB 
 
 
 
 
 
 
 
 
 
No 
 
 
 
 
 
 
Numbers & 
percentages of 
women 
overlapping 
between WEB & 
ISA-P 
 
 
Pearson 
correlation 
coefficient 
Cohen‟s kappa 
statistic 
Association with 
self reported poor 
mental health 
WEB+/ISA-P+ 
98=9% 
WEB+/ISA-P- 
92=8% 
WEB-/ISA-P+ 
16=1% 
WEB-/ISA-P-  
946=82% 
0.67 
 
 
60% 
 
Relative risk 6.25, 
95% CI 2.72 – 14.32 
 
- 
 
 
 
 
 
 
 
Good 
agreement 
 
Good 
agreement 
Strong 
association 
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STUDIES REFERENCE 
STANDARD 
CORRELATION 
COEFFICIENT 
ACTUAL VALUE PAPER‟S 
INTERPRET
-ATION 
Coker et al, 2001 
WEB 
Continued 
 Association with 
≥ 10 physician 
visits in last year 
Relative risk 1.05, 
95% CI 0.82 – 1.37 
- 
Brown et al, 1996 
Total 7 Q.WAST score 
Individual WAST Qs 
No  
- 
Spearman 
correlation 
coefficient 
 
0.96 
0.80 to 0.85 
 
Brown et al, 2000 
8 Q. WAST 
No Pearson 
correlation 
coefficient 
0.69  
Brown et al, 2001 
Total French 8 Q. WAST  
Individual French WAST 
Qs 
 
No 
 
- 
- 
 
0.96 
0.75 to 0.93 
 
Chen et al, 2007  
English WAST-Short  
 
HITS 
No   
0.81 
 
0.77 
 
Highly 
correlated 
Highly 
correlated 
Sagrestano et al, 2002 
First PSAI Q vs CTS 
(verbal agression subscale) 
Second PSAI Q vs CTS 
(verbal agression subscale) 
Second PSAI Q vs CTS 
(physical agression 
subscale) 
No -  
0.1 
 
0.03 
 
0.5 
 
 
No 
Correlation 
McFarlane et al, 1992 
3 AAS Qs 
No - No data presented Valid and 
specific in 
identifying 
abuse 
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Table 4: Internal consistency reliability measures and their 
interpretation 
 
STUDIES CRONBACH‟S 
ALPHA
 
CORRECTED ITEM-
TOTAL 
CORRELATIONS 
PAPER‟S 
INTERPRETATION 
UNIDIMENSIONAL 
CONSTRUCT 
Ernst et al, 
2004 
OVAT 
 
 
 
0.6 
 
  
 
Passable 
 
 
No 
 
Chen et al, 
2005 
English HITS 
Spanish HITS 
 
 
0.76 
0.61  
  
 
 
 
No 
No 
Sherin et al, 
1998 
English HITS  
 
 
0.8  
  
 
 
 
No 
Zink et al, 2007 
Five non-
graphic DV 
questions 
 
 
0.46 
  
 
Mediocre 
 
 
No 
Brown et al, 
1996 
Seven question 
WAST 
 
 
0.95 
 
 
0.81 – 0.89 
 
 
High 
 
 
No 
Brown et al, 
2000 
Eight question 
WAST 
 
 
0.75 
   
 
No 
Brown et al, 
2001 
French WAST-
Short 
 
 
0.95 
  
 
Good 
 
 
Yes 
Chen et al, 
2007 
English WAST-
Short 
English HITS 
 
 
0.80 
 
0.79 
  
 
Good 
 
Good 
 
 
Yes 
 
No 
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Table 5: QUADAS quality items 
 
STUDIES No.11 
Spectrum 
of 
patients 
represent
-ative 
No.22 
Inclusion 
criteria 
stated 
No.33 
Accept- 
able 
reference 
standard 
No.44 
Time 
period 
between 
tools short 
enough 
No.55 
Sample 
verified 
with 
refer-
ence  
standard 
No.66 
All 
receive 
same 
refer-
ence 
standard 
No.77 
Reference 
standard 
independ-
ent of index 
tool 
No.88 
Enough 
detail to 
replicate 
index tool 
 
No.99 
Enough 
detail to 
replicate 
reference 
standard 
No.1010 
Blind 
analysis 
of index 
tool 
No.1111 
Blind 
analysis 
of refer-
ence 
standard 
No.1212 
Same 
clinical 
data 
available 
in 
practice 
No.1313 
Un-
interpret-
able / 
intermed-
iate 
results 
presented 
No.1414 
With- 
drawals 
from 
study 
explained 
No. of 
items 
fulfilled 
Five diagnostic accuracy studies 
Peralta et 
al, 2003 
Safety 
Question 
 
 
Yes 
 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
10 
Paranjape 
et al, 2006 
STaT 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
11 
Feldhaus et 
al, 1997 
PVS 
 
 
Yes 
 
 
Yes 
ISA:  
Yes 
mCTS 
No 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
11 
MacMillan 
et al, 2006 
PVS & 
WAST 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
11 
Sohal et al, 
2007 
HARK 
 
 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
14 
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STUDIES No.1 
Spectrum 
of 
patients 
represent
-ative 
No.2 
Inclusion 
criteria 
stated 
No.3 
Accept-
able 
reference 
standard 
No.4 
Time 
period 
between 
tools short 
enough 
No.5 
Sample 
verified 
with 
referen-
ce stan-
dard 
No.6 
All 
receive 
same 
referen-
ce stan-
dard 
No.7 
Reference 
standard 
independ-
ent of index 
tool 
No.8 
Enough 
detail to 
replicate 
index tool 
No.9 
Enough 
detail to 
replicate 
reference 
standard 
No.10 
Blind 
analysis 
of index 
tool 
No.11 
Blind 
analysis 
of 
reference 
standard 
No.12 
Same 
clinical 
data 
available 
in 
practice 
No.13 
Un-
interpret
able / 
intermedi
ate 
results 
presented 
No.14 
Withdra- 
wals from 
study 
explained 
No. of 
items 
fulfilled 
Eight studies using diagnostic accuracy and validation paradigms 
Tiwari et 
al, 2007 
Chinese 3 
AAS Qs 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Unclear 
 
 
Yes 
 
 
Unclear 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
9 
Reicheheim 
et al, 2004 
Portuguese 
1 AAS Q.  
 
 
Yes 
 
 
- 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
Unclear 
 
 
No 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
9 
Ernst et al, 
2004 
OVAT 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
No 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
No 
 
10 
Chen et al, 
2005 
English & 
Spanish 
HITS 
 
 
Yes 
 
 
Yes 
Unclear 
X4 
reference 
standards 
 
 
Yes 
 
 
Yes 
 
 
No 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
9 
Sherin et 
al, 1998 
HITS 
 
No 
 
Yes 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
No 
 
9 
Zink et al, 
2007 
5 DV Qs  
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
Yes 
 
12 
Bonomi et 
al, 2006 
BRFSS 
 
Yes 
 
Yes 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
No 
 
Yes 
 
Yes 
 
10 
Coker et al, 
2001 
WEB 
 
 
Yes 
 
Yes 
 
Unclear 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
Yes 
 
11 
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STUDIES No.1 
Spectrum 
of 
patients 
represent
-ative 
No.2 
Inclusion 
criteria 
stated 
No.3 
Accept-
able 
reference 
standard 
No.4 
Time 
period 
between 
tools short 
enough 
No.5 
Sample 
verified 
with 
referen-
ce stan-
dard 
No.6 
All 
receive 
same 
referen-
ce stan-
dard 
No.7 
Reference 
standard 
independ-
ent of index 
tool 
No.8 
Enough 
detail to 
replicate 
index tool 
No.9 
Enough 
detail to 
replicate 
reference 
standard 
No.10 
Blind 
analysis 
of index 
tool 
No.11 
Blind 
analysis 
of 
reference 
standard 
No.12 
Same 
clinical 
data 
available 
in 
practice 
No.13 
Un-
interpret
able / 
intermedi
ate 
results 
presented 
No.14 
Withdra- 
wals from 
study 
explained 
No. of 
items 
fulfilled 
Six studies using validation paradigm methods only 
Brown et 
al, 1996 
7 Q. WAST 
 
No 
 
Yes 
 
Unclear 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
No 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
Yes 
 
9 
Brown et 
al, 2000 
8 Q. WAST 
 
Yes 
 
Yes 
 
Unclear 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
No 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
No 
 
9 
Brown et 
al, 2001 
French 8 Q. 
WAST & 
WAST-S 
 
 
No 
 
 
- 
 
 
Unclear 
 
 
- 
 
 
- 
 
 
- 
 
 
Yes 
 
 
Yes 
 
 
No 
 
 
Unknown 
 
 
Unknown 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
Chen et al, 
2007 
English 
WAST-
Short, HITS 
 
 
Yes 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
No 
 
 
Yes 
 
 
Yes 
 
 
Unknown 
 
 
Unknown 
 
 
Yes 
 
 
Yes 
 
 
Yes 
 
 
10 
Sagrestano 
et al, 2002 
2 PSAI Qs 
 
Yes 
 
Yes 
 
No 
 
No 
 
Yes 
 
Yes 
 
No 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
Yes 
 
Yes 
 
9 
McFarlane 
et al, 1992 
3 AAS Qs 
 
Yes 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
No 
 
Yes 
 
10 
One study using neither research paradigm 
Connelly et 
al, 2000 
Single Q 
 
No 
 
Yes 
 
No 
 
No 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Yes 
 
Unknown 
 
Unknown 
 
Yes 
 
No 
 
Yes 
 
8 
*Important results are highlighted in bold 
1 
Item No. 1) Spectrum of patients‟ representative? 
2 
Item No. 2) Inclusion criteria stated? 
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3 
Item No. 3) Acceptable reference standard? 
4 
Item No. 4) Time period short enough between administered tools? 
5 
Item No. 5) Whole / random selection of sample verified with reference standard? 
6 
Item No. 6) All participants receive the same reference standard? 
7 
Item No. 7) Reference standard independent of index tool? (did not form part of reference standard) 
8 
Item No. 8) Enough detail to replicate execution of index tool? 
9 
Item No. 9) Enough detail to replicate execution of reference standard? 
10 
Item No. 10) Blind analysis of index tool? 
11 
Item No. 11) Blind analysis of reference standard? 
12 
Item No. 12) Same clinical data available when interpreted as would be available in practice? 
13 
Item No. 13) Un-interpretable / intermediate results presented? 
14 
Item No. 14) Withdrawals from the study explained? 
 131 
Table 6: Ethnicity quality criteria 
 
STUDIES IS ETHNICITY 
DESCRIBED? 
TERMS USED TO 
DESCRIBE ETHNICITY: 
IS CLASSIFICATION 
SYSTEM USING 
ETHNICITY 
JUSTIFIED? 
IS ETHNICITY 
SELF-ASSIGNED? 
ARE SOCIO-
ECONOMIC 
FACTORS 
CONSIDERED? 
Peralta et al, 
2003 
Safety 
Question 
Yes “Racial identity” 
“Ethnic differences” – used 
in Discussion  
No Yes Yes 
Paranjape et 
al, 2006 
STaT 
Yes - No Unclear - 
Feldhaus et 
al, 1997 
PVS 
Yes “Racial or ethnic” No Yes - 
MacMillan et 
al, 2006 
PVS & 
WAST 
Yes “Born in Canada” No Unclear - 
Sohal et al, 
2007 
HARK 
Yes “Ethnic origin” 
- based on national census 
categories 
Representativeness 
checked 
Yes - 
Tiwari et al, 
2007  
Chinese 3 
AAS Qs 
Uncertain “Chinese” 
(?ethnicity / language / 
nationality) 
No Unclear - 
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STUDIES IS ETHNICITY 
DESCRIBED? 
TERMS USED TO 
DESCRIBE ETHNICITY 
IS CLASSIFICATION 
SYSTEM USING 
ETHNICITY 
JUSTIFIED? 
IS ETHNICITY 
SELF-ASSIGNED? 
ARE SOCIO-
ECONOMIC 
FACTORS 
CONSIDERED? 
Reicheheim 
et al, 2004 
Portuguese 1 
AAS Q. 
Yes “Portuguese speaking in 
Brazil” 
(Language) 
No - - 
Ernst et al, 
2004 
OVAT 
Yes “Race” – including 
“Caucasian.” 
No Yes - 
Chen et al, 
2005 
English & 
Spanish 
HITS 
Yes “Race / ethnicity.” 
(Language spoken and 
country of origin was 
described for the Hispanic 
population). 
No Unclear Yes 
Sherin et al, 
1998 
HITS 
No - - - - 
Zink et al, 
2007 
5 DV Qs  
 
Yes “Ethnicity/race” & 
“Ethnicity” 
No Unclear Yes 
Bonomi et al, 
2006 
BRFSS 
Yes “Race / ethnicity.” No Yes - 
Coker et al, 
2001 
WEB 
Yes “Race” No Unclear - 
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STUDIES IS ETHNICITY 
DESCRIBED? 
TERMS USED TO DESCRIBE 
ETHNICITY: 
IS CLASSIFICATION 
SYSTEM USING 
ETHNICITY 
JUSTIFIED? 
IS ETHNICITY 
SELF-ASSIGNED? 
ARE SOCIO-
ECONOMIC 
FACTORS 
CONSIDERED? 
Brown et al, 
1996 
7 Q. WAST 
No - - - - 
Brown et al, 
2000 
8 Q. WAST 
Yes - No Unclear - 
Brown et al, 
2001 
French 8 Q. 
WAST & 
WAST-S 
Yes “Francophone” 
(Language) 
No - - 
Chen et al, 
2007 English 
WAST-Short 
& HITS 
Yes “Race / ethnicity” No Yes - 
Sagrestano et 
al, 2002 
2 PSAI Qs 
Yes “Multiethnic women” & “ethnic 
minority women” 
No Unclear - 
McFarlane et 
al, 1992 
3 AAS Qs 
Yes “Ethnic or racial” No Yes No 
Connelly et 
al, 2000 
Single Q. 
Yes No specific terms used though 
categories included “Caucasian,” 
“Hispanic” and “Asian” 
No Unclear - 
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I now present my narrative results. I have grouped studies together according to the 
methods used to obtain evidence of validation. The first group are the five studies that 
reported exclusively diagnostic accuracy. The second group are the eight studies that 
reported validation paradigm methods and which also made use of diagnostic 
accuracy. Immediately after these first two groups‟ narrative results, I have presented 
an analysis of their collective results. This overview allows a clear interpretation of 
what the study results actually mean. The third group of studies are the six studies that 
exclusively reported validation paradigm methods. Following this third group‟s 
narrative results, I have examined the meaning of the correlation measures which 
appear consistently in the studies in this third group and a number of the other 
systematic review studies. This includes an analysis of the effect of the heterogeneity 
of the study population on these correlation measures. 
 
 
3.2.1.  Five studies reporting exclusively diagnostic 
accuracy (i.e. criterion related concurrent 
validity) 
 
3.2.1.1. Single Safety Question 
 
Peralta and Fleming,[208] compared the single question: “Do you feel safe at home?” 
to identify IPV to a modified six question version of the Conflict Tactic Scale (6 item 
mCTS) in 399 English speaking women attending urban family practice in the US. 
They were 61% white, 26% African-American and 13% other. The validation of the 
safety question was not compared between these groups. 
 
Quality Appraisal 
The 6 item mCTS was not an acceptable reference standard. It only contained six 
items from the original CTS instead of 19. Five of these items related to psychological 
violence and only one to physical violence. It had not undergone a validation process 
(unlike the original CTS or the CTS 2). The terms “African American” and “black” 
were used interchangeably as well as the terms “racial identity” and “ethnicity.” The 
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“other” grouping included women of Hispanic, Asian and Native American descent. It 
was justified on the basis that there were too few numbers participating for 
meaningful analysis to be conducted. 
 
 
3.2.1.2. Slapped, Threatened or Thrown (STaT) 
 
Paranjape and colleagues,[209] evaluated the three question STaT against the 30 
question Index of Spouse Abuse (ISA), in 240 women attending an urgent care centre 
in south-eastern US who were 91% African-American and all English speaking. This 
study was in effect looking at the validation evidence for the STaT questions in one 
ethnic group. There was no assessment of STaT‟s validity in any other ethnic group 
apart from the African-Americans. Therefore no comparison can be made of whether 
STaT‟s validity varies between ethnic groups. 
 
Box 2: STaT (Slapped, Threatened or Thrown) questions 
 
Quality Appraisal 
The reference standard (ISA) was not completely independent of the index tool 
(STaT) as some of the questions overlapped. Though the ISA has been generally 
recognised as an acceptable reference standard, [226] I would suggest that as it 
contains only one question about sexual abuse it is not a perfect gold standard for 
IPV. Socio-economic data was collected in this African-American sample with a 
 
1. Have you ever been in a relationship where your partner has pushed or 
slapped you? 
2. Have you ever been in a relationship where your partner threatened you 
with violence? 
3. Have you ever been in a relationship where your partner has thrown, 
broken or punched things? 
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conclusion that STaT‟s diagnostic properties could only be generalised to similar 
patient populations. 
 
 
3.2.1.3.  Partner violence screen (PVS) – two studies 
 
Two studies investigated the PVS which contains one question about physical IPV 
and two questions about safety. 
 
The three question PVS was tested against two comparators, the thirty question ISA 
and the modified 16 question version of the Conflict Tactic Scale (16 item 
mCTS).[210] This comprised the verbal aggression and violence scales of the original 
CTS. Both comparators were being used as criterion standards by Feldhaus and 
colleagues
 
in an urban accident and emergency department setting. The 278 women 
who stayed for the CTS scales were 45% white, 30% Hispanic, 19% black and 6% 
other. All were English speaking. The PVS‟s diagnostic accuracy was not tested 
individually in specific ethnic groups. 
 
Box 3: Partner Violence Screen (PVS) questions 
 
The single question about physical IPV was more sensitive and specific than the two 
questions about safety, functioning very similarly to the full PVS. 
 
 
 
1. Have you been hit, kicked, punched, or otherwise hurt by someone 
within the past year? If so, by whom? 
2. Do you feel safe in your current relationship? 
3. Is there a partner from a previous relationship who is making you feel 
unsafe now? 
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Quality Appraisal 
The 16 item mCTS is not an acceptable reference standard as in its modified state its 
validity for identifying IPV has not been assessed by any preceding empirical 
research. Additionally it does not have a question specific to sexual IPV. 
 
 
MacMillan and colleagues,[211] 
 
reported a validation of the three question PVS and 
the eight question Woman Abuse Screening Tool (WAST), using the thirty question 
Composite Abuse Scale (CAS), a relatively new comparator, in 2,461 women 
attending either one of two accident and emergency departments, two family practices 
or two women‟s health clinics. The CAS was described as the criterion standard. 87% 
of the total study population was born in Canada. All were able to speak and read 
English. 
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Box 4: Woman Abuse Screening Tool (WAST) questions 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
1. In general, how would you describe your relationship? 
 
 
 
2. Do you and your partner work out arguments with: 
 
 
 
3. Do arguments ever result in you feeling down or bad about yourse1f? 
 
 Sometimes 
 
4. Do arguments ever result in hitting, kicking or pushing? 
 
 
 
5. Do you ever feel frightened by what your partner says or does? 
 
 
 
6. Has your partner ever abused you physically? 
 
 
 
7. Has your partner ever abused you emotionally? 
 
 
 
8. Has your partner ever abused you sexually? 
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Quality Appraisal: 
87% of the total study population was born in Canada. This corresponds closely to 
their nationality. 
 
 
3.2.1.4.  HARK 
 
Sohal and colleagues,[200] validated the four question HARK which was developed 
from the Abuse Assessment Screen (AAS). The HARK was compared to the 30 
question CAS, (the same comparator that was used in the MacMillan study above) in 
232 women attending UK general practice. The study population was ethnically 
diverse but the HARK questions‟ validity was not compared between ethnic groups. 
 
Box 5: HARK (Humiliation, Afraid, Rape, Kick) questions 
 
 
1 HUMILIATION 
Within the last year, have you been humiliated or 
emotionally abused in other ways by your partner or your 
ex-partner? 
2 AFRAID 
Within the last year, have you been afraid of your partner 
or ex-partner? 
3 RAPE 
Within the last year, have you been raped or forced to 
have any kind of sexual activity by your partner or ex-partner? 
4 KICK 
Within the last year, have you been kicked, hit, slapped or 
otherwise physically hurt by your partner or ex-partner? 
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Quality Appraisal: 
This is the only study that had blind analysis of the index tool and the reference 
standard in that when the researcher totalled a participant‟s score on the four HARK 
questions she did not know the individual‟s CAS score and vice versa. National 
census categories were used. 40% of the study population described their ethnic origin 
as white British, 25% as black British, African or Caribbean and 18% as Indian, 
Pakistani or Bangladeshi. 
 
The ethnicity of the study population was compared to the local population in the 
London borough of Newham by using the National Census 2001 figures. This 
comparison neatly showed that the percentage of the study population that described 
their ethnic origin as white British was 40% (6% higher than that in the local 
population according to the census, i.e. 34%) whilst 18% of the study population 
described their ethnic origin as Indian, Pakistani or Bangladeshi (11% lower than that 
in the local population according to the census i.e. 29%). The authors concluded that 
this analysis showed that the study population was not representative of the local 
population. This lack of representativeness would not have necessarily affected the 
sensitivity or specificity calculations unless the women who did not take part in the 
study (i.e. the missing south Asian women) answered differently with regards to only 
one of the instruments (the HARK or the CAS). If these missing south Asian women 
affected the prevalence of IPV (either increasing or decreasing it) then this may have 
had an effect on the PPV and NPV for the HARK. Comparison to the local population 
revealed that the study population was of a higher socio-economic status, as reflected 
by the higher percentage in a paid job (12% higher) and owning a house or flat (9% 
higher).[200] 
 
I now consider the results of these five studies collectively. This allows a clear 
interpretation of what the study results actually mean. 
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3.2.1.5.  Overview of five studies reporting exclusively diagnostic 
accuracy 
 
Out of these five studies that exclusively reported diagnostic accuracy data,[200, 208-
211] one did not use an acceptable reference standard which makes it impossible to 
interpret the poor diagnostic accuracy indices generated.[208] Out of the four 
remaining studies, two did not attempt to identify sexual IPV [209, 210] which was 
not reflected in the diagnostic indices as the reference standard (ISA) only contained 
one question about sexual IPV. Out of the final two studies,[200, 211] , the questions 
in one[200] resulted in a far greater change from pre-test to post-test probability 
(60%) than the questions in the other (37% for PVS and 45% for eight question 
WAST).[211] Additionally, the HARK questions have a simple scoring system 
whereas the WAST‟s scoring is more complex (uses a likert type scale), potentially 
affecting response processes. The HARK questions also have good content validation 
with separate questions on physical, sexual and emotional IPV. 
 
I will now consider the eight studies reporting validation paradigm methods which 
also made use of diagnostic accuracy. 
 
 
3.2.2. Eight studies reporting validation paradigm 
methods with diagnostic accuracy 
 
3.2.2.1.  Three question Chinese Abuse Assessment Screen (AAS) 
 
Tiwari and colleagues compared three individual questions from the Chinese Abuse 
Assessment Screen with the three corresponding subscales for physical, emotional and 
sexual IPV from the 39 item Revised Chinese Conflict Tactics Scales (CTS2) in 100 
pregnant and 157 non-pregnant Chinese women attending an antenatal clinic of a 
public hospital and a community centre in Hong Kong.[212] 
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Box 6: Three Chinese AAS questions 
 
 
 
 
 
 
 
Quality Appraisal 
The paper explicitly stated that the CTS2 was a “gold standard,” [227] also having 
been validated using data from the first representative household study of spousal 
battering in Hong Kong.[228] It was unclear whether the reference standard was 
independent of the index tool. The Chinese AAS has been adapted and changed from 
the English AAS. It was impossible to judge it alongside the Chinese CTS2 for which 
a supporting reference was given which I was unable to access. Thus it was deemed 
unclear as to whether there was enough detail to replicate execution of the reference 
standard. This paper reports that the study is of Chinese women in Hong Kong. It is 
unclear whether Chinese is referring to the women‟s ethnicity, nationality or language 
spoken. There is some ethnic diversity in Hong Kong. Socioeconomic status was 
considered. The study population was less educated and poorer than the general 
population of Hong Kong. 
 
 
3.2.2.2.  Portuguese AAS’s anchor question 
 
In the second of the AAS papers, Reichenheim and colleagues, evaluated the test 
performance of the Portuguese AAS‟s anchor question on physical abuse during 
pregnancy against the 12 item physical violence scale of the modified Revised 
Portuguese conflict tactics scale (12 item mCTS2), in 748 post-natal Portuguese 
speaking women on the maternity wards of three public sector hospitals in Rio de 
Janeiro, Brazil.[213] 
 
 
 
1. Within the last year, have you been physically hurt by someone? 
2. Within the last year, have you been emotionally hurt by someone? 
3. Within the last year, has anyone forced you to have sexual activities? 
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Box 7: Portuguese AAS’s anchor question on physical IPV during pregnancy 
 
Quality Appraisal 
The inclusion criteria were not explicitly stated in their Methods section though the 
exclusion criteria were clear. The paper stated that the translated Portuguese CTS2 
was used as a standard, its content validity having been considered by evaluating its 
concept, item and semantic equivalences. Acceptable reliabilities were shown for each 
subscale, factor analysis identifying the underlying dimensions.[213] It should be 
noted that it was only the 12 item physical violence scale of the Portuguese CTS2 that 
was actually then used alone as the reference standard for physical IPV. It was unclear 
whether the reference standard was independent of the index tool. There was not 
enough detail in the paper to replicate the index tool. This was partly because the 
Portuguese versions were not in the paper but also because the paper stated in the 
Abstract that “…three anchor questions…..are the main focus of this article.” 
However the evidence for validity was only collected using the one AAS anchor 
question on physical abuse during pregnancy. This paper reported that the study 
population was a Portuguese speaking population in Brazil. No further information 
was given about the ethnicity of this study population. Brazil is an ethnically diverse 
society. Socioeconomic data was collected showing that the study population was 
poorly educated and from low income families. 
 
 
3.2.2.3.  Ongoing Violence Assessment Tool (OVAT) 
 
Ernst and colleagues investigated the four question Ongoing Violence Assessment 
Tool (OVAT) by testing it against the 30 question ISA in 306 women and men 
attending an Emergency Department in a US city, in a study population who were 
described as being 49% Caucasian, 20% Hispanic, 16% African-American and 15% 
 
Since you have been pregnant, have you been hit, slapped, kicked, or otherwise 
physically hurt by someone? 
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Asian or other.[214] OVAT‟s validity was not estimated according to these groups, 
hence one cannot determine if there were any differences in validity between them. 
 
Box 8: Ongoing Violence Assessment Tool (OVAT) questions 
 
Quality Appraisal: 
The paper explicitly stated that the ISA was the “gold standard” for detection of 
present ongoing IPV. It has already been noted above that the ISA only contains one 
question about sexual abuse. This reference standard (ISA) was not independent of the 
index tool (OVAT) as the OVAT was developed from questions in the ISA which had 
high predictive values but fewer Likert scale responses. It used the category of 
“Caucasian,” when describing race. 
 
 
 
 
 
 
 
1. Within the last month my partner has threatened me with a weapon 
2. Within the last month my partner has beaten me so badly that I had to seek 
medical care 
3. Within the last month my partner has had no respect for my feelings 
4. Within the last month my partner has acted like he or she would like to kill 
me 
OVAT- Questions 1, 2, & 4 are Yes No responses 
Question 3 rated on a 5 point Likert scale - Never to Very Frequently 
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3.2.2.4.  HITS – two studies 
 
Box 9: HITS (Hurt, Insult, Threaten, Scream) questions 
 
 
 
*Answers
 
were summed to form an interval scale of the total HITS score,
 
which could 
range from 4 to 20. 
 
Chen and colleagues, evaluated the English and Spanish versions of the four question 
HITS, against different comparators – the English and Spanish versions of the 11 
question ISA–Physical dimension (ISA-P, measures physical IPV) and the eight 
question WAST.[198] The study population were 202 English speaking and Spanish 
speaking Hispanic and non Hispanic women (72% Hispanic, 20% non-Hispanic 
White, 6% non-Hispanic Black, 1% non-Hispanic Other), attending an urban family 
practice in the US. They tried to compare the performance of the four HITS questions 
in the two different language groups. 
 
Quality Appraisal 
It is unclear whether the reference standard was acceptable. The situation is confusing 
due to the use of two comparators, in two languages which is in effect four reference 
standards in one paper. Certainly the evidence suggests that the 8 question English 
WAST is not an acceptable reference standard (see section 3.2.3.1.). The reference 
standard was not independent of the index tool. Most importantly not all the 
participants received the same reference standard. The study population‟s ethnicity 
profile reflected the practice population‟s of which 70% was also of Hispanic origin. 
There was also information on country of origin for the Hispanic women (with 39% 
Cuban / Cuban American, 35% Puerto Rican, 11% Dominican, 5% Mexican / 
 
1. How often does your partner physically hurt you? 
 
2. How often does your partner insult you?  
 
3. How often does your partner threaten you with harm?  
 
4. How often does your partner scream or curse at you?  
 
Answers to each item of HITS  
Never Rarely Sometimes Fairly often Frequently 
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Mexican American, 10% other Latin American); and language spoken (44% of 
women completed interviews in Spanish). Socioeconomic status was measured as 
well as ethnicity. Hispanics and non-Hispanics were similar in all demographic
 
characteristics. In contrast there were significant demographic differences between the 
two language groups - those who carried out the interview in English (would have 
included Hispanic women and non-Hispanic women) and those participants
 
who 
completed the interview in Spanish (included only Hispanic women). The latter group 
tended to be older (P
 
< 0.001), to have lower incomes (P < 0.001), to be married
 
(P < 
0.001), to have longer relationships (P < 0.01),
 
and to be pregnant (P < 0.05). These 
significant differences persisted between Hispanic women who completed
 
the 
interview in Spanish compared to Hispanic women who completed
 
the interview in 
English. Spanish speaking Hispanic women were more likely to be Cuban and Cuban
 
American (P < 0.001) (and less likely to be Puerto Rican
 
and other Latin American) 
but tended to be older (P < 0.001),
 
to have lower incomes (P < 0.01) and to be married 
(P <
 
0.01).[198] 
 
The second paper examining the HITS, was by Sherin and colleagues.[215] The HITS 
was compared to a 15 item modified version of the CTS (15 item mCTS), consisting 
of the verbal and physical aggression items only. There were no ethnicity data 
describing the study population. The convergent validity correlation and internal 
consistency reliability were calculated during phase 1, in which 160 women were 
recruited from general practice. The diagnostic indices were generated during phase 2, 
a known group comparison of 99 self-identified survivors of IPV and 160 women 
from phase 1 (i.e. general patients visiting their physician). This would have included 
abused and non-abused women as suggested by the range of HITS scores generated in 
phase 1 (4-18). 
 
Quality Appraisal 
A known group comparison was used to calculate diagnostic accuracy. This study 
population was not representative of all women who attend general practice. 
Therefore there is no diagnostic accuracy evidence that HITS is able to identify 
women who had experienced abuse in a general clinical population. An acceptable 
reference standard was not used. This modified CTS had four reasoning items 
contained in the original CTS deducted from it on the basis that they were not directly 
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related to domestic violence. This left 15 physical and verbal violence items. Internal 
consistency reliability for the 15 item modified CTS in the same study population was 
0.87. Apart from this evidence of validity based on internal structure there was no 
data presented external to the modified CTS to support that it could identify IPV. In 
addition to no ethnicity data there was also no socio-economic data about the study 
population. 
 
 
3.2.2.5.  Five non-graphic domestic violence (DV) questions 
 
Zink and colleagues[216] compared five non-graphic domestic violence questions that 
can be used when children are present to the 39 item revised Conflict Tactics 
Scale[227] in 393 mothers recruited from primary care waiting rooms in Cincinnati, 
Ohio. 49% were white and 51% African American or other. Ethnicity was said to be 
potentially related to domestic violence status and hence included as a covariate in a 
logistic model evaluating the predictive ability of each question, by examining the 
areas under ROC curves. 
 
Box 10: Five non-graphic domestic violence questions 
 
 
1. How do you and your partner work out arguments? 
2. In general how do you describe your relationship? 
3. How is your partner treating you and the kids? 
4. Do you feel safe in your current relationship? 
5. Considering your current partners or friends or any past partners or friends, 
is there anyone who is making you feel unsafe now? 
Likert format response scale, with 3 - 5 response options used for these 5 
questions. 
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Quality Appraisal 
Odds ratios adjusted for ethnicity (as well as age, education and income) were 
obtained from logistic regression. There were no significant differences in ROC areas 
between the five questions when logistic regressions were carried out. This implies 
that ethnicity is unlikely to affect the diagnostic accuracy of each question. This 
cannot be firmly concluded as the odds ratios presented were adjusted together for 
age, education, income and ethnicity. This study did in effect analyse ethnic 
differences in the five questions‟ validity whilst considering socio-economic factors. 
 
 
3.2.2.6.  Behavioural Risk Factor Surveillance Survey (BRFSS) 
 
Bonomi and colleagues,[217]
 
assessed the agreement between the Behavioural Risk 
Factor Surveillance Survey (BRFSS, five behavioural
 
tactic abuse questions) with the 
Women‟s Experience with Battering scale (WEB, 10 impact questions), in a study 
population of 2,504 women accessed via telephone. They were 83% white and 4% 
Hispanic. This study was essentially looking at the validation evidence for the BRFSS 
questions in one ethnic group. There was no assessment of the validity of the BRFSS 
in any other ethnic group. Therefore no comparison can be made of BRFSS‟s validity 
in different ethnic groups. 
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Box 11: Behavioural Risk Factor Surveillance Survey (BRFSS) questions 
 
Convergent validity was assessed as the BRFSS questions were directly compared to 
the WEB questions without labelling either as a reference standard. The numbers and 
percentages of women who were WEB positive / BRFSS positive, WEB negative / 
BRFSS negative, WEB negative / BRFSS positive and WEB positive / BRFSS 
negative were calculated without using correlation. It was possible to calculate 
diagnostic accuracy results from the data contained in this paper, for the different 
components of the BRFSS using the WEB, the longer tool as the comparator. 
 
Quality Appraisal 
It is not known whether the WEB is an acceptable reference standard (see Coker et al, 
2001, section 3.2.2.7. and table 1). 
 
 
 
1. Now I want to ask you about forced sex involving vaginal, oral, or anal 
penetration. Has an intimate partner ever forced you to participate in a sex 
act against your will? 
2. Has an intimate partner ever threatened, coerced, or physically forced you 
into any sexual contact that did not result in intercourse or penetration? 
3. Has an intimate partner ever hit, slapped, shoved, choked, kicked, shaken, 
or otherwise physically hurt you? 
4. Have you ever been frightened for your safety, or that of your family or 
friends because of the anger or threats of an intimate partner? 
5. Has an intimate partner ever put you down, or called you names repeatedly, 
or controlled your behavior? 
Yes / no response scale used for these 5 questions. 
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3.2.2.7.  Women’s Experience with Battering Scale (WEB) 
 
Coker and colleagues,[218] compared the ten question WEB to the 15 question 
modified ISA-Physical (15 item mISA-P),[226] in a study population of 1,152 
participants who were recruited from two university family practice clinics in the US. 
62% were African American and 38% white. Differences in these two groups were 
not analysed. 
 
Box 12: Women’s Experience with Battering Scale (WEB) questions 
 
Association with external variables was measured by using correlation to assess the 
relationship between index scores and health indicators (number of physician visits in 
the last year and self-perceived poor mental health) – see table 3, on page 124. 
 
1. My partner made me feel unsafe even in my own home 
2. I felt ashamed of the things my partner did to me 
3. I tried not to rock the boat because I was afraid of what my partner might 
do 
4. I felt like I was programmed to react a certain way 
5. I felt like my partner kept me a prisoner 
6. My partner could scare me without laying a hand on me 
7. I hid the truth from others because I was afraid not to 
8. I felt owned and controlled by my partner 
9. My partner made me feel like I had no control over my life 
10. My partner had a look that went straight through me and terrified me 
WEB- Scored on a Likert scale of 1 (Strongly Disagree) to 6 (Strongly Agree) 
Sum the responses for items 1 – 10. The range of scores is 10-60. Score of equal to 
or >20 indicates battering. 
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Convergent validity was also assessed by using correlation coefficients between the 
WEB score and the 15 item mISA-P score without labelling either as a reference 
standard. From the numbers and percentages of women who were WEB+/mISA-P+, 
WEB-/mISA-P-, WEB-/mISA-P+ and WEB+/mISA-P- it was possible to calculate 
diagnostic accuracy results from the data contained in this paper, using the 15 item 
mISA-P, the longer tool as the comparator. 
 
Quality Appraisal 
The ISA-P is recognised as an acceptable reference standard to identify physical IPV. 
In the introduction to this paper, the authors stated that the ISA-P was being used. 
Later in the Method it was revealed that they were actually using a 15 item modified 
ISA-P as opposed to the original 25 item ISA-P assessing physical abuse. This 15 
question modified ISA-P has a Cronbach‟s alpha of 0.93, suggesting high internal 
consistency. This high internal consistency gives no indication about whether the 
modified ISA-P questions are identifying IPV. Hence it is unclear whether the 
modified ISA-P is an acceptable reference standard. An area of bias that is not 
captured by the QUADAS is that the modified version of the ISA-P which assesses 
physical IPV is an inappropriate comparator for the WEB which is probably 
identifying emotional IPV as well as physical. Having an inappropriate reference 
standard takes precedence over other less important areas of bias. 
 
I will now consider collectively these eight studies which reported validation 
paradigm methods but which also made use of diagnostic accuracy in order to decide 
what their results actually mean. This qualitative overview of their results also 
provides an opportunity to compare these two different types of methods generating 
validity evidence. 
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3.2.2.8.  Overview of eight studies reporting validation paradigm 
methods with diagnostic accuracy 
 
Tiwari and colleagues explicitly used methods from both paradigms.[212] Their use 
of diagnostic accuracy and Kappa coefficients was consistent with the data generated 
from the three Chinese AAS questions and Chinese CTS2 being categorical and 
dichotomous. However there was an incongruity in the results arising from these 
methods and their interpretation in that the sensitivity levels of the Chinese AAS 
questions (36 to 66%) were felt to be too low to be clinically useful whilst the kappa 
coefficients (0.56, 0.52 and 0.47) were interpreted as showing fair agreement between 
the Chinese AAS questions and the Chinese CTS2 by the authors. 
 
Reichenheim and colleagues,[213] also used methods from both paradigms but by 
using the diagnostic accuracy model it treated the 12 question modified CTS2 data as 
being categorical whilst the point biserial correlation treated this CTS2 score as being 
dimensional. There was no discussion about whether it was reasonable or permissible 
to treat the CTS2 score as being both categorical and dimensional. There was a 
discrepancy again in the results from these different methods in that the point-biserial 
correlation of 0.68 was construed as being high, appearing to indicate that the AAS 
question was functioning well whilst the sensitivity and specificity indicated that two 
thirds of minor and one third of severe episodes
 
of IPV were being missed. The PPVs 
were higher than the sensitivities with considerable differences in the pre- to post-test 
probabilities. This was less important than the poor content validation with neither 
sexual IPV nor emotional IPV being considered. 
 
Ernst and colleagues,[214] use of diagnostic accuracy and Kappa statistic was 
consistent with the data generated from the OVAT and the ISA being categorical and 
dichotomous. Most of the diagnostic indices were high (except the PPV of 56%) 
whilst the kappa statistic of 0.58 was not interpreted by the authors. The PPV of 56% 
in an area of relatively high IPV prevalence (20% according to the ISA) is 
disappointing indicating a change from pre- to post-test probability of only 36%. In a 
lower prevalence area (for example primary care as opposed to an emergency 
department), the PPV is likely to be even lower. 
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Chen and colleagues,[198] used methods from both paradigms but did not state the 
statistical test used to calculate correlation. All the correlations were either more than 
or equal to 0.75. The sensitivities and specificities were also all above 86% but the 
PPV of the Spanish-HITS was only 45% with a resulting change from pre- to post- 
test probability of just 35%. Most importantly different comparators were used for the 
English and Spanish version of the HITS with no reasonable rationale for this 
disparity. 
 
In Sherin and colleagues‟ study both correlation and diagnostic accuracy indices had 
consistently high results (r=0.85, sensitivity 96%, specificity 91%) but whilst 
correlation was calculated using a general practice population, the diagnostic indices 
were derived from a known group comparison.[215] Section 3.2.4.2. details the 
consequences of known group comparisons on study population heterogeneity and the 
impact on validity evidence, including diagnostic accuracy indices. 
 
In these last four studies,[198, 213-215] I would suggest that the validity evidence 
based on relations to other variables is less important then the decreased validity 
evidence based on test content as sexual IPV is not explicitly assessed by either the 
Portuguese AAS single anchor question, OVAT or the HITS. 
 
Zink et al[216] was the final study to use both the diagnostic accuracy method and 
from the validation paradigm, internal consistency reliability (see section 3.2.4.2.). In 
this study along with the last three studies, the validity evidence based on response 
processes is decreased by use of a Likert scale.[198, 215, 216, Ernst, 2004 #562] This 
potentially can cause problems for the respondent. More importantly, these questions 
cannot be used as part of a routine verbal history, taken in any clinical consultation. 
 
Out of these six studies,[198, 212-216] five directly use diagnostic accuracy and 
criterion related correlation alongside each other.[198, 212-215] The first three studies 
suggest that the diagnostic accuracy data is more informative than methods correlating 
scores when assessing the validity of questions trying to identify IPV.[212-214] All 
five studies demonstrate that if the questions produce categorical data and a quality 
reference standard exists, diagnostic accuracy yields more clinically useful 
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information than just a single figure representing the correlation coefficient.[198, 212-
215] 
 
There were two further studies based on the validation paradigm which reported data 
allowing the computation of diagnostic accuracy results.[217, 218] In Bonomi et al‟s 
study,[217] the numbers and percentages of women who were BRFSS+/WEB+, 
BRFSS-/WEB-, BRFSS+ /WEB- and BRFSS-/WEB+, are not intuitive to interpret 
partly as there was no explicit theory describing how these two tools related to each 
other. Instead it was stated that they both identified “abuse” but no evidence was 
presented to support this. Generating diagnostic accuracy data provided one clearer 
interpretation of this data but forced the WEB to be a reference standard. It showed 
that the BRFSS for any kind of abuse had a low PPV; and a small difference between 
the pre- and post-test probabilities. 
 
In Coker et al‟s study,[218] as in the Bonomi study, the numbers and percentages of 
women who were WEB+/mISA-P+, WEB-/mISA-P-, WEB+/mISA-P- and WEB-
/mISA-P+ were presented but also initially difficult to construe. Calculating 
diagnostic accuracy helped to give more meaning to the data showing that WEB‟s 
PPV was only 52%. Clinically it is more meaningful to know that if a person answers 
positively that there is a 52% probability that she experiences physical IPV rather than 
a Cohen‟s kappa statistic of 60% indicating the agreement between two dichotomised 
measures. 
 
I now consider the six studies that exclusively reported validation paradigm methods. 
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3.2.3.  Six studies reporting exclusively validation 
paradigm methods 
 
3.2.3.1.  Woman Abuse Screening Tool (WAST) – three studies 
 
Four papers evaluating the WAST were identified in this systematic review.[211, 
219-221] Three of these studies followed the validation paradigm only, using a 
variety of different methods to generate evidence of validity but not diagnostic 
accuracy data.[219-221] 
 
The first WAST study was conducted by Brown and colleagues.[219] In purposive 
samples of 24 abused and 24 non-abused women, the seven question WAST and the 
two question WAST-Short were compared to the Abuse Risk Inventory (ARI), in 
Canada. No ethnicity data was reported. The seven question WAST, unlike the eight 
question WAST, did not include the last question on sexual IPV. The two question 
WAST-Short were the two questions that women were most comfortable with from 
the seven question WAST. 
 
Box 13: Woman Abuse Screening Tool-Short (WAST-short) questions 
 
 
 
 
 
 
 
 
 
 
 
 
1. In general, how would you describe your relationship? 
 
 
on 
2. Do you and your partner work out arguments with: 
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Quality Appraisal 
The most important bias in this study was that the spectrum of patients was not 
representative of either the local population or of all women attending general 
practice. Instead two extreme groups of intentionally selected women were used, 
consisting of women from a local shelter for abused women and women accessed via 
the principal investigator‟s contacts. There was not enough detail to replicate the ARI 
and so to judge objectively whether the ARI was an acceptable reference standard. 
The lead author of the paper was unsuccessfully approached for a copy of the ARI. 
The actual reference supporting the ARI (“Yegidis BL. Abuse risk inventory manual. 
Palo Alto, Calif: Consulting Psychologist Press, 1989”) was unobtainable. The ARI 
was said to have demonstrated reliability and validity in identifying women who are 
being abused by their partners though it was not specifically described as a standard 
criterion. The study population was small using only 24 abused women and 24 non-
abused women. This study limitation was not highlighted by QUADAS. 
 
 
The work of the first WAST study was developed by the second WAST study 
conducted by Brown et al.[220] Now an eight question WAST (included an extra 
question on sexual IPV) was compared to the Abuse Risk Inventory (ARI) in 307 
women in a family practice setting (attending urban and rural family physician 
practices in South Western Ontario, Canada). The study population was homogeneous 
with 98% of it being white. All were English speaking. In effect this study was 
looking at the evidence of validity for the WAST questions in one specific group. 
 
WAST‟s additional last question “Has your partner ever abused you sexually?” – is 
not clear in that the term “abuse” is quite technical and may not correspond to 
women‟s experiences of sexual IPV, for example being forced to have any kind of 
sexual activity or being raped. This decreases WAST‟s validity evidence based on 
response processes. 
 
Quality Appraisal 
There was not enough detail to replicate the ARI and so to judge objectively whether 
the ARI was an acceptable reference standard (see above). In this paper, the ARI‟s 
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role was not of a standard criterion but the theoretical relationship linking the ARI to 
the WAST was not explicitly discussed. 
 
 
Brown repeated the study in a Francophone community, again using a convenience 
sample of 25 abused women residing in two women‟s shelters and 21 non-abused 
women, in Ontario and Quebec, using a French version of the WAST and the WAST-
Short.[221] No further information was given on the ethnicity of the study population. 
 
Quality Appraisal 
The spectrum of patients was not representative being a known group comparison. 
This study, in common with the earlier study from 1996, had a very small study 
population – with 25 abused and 21 not abused. The study population was a 
Francophone community in Ontario and Quebec. No further ethnicity details were 
provided. The authors stated that the abused and not abused women were 
demographically similar. This was surprising given that 9% of the abused women 
were employed and 92% of the non-abused; 32% of the abused women were married 
and 81% of the non-abused women (see table 2, on page 121). 
 
 
3.2.3.2.  WAST-Short and HITS 
 
Most recently Chen and colleagues, in 2007, have validated both the English WAST – 
Short (two questions) and the English HITS (four questions) by comparison to the 
eight question WAST.[222] This was in a study population of 523 minority women, 
predominantly African American (71%) attending four urban family medicine 
practices. Ethnicity was not used as a study variable to assess validity evidence 
between groups. Convergent validity was assessed using correlations of the WAST – 
Short and the HITS with the eight item WAST. 
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Quality Appraisal 
The eight question WAST is not an acceptable reference standard – as shown recently 
in a study.[211] However in this paper its role was not that of a standard criterion. The 
theoretical relationship linking the eight question WAST to either the Short-WAST or 
the HITS, was not explicitly described. The eight question WAST was not 
independent of the index tool, the WAST-Short, in that both of them were developed 
together.[219-221] This causes incorporation bias as the comparator (eight question 
WAST) in effect includes the WAST-Short, possibly increasing multicolinearity. This 
probably explains the high correlation of the WAST–Short score with the WAST total 
score (0.81, p<.001). 
 
 
3.2.3.3.  Perinatal Self-Administered Inventory (PSAI) 
 
Sagrestano and colleagues compared the 2 questions on IPV within the Perinatal Self-
Administered Inventory (PSAI) to the seven verbal aggression questions and nine 
physical violence questions of the CTS in 166 women in antenatal clinics [223] of 
whom 48% were African American, 46% Hispanic, 6% white or other. 25% (n=42) 
completed the interview in Spanish. There was no analysis to examine the difference 
between either the different ethnic groups, or the two different language groups. 
 
Box 14: Two Perinatal Self-Administered Inventory questions 
 
Both the PSAI questions were complex impacting on the response processes and the 
consequential validity evidence. The first question ("are you experiencing severe 
conflicts with anyone in your home?”) is not only asking whether there is conflict 
(what is conflict?) at home, but whether it is severe (how should severity be graded?) 
 
First question: Are you experiencing severe conflicts with anyone in your home? 
Second question: Are you suffering mental or physical violence abuse now? 
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and “…anyone at home” is non-specific. The second question enquires about abuse 
rather than a specific act, lumping together mental and physical violence and asks 
whether it is happening right now (what does “right now” mean? “Right now” I am 
being interviewed and not being abused or does “right now” mean today or this week 
or this month etc.). This timescale is very different from that in the CTS (“in the last 
year”). Therefore it is not surprising that it neither correlated to either the verbal or 
physical abuse sub-scales of the CTS. 
 
Quality Appraisal 
The time period was not short enough between administered tools with an average 
time lag of three weeks mentioned. The CTS subscales of verbal aggression and 
physical violence are not known to be acceptable reference standards. Neither were 
they independent of the index tool. However in this paper their role was not that of 
standard criterions but the theoretical relationship linking the PSAI questions and the 
CTS was not explicitly described. The study population was diverse with 25% (n=42) 
completing the interview in Spanish. 
 
 
3.2.3.4.  Three question English AAS 
 
McFarlane and colleagues[224] 
 
tested three questions from the AAS (numbers 2, 3 & 
4 – see Box 15, on page 159) against the 30 item ISA, using correlation to assess 
convergent validity, in 691 pregnant women in Houston, Texas and Baltimore in the 
US. The questions were offered in English and Spanish. The number of women who 
completed the questions in Spanish was not stated. There was no comparison of 
AAS‟s validity between specific language or ethnic groups in this study. 
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Box 15: Three questions from the AAS 
 
Quality Appraisal 
The results were un-interpretable with no data presented to support that those 
positively screened for IPV with the AAS were more likely to have a significantly 
higher score on the ISA. The authors still concluded that the AAS questions were 
valid and specific in identifying abuse. 
 
 
3.2.4.  Overview of correlation measures 
 
Correlation measures appeared in the six studies above that exclusively reported 
validation paradigm methods along with some of the earlier studies which used 
intersecting methods. Correlation measures have been used in these studies to 
measure validity evidence based on relations to other variables (for example criterion 
related validity and convergent validity) as well as validity evidence based on internal 
structure (i.e. internal consistency reliability). The analysis of these correlation 
measures collectively is presented below. 
 
 
3.2.4.1.  Validity evidence based on relations to other variables 
 
See table 3 for a summary of studies that used correlation measures to assess criterion 
correlation validity, (i.e. used a reference standard), convergent validity and the 
 
2. Within the last year, have you been hit, slapped, kicked or otherwise 
physically hurt by someone? 
3. Since you‟ve been pregnant, have you been hit, slapped, kicked, or 
otherwise physically hurt by someone? 
4. Within the last year, has anyone forced you to have sexual activities? 
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association between index scores with external variables. This table includes a précis 
of each paper‟s interpretation of this data. 
 
Out of the 20 studies included in the systematic review, five studies used correlation 
to establish criterion related validity.[198, 212-215] Two of these studies used the 
kappa coefficient to calculate the criterion related validity,[212, 214] one used biserial 
correlation,[213] and two did not state the statistical method used.[198, 215] The 
criterion related validity coefficients ranged from 0.47 to 0.85. The lowest criterion 
related validity coefficients was seen in the Tiwari study - a kappa coefficient of 0.47 
for sexual IPV.[212] 
 
Eight other studies were association studies, containing 21 estimates of convergent 
validity for nine sets of questions trying to identify IPV.[217-224] The majority of 
these were correlation coefficients though in two cases convergent validity was 
expressed simply using the numbers and percentages of women in overlapping 
groups.[217, 218] The statistical method used to calculate the correlation coefficient 
was most commonly not stated (nine instances). When the statistical method was 
stated Pearson‟s correlation coefficient was used for two estimates,[218, 220] Cohen‟s 
kappa coefficient for one estimate[218] and Spearman correlation for one.[219] The 
convergent validity correlation coefficients ranged from 0.03 to 0.96. 
 
None of the eight studies examining convergent validity contained explicit 
information on the theories about IPV linking different sets of questions. This is a 
central issue to interpreting the meaning of a correlation coefficient. Instead there 
often appeared to be the assumption that the higher the correlation coefficient, the 
better the index set of questions. For example, Coker et al[218] in their introduction 
considered that the WEB identified battering (related to loss of power and control) 
whilst the ISA assessed episodic physical assaults. There was recognition that both 
were conceptually and empirically distinct but the method still measured the 
agreement between the two measures using correlation. 
 
I now examine the studies that used correlation measures to measure internal 
consistency reliability. 
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3.2.4.2.  Validity evidence based on internal structure 
 
See table 4 for a summary of studies that used correlation measures to assess internal 
consistency including each paper‟s interpretation of the values. Eight studies 
contained 11 estimates of internal consistency for eight sets of questions trying to 
identify IPV.[198, 214-216, 219-222] Ten of these measures were Cronbach‟s alpha 
whilst one was a corrected item-total correlation. The Cronbach alphas ranged from 
0.46 (interpreted as being mediocre) to 0.95 (interpreted as being good). 
 
None of the papers contained any explicit discussion about whether the sets of 
questions trying to identify IPV 
i. were operating over one dimension (uni-dimensional) or many dimensions of 
IPV (multi-dimensional) or  
ii. comprised categorical or dimensional data 
These are central principles that should be considered prior to calculating internal 
consistency measures. 
 
Out of the eight sets of questions identifying IPV, five operate over more than one 
dimension. Both the English HITS (and presumably the Spanish HITS), the OVAT 
and the seven question WAST contain questions about physical IPV and emotional 
IPV. Hence they are not uni-dimensional but instead operate across two different 
dimensions. The eight question WAST contains questions about physical, emotional 
and sexual IPV, covering three dimensions of IPV. It is inappropriate to measure 
internal consistency for these question sets as done by seven of these studies.[198, 
214, 215, 219, 220, 221, 222] Zink‟s five non-graphic questions are said to cover the 
major domains of domestic violence, including personal safety, the treatment of 
children as well as containing the 2 WAST-Short questions.[216] It therefore also 
seems unlikely that these five questions will be operating over just one dimension for 
which it is appropriate to apply an internal consistency reliability measure. All the sets 
of questions were trying to categorise women into those experiencing IPV and those 
that were not. Hence overall the evidence points to internal consistency measures not 
being applied appropriately in the majority of these studies. 
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The English WAST-Short and presumably the French WAST-Short are uni-
dimensional. Both had high Cronbach alphas of 0.8 and 0.95 respectively, interpreted 
as being good.[221, 222] However it is important to note that the Cronbach alpha (in 
common with all correlation coefficients), is not just a reflection of internal 
consistency (or how strong the relationship is between 2 measures) but also the study 
population‟s heterogeneity, (see section 1.3.6.4.) 
 
This is demonstrated by this systematic review which shows that in the two known 
group comparisons, used to generate not only internal consistency reliability 
(Cronbach‟s alphas) but also convergent validity correlation coefficients, the results 
were the highest seen.[219, 221] The Cronbach alpha for the 7 question WAST was 
0.95,[219] whilst the Cronbach alpha for the French WAST was 0.95.[221] For the 
total 7 question WAST, r=0.96, for individual WAST questions r=0.80 to 0.85.[219] 
For the total 8 question French WAST, r=0.96, for individual WAST questions r=0.75 
to 0.93.[221] These results most likely reflect that both these two known group 
comparisons contained two extreme populations of abused and non-abused women 
with the widest score ranges and greatest study population heterogeneity. It does not 
necessarily indicate that these questions were most highly correlated to each other 
(internal consistency reliability) or that they were the most highly correlated to other 
instruments (convergent validity). 
 
The heterogeneity of the study population was supported in the Brown 1996 study by 
the significant differences found in all socioeconomic indicators (employment status, 
income and education), age and percentage married between the two groups of abused 
and not abused women. 
 
These two known group comparisons and a further known group comparison was also 
used to generate diagnostic accuracy indices.[215, 219, 221] These figures were also 
artificially inflated due to the increased study population heterogeneity. This makes 
their values incomparable to those derived in studies using participants representative 
of patients attending general practice (see Table 1, on page 110). 
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3.2.5.  One study using neither research paradigm 
 
Connelly and colleagues[225] tested a single question which was part of a hospital 
admission protocol against the 9 question physical subscale of the CTS, the 
comparator, in 436 high risk post partum mothers. The study population was 40% 
Hispanic, 23% African-American, 27% Caucasian and 9% Asian, Pacific Islander, 
Native American and other. The validation of the single question was not compared 
between these groups. 
 
Box 16: One question from hospital admission protocol 
 
Apart from presenting the prevalence of IPV according to the CTS and the percentage 
of the sample that were threatened, scared or hurt, the relationship between the two 
was not analysed. 
 
Quality Appraisal 
The study population spectrum was not representative of all patients instead being 
high risk post-partum mothers in whom the risk of moderate to severe violence is 
thought to be greatest.[229, 230] An acceptable reference standard was not used. The 
time period was not short enough between administered tools. 
 
 
I have now presented all the systematic review results. I now present the results of my 
secondary data analysis. 
 
 
“Are you in a relationship in which you have been threatened, scared or hurt by 
someone?  
If yes, whom?” 
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3.3.  Secondary data analysis results 
 
The chief findings of my secondary data analysis results are presented in  
tables showing diagnostic accuracy indices with 95% confidence intervals of HARK 
at different cut off scores for the south Asian, African-Caribbean and white groups 
(see tables 7, 8 and 9). There is also a receiver operator characteristic curve for each 
ethnic group (see figures 6, 7 and 8). Figure 9 compares the three receiver operator 
characteristic curves generated by the three groups. For a complete record of my 
secondary data analysis, see Appendix F. My commentary focuses on what potentially 
may be clinically important results. 
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Table 7: The sensitivity, specificity, PPV, NPV, LR (with 95% confidence intervals), post-test odds and pre- to post-
test probability of IPV at different HARK cut off scores, in the African-Caribbean groups (N = 59). 
Hark cut 
off scores 
% of 
study 
sample 
Sensitivity 
with 95% 
C.I. 
Specificity 
with 95% 
C.I. 
Positive 
predictive 
value with 
95% C.I. 
Negative 
predictive 
value with 
95% C.I. 
Likelihood 
ratio with 
95% C.I. 
Post-test 
odds  
Change 
from pre- 
to post-test 
probability 
of IPV 
= 4 2% 5% 
(0% to 28%) 
100% 
(89% to 100%) 
100% 
(5% to 100%) 
69% 
(55% to 80%) 
Undefined Undefined 68% 
(62% to 74%) 
≥ 3 10% 32% 
(13% to 56%) 
100% 
(89% to 100%) 
100%    
(52% to 100%) 
75.5% 
(61% to 86%) 
Undefined  Undefined  68% 
(62% to 74%) 
≥ 2 15% 47% 
(25% to 70%) 
100% 
(89% to 100%) 
100% 
(63% to 100%) 
80% 
(66% to 89%) 
Undefined 
 
Undefined 68% 
(62% to 74%) 
≥ 1 34% 89.5% 
(65% to 98%) 
92.5%  
(78% to 98%) 
85%  
(61% to 96%) 
95%  
(81% to 99%) 
12 
(4 to 36) 
6 53% 
(45% to 60%) 
≥ 0 100% 100% 
(79% to 100%) 
0% 
(0% to 11%) 
32% 
(21% to 46%) 
Undefined 1 0.5 0% 
(-8% to 8%) 
When the specificity is 100%, the likelihood ratio and post test odds are undefined. Confidence intervals for likelihood ratios are approximate since they were calculated by 
the delta method which is less reliable when some cell sizes are small (Armitage P, Matthews JNS, Berry G. Statistical methods in medical research. Oxford; Blackwell, 
1994).
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Table 8: The sensitivity, specificity, PPV, NPV, LR (with 95% confidence intervals), post-test odds and pre- to post-
test probability of IPV at different HARK cut off scores, in the south Asian groups (N = 48). 
Hark cut 
off scores 
% of 
study 
sample 
Sensitivity 
with 95% 
C.I. 
Specificity 
with 95% 
C.I. 
Positive 
predictive 
value with 
95% C.I. 
Negative 
predictive 
value with 
95% C.I. 
Likelihood 
ratio with 
95% C.I. 
Post-test 
odds  
Change 
from pre- 
to post-test 
probability 
of IPV 
= 4 0% 0% 
(0% to 30%) 
100% 
(88% to 100%) 
Undefined 
 
75% 
(60% to 86%) 
Undefined Undefined - 
≥ 3 4% 17% 
(3% to 49%) 
100% 
(88% to 100%) 
100%    
(20% to 100%) 
78% 
(63% to 88%) 
Undefined  Undefined  75% 
(69% to 80%) 
≥ 2 12.5% 42% 
(16% to 71%) 
97% 
(84% to 100%) 
83% 
(36% to 99%) 
83% 
(68% to 92%) 
15 
(2 to 116) 
5 58% 
(50% to 65%) 
≥ 1 21% 75% 
(43% to 93%) 
97%  
(84% to 100%) 
90%  
(54% to 99%) 
92%  
(77% to 98%) 
27 
(4 to 192) 
9 65% 
(58% to 71%) 
≥ 0 100% 100% 
(70% to 100%) 
0% 
(0% to 12%) 
25% 
(14% to 40%) 
Undefined 1 0.3 0% 
(-8% to 8%) 
When the specificity is 100%, the likelihood ratio and post test odds are undefined. Confidence intervals for likelihood ratios are approximate since they were calculated by 
the delta method which is less reliable when some cell sizes are small (Armitage P, Matthews JNS, Berry G. Statistical methods in medical research. Oxford; Blackwell, 
1994).
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Table 9: The sensitivity, specificity, PPV, NPV, LR (with 95% confidence intervals), post-test odds and pre- to post-
test probability of IPV at different HARK cut off scores, in the white groups (N = 112). 
Hark cut 
off scores 
% of 
study 
sample 
Sensitivity 
with 95% 
C.I. 
Specificity 
with 95% 
C.I. 
Positive 
predictive 
value with 
95% C.I. 
Negative 
predictive 
value with 
95% C.I. 
Likelihood 
ratio with 
95% C.I. 
Post-test 
odds  
Change 
from pre- 
to post-test 
probability 
of IPV 
= 4 1% 5% 
(0% to 27%) 
100% 
(95% to 100%) 
100% 
(52 to 100%) 
83% 
(74% to 89%) 
Undefined Undefined 77% 
(71% to 82%) 
≥ 3 5% 30% 
(13% to 54%) 
100% 
(95% to 100%) 
100%    
(52% to 100%) 
87% 
(79% to 92%) 
Undefined  Undefined  77% 
(71% to 82%) 
≥ 2 13% 65% 
(41% to 84%) 
98% 
(92% to 100%) 
87% 
(58% to 98%) 
93% 
(85% to 97%) 
30 
(7 to 122) 
6.5 64% 
(57% to 70%) 
≥ 1 17% 75% 
(51% to 90%) 
96%  
(89% to 99%) 
79%  
(54% to 93%) 
95%  
(87% to 98%) 
17 
(6 to 46) 
4 56% 
(48% to 63%) 
≥ 0 100% 100% 
(80% to 100%) 
0% 
(0% to 5%) 
18% 
(11% to 26%) 
Undefined 1 0.2 - 5% 
When the specificity is 100%, the likelihood ratio and post test odds are undefined. Confidence intervals for likelihood ratios are approximate since they were calculated by 
the delta method which is less reliable when some cell sizes are small (Armitage P, Matthews JNS, Berry G. Statistical methods in medical research. Oxford; Blackwell, 
1994). 
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Figure 8: Receiver operator characteristic curve for the African-Caribbean groups, showing sensitivity of different 
HARK scores verses 1 - specificity 
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Figure 9: Receiver operator characteristic curve for the south Asian groups, showing sensitivity of different HARK 
scores verses 1 - specificity 
 
                                                         
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
S
e
n
s
it
iv
it
y
0.00 0.25 0.50 0.75 1.00
1 - Specificity
Area under ROC curve = 0.8588
 
95% confidence interval for area under ROC curve: 0.73 to 0.99 
 
≥0 
≥1 
≥2 
≥3 
=4 
 
 
 
 
 
 
 
 
 
 
 171 
Figure 10: Receiver operator characteristic curve for the white groups, showing sensitivity of different HARK scores 
verses 1 - specificity 
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Figure 11: Comparing the three receiver operator characteristic curves in the African-Caribbean, south Asian and 
white groups 
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3.3.1.  Commentary 
 
Tables 7, 8 and 9 (on pages 166 to 168) consistently show wide and overlapping 95% 
confidence intervals suggesting that this study was underpowered to detect any 
statistically significant ethnic differences in the ability of HARK to identify IPV. 
Therefore my commentary rather than focussing on the statistical significance of these 
results will focus on what potentially may be clinically important results. This includes 
the ethnic similarities seen in the data as well as some of the differences seen in the 
validity evidence for the HARK questions‟ ability at identifying IPV. 
 
For all three groups, African-Caribbean, south Asian and white, the receiver operator 
characteristic curves (see figures 7, 8 and 9, on pages 169 to 171) clearly demonstrate 
that a HARK score of ≥1 is the optimal cut off for identifying IPV, as it is for the entire 
population.[200] This cut off maximises the true positives whilst minimising the false 
positives, in each group. Figure 10 (on page 172) shows that there was no significant 
variation in the areas under the three ROC curves for the three groups, (also see 
Appendix E, page 276). 
 
The diagnostic indices generated using the HARK cut off of ≥ 1 were at a high level, for 
the African-Caribbean, south Asian and white groups. Most importantly in all three 
groups, using the HARK questions resulted in wide differences in the pre- to post-test 
probabilities of IPV (53%, 65% and 56% respectively). There appeared to be no 
statistically significant differences in the diagnostic indices between these three groups. 
This was not unexpected, however, because the study did not have the power to detect 
differences between the ethnic groups of the orders that are to be expected. The simple 
scoring system and good content validation of the HARK questions was equally 
applicable to all three ethnic groups as all the study participants were English speaking, 
completing the HARK questions in English. 
 
The kick question for identifying IPV also appeared to operate in the same way in the 
three groups in that it had a PPV and specificity of 100% and consequently undefined 
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LRs and PTOs (approaching infinity) in all three groups. The pre- to post-test probability 
of IPV detected using the kick question was 77%. The kick question for identifying 
physical IPV also had 100% PPV and specificity with undefined LRs and PTOs again in 
all three groups. The change from pre- to post-test probability of physical IPV detected 
whilst using the kick question to identify physical IPV was 82%. 
 
In contrast, the afraid question for identifying IPV and for identifying emotional IPV only 
had 100% PPVs and specificities with consequently undefined LRs and PTOs 
(approaching infinity) in the African-Caribbean groups. When using the afraid question 
for identifying IPV in the African-Caribbean groups, there was also a wider difference in 
the pre- to post-test probability of IPV (100 – 32 = 68%) than when actually using all 
four HARK questions (53%). When using the afraid question for identifying emotional 
IPV in the African-Caribbean groups, there was also a wide difference in the pre- to post-
test probabilities of emotional IPV (100 – 25 = 75%). 
 
Only three women answered “yes” to the HARK “rape” question. Therefore it was 
decided not to examine sexual IPV (or the CAS dimension of severe combined abuse 
which includes sexual IPV) as this number was too small for any meaningful analysis. 
 
I have now presented all my results. In the next chapter, I will discuss these results. 
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Chapter 4: Discussion 
 
 
4.1. Overview 
 
In this chapter I will be discussing my results and their implications. I will first 
summarise the answer to my principal research question and then my related secondary 
research question using the results of the systematic review and my data analysis. I will 
then consider why these findings are important and the potential impact that they have for 
clinical practice. Next there is discussion about my quality appraisal of methodology and 
my quality appraisal of the use of ethnicity data in the 20 primary studies included in the 
systematic review and my secondary data analysis. Following on from this, in section 
4.6., I will consider the limitations of QUADAS as a quality appraisal tool. I compare 
QUADAS to the Standards
 
for Reporting of Diagnostic Accuracy (STARD) statement 
which is also concerned with the quality of the methods of diagnostic accuracy studies. 
 
In section 4.7., I will consider the strengths of my thesis which builds on previous work 
into identifying IPV. Many of the strengths centre on my bringing of psychometric 
principles to bear on the subject of IPV identification and applying the evidence base for 
clinical diagnosis to IPV identification. I used the Standards for educational and 
psychological testing as the basis for my comprehensive categorisation of evidence of 
validity and throughout my thesis employed contemporary terminology which these 
Standards promoted. Additionally, my focus on first principles has resulted in my 
drawing attention to the most important function of index questions, i.e. being able to 
change the pre-test probability of IPV to the post-test probability of IPV by the greatest 
percentage. Following this discussion, I will consider the limitations of my work. These 
relate to financial constraints and largely failing to study language as an integral 
component of ethnicity. 
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4.2.  What is the evidence for the validity of questions 
trying to identify IPV in specific ethnic groups? 
 
The systematic review showed that in six studies the study population in effect consisted 
of one predominant group, allowing the evidence for the validity of questions used in 
specific ethnic groups to be assessed: African-Americans (see section 3.2.1.2), Chinese 
women in Hong Kong (see section 3.2.2.1.), white Americans (see section 3.2.2.6.), white 
English speaking Canadians, French speaking Canadians (see section 3.2.3.1.) and 
English speaking Canadian born women (see section 3.2.1.3.). 
 
The evidence for the validity of the STaT questions to identify IPV in an African-
American population shows that they could not be used to identify IPV in brief clinical 
consultations. This is verified by the STaT not identifying sexual IPV and its low PPV 
(all < 48%) regardless of the STaT cut off point used. In a population with a high 
prevalence of IPV (33% according to the ISA), having PPVs of this magnitude is too low 
to be of practical use to a clinician. This is reflected by the change from pre-test 
probability to post-test probability of IPV being only 15% at most. 
 
The evidence for the validity of the two individual questions from the Chinese AAS to 
identify physical and sexual IPV in Chinese women in Hong Kong shows that they also 
could not be used in clinical practice. This is confirmed by sensitivities of 45% and 36% 
suggesting one could not be confident that either physical IPV or sexual IPV 
(respectively) is being identified. The PPVs were higher than the sensitivities with 
considerable change from the pre- to post-test probability, for physical and sexual IPV. 
This means that individuals that test positive on these Chinese AAS questions are likely 
to have IPV but many other women with IPV will not test positive at all with these 
questions. Sackett reasoned that predictive values were more important than either 
sensitivity or specificity in identification (see Background, section 1.3.6.2.1.1.). I would 
contend that in IPV identification, ideally questions should have a high PPV combined 
with a high sensitivity so that not only women who test positive are likely to have IPV 
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but also so that most women with IPV do test positive. These two Chinese AAS questions 
both have a high NPV combined with a high specificity so that not only are women who 
test negative unlikely to have IPV but most women who do not experience either physical 
or sexual IPV do test negative. For IPV identification, questions that have high predictive 
values combined with high sensitivities and specificities are better than those that only 
have high predictive values. 
 
The evidence for the validity of the BRFSS questions to identify IPV in a white 
American population is inconclusive as though the BRFSS appears to have a moderate 
level of diagnostic accuracy for any kind of abuse, this study needs to be repeated using a 
verified reference standard, instead of the WEB. 
 
In a white English speaking Canadian family practice population the eight question 
WAST‟s correlation with the ARI of r=0.69 is impossible to interpret as there is not 
enough detail to replicate execution of the ARI and internal consistency reliability 
(Cronbach‟s coefficient 0.75) should not have been applied to this multi-dimensional 
scale. 
 
In a French speaking Canadian population, the French eight question WAST‟s correlation 
with the ARI of r = 0.96 is also impossible to interpret as there is not enough detail to 
replicate execution of the ARI. The high value of r foremost represents the heterogeneity 
of extreme groups generated by using a known group comparison, as opposed to the 
closeness of the relationship between the two measures. This second point is equally true 
of the internal consistency coefficient alpha of 0.95 for the French WAST and for the 
sensitivity / specificity values given for the two question French WAST-Short. 
 
A study in a predominantly Canadian born English speaking population showed that the 
eight question WAST and the PVS cannot identify IPV in this population in brief clinical 
consultations. The low sensitivities for both the WAST and the PVS means that both 
were not identifying women who were identified with IPV on the CAS. This was 
accompanied by low PPVs. 
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Overall, with regard to the validity of questions trying to identify IPV in specific ethnic 
groups (including the white groups) analysed in the systematic review, there is 
insufficient evidence to justify their use in clinical practice. 
 
My secondary data analysis showed that in self-classified UK census categories of south 
Asian, African-Caribbean and white groups, the four HARK questions whilst using a cut 
off of ≥1 were able to identify IPV as shown by high diagnostic accuracy indices 
(predictive values as well as sensitivity and specificity) and the four HARK questions 
produced a substantial difference between the pre- to post-test probabilities of IPV (see 
tables 7, 8 and 9, on pages 166 to 168). 
 
The secondary data analysis, unlike the systematic review, provides tentative evidence 
for the validity of questions trying to identify IPV in some specific ethnic groups (i.e. 
self-classified national census categories of Asian, African-Caribbean and white groups). 
 
I now summarise the answer to my second research question. 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
179 
4.3.  Does the evidence for the validity of questions 
trying to identify IPV vary between different ethnic 
groups? 
 
None of the six studies in which the study population consisted of one ethnic group were 
repeated in another ethnic group. Therefore comparisons between groups from different 
studies were not possible. Four further studies did try to analyse the differences between 
ethnic groups within the same study. Two of these studies examined the ethnic 
differences in the validity evidence for questions trying to identify IPV.[198, 216] 
 
Chen and colleagues looked at the differences in two ethnic groups - English speaking 
and Spanish speaking Hispanic and non Hispanic women.[198] Their use of a different 
comparator in each of the two groups means that a direct comparison cannot be made. 
The study still concluded that there was a difference in the use of HITS in the two groups 
(cut-off score for the Spanish HITS was half of the cut-off
 
score for the English HITS) 
which they attributed to culture. No data were measured reflecting cultural attributes 
apart from the language difference itself. The results did show that there were clear socio-
economic differences between the English and Spanish speaking groups which the 
authors thought supported the cultural differences between the two language groups. 
However Hispanics and non-Hispanics were similar in all socio-economic characteristics, 
though are likely to have cultural differences. It is misleading to conflate culture with 
socio-economic status. 
 
Zink and colleagues found that ethnicity (white versus African American) combined with 
age, education and income did not significantly affect the diagnostic accuracy of five 
non-graphic questions used to identify IPV.[216] This finding is consistent with the five 
questions being equally valid in white and African American populations. However the 
sensitivities and PPVs for these questions were small, they did not demonstrate internal 
consistency reliability, a Likert type scale (see section 1.3.6.5.) was used and the content 
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validation of these questions indicated that they did not explicitly ask about physical or 
sexual IPV. This last point is to be expected as the questions were trying to be non-
graphic. Poor evidence of validity based on the questions‟ content could be overcome by 
high diagnostic indices. However when this is not achieved the failure of the contents to 
have validity becomes paramount. Overall this validity evidence does not support the use 
of these questions in white or African American populations. 
 
My secondary data analysis showed that there were no statistically significant ethnic 
differences in the ability of the HARK questions to identify IPV or its dimensions of 
physical or emotional IPV. This included when the four HARK questions were used 
together to identify IPV and when the HARK questions were used individually to identify 
IPV and its dimensions, i.e. the “kick” question to identify physical IPV, the 
“humiliation” question to identify emotional IPV and the “afraid” question to identify 
emotional IPV. However the analysis is underpowered to detect differences of the 
magnitude that may occur between the ethnic groups. 
 
The “afraid” question seemed to be more valid in the African-Caribbean groups than the 
south Asian or white groups at identifying both IPV and emotional IPV (see section 
3.3.1.) in that its PPV for both was 100% with wide differences in the pre- to post-test 
probabilities. However the differences in these and all diagnostic indices for the afraid 
question between the three groups were not statistically significant (illustrated by wide 
overlapping confidence intervals). Hence checking for confounding by socio-economic 
status was not required. It is plausible that the very high PPV of the “afraid” question in 
the African-Caribbean groups simply reflects higher IPV prevalences which are manifests 
of possibly lower socio-economic statuses in the African-Caribbean groups. Alternatively 
this could be a potentially clinically important ethnic difference (see section 4.4.). 
 
Overall my secondary data analysis concurs with the primary studies included in the 
systematic review: there is nothing to suggest that the evidence for the validity of 
questions trying to identify IPV varies between ethnic groups. 
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I now consider why the answers to my two research questions are important by putting 
them in the context of previous reviews and examining their potential impact for clinical 
practice. 
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4.4. Findings in context of other reviews and clinical 
practice 
 
These are important results as firstly they are novel and very different from the results of 
previous systematic reviews looking at questions to identify IPV. Secondly, these results 
are also potentially clinically important as they may impact on clinical practice. I will 
expand on both of these areas below. 
 
In previous systematic reviews a number of the questions that I have judged to not be 
useful for clinical practice have been commended. I think that these distinct conclusions 
arise as a result of previous reviewers taking numerical results at face value rather than as 
in this study in which I have worked from first principles (as described in the Background 
chapter) and examined the process by which these figures have been generated. This has 
allowed me to judge the legitimacy of data. I will now compare the results of four 
previous systematic reviews[7, 50, 231, 232] with the results of my systematic review. 
 
The Canadian Task Force on Preventive Health Care in 2003, after having conducted a 
systematic review concluded that the WAST had “…acceptable psychometric properties 
…for primary care settings…”.[231] This appears to have been based on evidence from 
three studies.[219-221] I have interpreted the evidence for the WAST questions from 
these studies as not being particularly compelling: internal consistency reliability 
measures have been used inappropriately and convergent validity was un-interpretable as 
the ARI was not accessible (see section 3.2.3.1.). Additionally values for internal 
consistency reliability and convergent validity are amplified having been derived from 
known group comparisons.[219, 221] It was on the basis of this Canadian Task Force 
systematic review that MacMillan and colleagues,[211] from the McMaster Violence 
Against Women Research Group decided to use the eight question WAST as index 
questions in their validation study. Their diagnostic accuracy data showed that WAST‟s 
sensitivity was 47%, PPV 55% and that the WAST questions changed the pre-test 
probability to post-test probability of IPV by 45%. The low values of these diagnostic 
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indices were attributed to errors associated with the reference standard, the CAS, though 
this was also recognised as the most comprehensive measure of IPV. This interpretation 
is more debatable in the context of the HARK questions achieving a sensitivity of 81%, a 
PPV of 83% and a change from pre- to post-test probability of 60% whilst using the same 
comparator (CAS) as the MacMillan study. I would argue that the diagnostic accuracy 
data from the MacMillan study confirms that the WAST cannot accurately identify IPV. 
Despite the poor evidence supporting the WAST, it continues to be used.[233] 
 
The U. S. Preventive Services Task Force‟s systematic review from 2004 supported the 
use of the HITS and the WEB,[50] unlike my systematic review. The U. S. Preventive 
Services Task Force attached importance to the good internal consistency demonstrated 
by the HITS and WEB. They did not take into account that evidence based on internal 
structure does not reveal what questions are actually identifying (see section 1.3.6.3.); 
and that as the HITS is a bi-dimensional scale internal consistency reliability had not 
been used appropriately. The WEB uses a version of the safety question,[208] versions of 
which have also been used in the PVS[210, 211] and recommended by a systematic 
review to identify IPV.[231] Evidence from 1997 shows that the PVS safety questions 
have a PPV of 51%.[210] Feldhaus and colleagues interpreted their results as confirming 
that the PVS can detect a large number of women who have a history of IPV. Now in the 
context of the HARK questions achieving PPVs of over 79%, the PVS‟s PPV of 51% 
(whilst changing pre to post test probability by only 27%) appears to be too low. 
 
A third systematic review from 2009 also concluded that the HITS had the best 
reliability, predictive power and concurrent validity with a suitable cut-off score.[7] 
Again there was no mention that as the HITS is not uni-dimensional that it was 
inappropriate to measure internal consistency reliability using Cronbach‟s alpha. This 
review also did not take into account the use of unacceptable reference standards by the 
three studies that investigated the HITS.[198, 215, 222] There was no recognition that in 
one study the very high sensitivity and specificity are likely to have been artificially 
inflated, having been derived from a known group comparison.[215] This systematic 
review did acknowledge that the HITS did not ask about sexual abuse and stated that this 
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could be overcome by using another tool to detect sexual IPV. I would argue that HITS‟ 
poor evidence of validity based on its content makes it inappropriate to use in clinical 
practice to identify IPV. This is especially so in the current context of tools that do 
achieve good evidence of validity based on content by including an enquiry about sexual 
IPV, i.e. the HARK questions,[200] the BRFSS questions[217] and the 8 question 
WAST.[211, 220] 
 
The HARK study having been published in 2007 did not feature in the three systematic 
reviews examined above.[7, 50, 231] The most recent systematic review from 2009 did 
include the HARK, rating it as a good quality study, along with 13 other studies.[232] 
Overall this systematic review concluded that “No single IPV tool had well-established 
psychometric properties.” It was noted that all the IPV tools needed additional reliability 
and validity testing. However like the three systematic reviews discussed above, existing 
numerical reliability and validity data were again taken at face value without unravelling 
their meaning. For example, for the HITS the same psychometric results, sensitivity and 
specificity were presented as in the systematic review above.[7] The erroneous use of 
internal consistency reliability and the impact of known group comparisons on results 
were not highlighted. The lack of consensus about appropriate reference standards was 
acknowledged in the discussion  
 
I now reflect on the potential clinical importance of my research findings and how they 
could influence clinical practice. My systematic review did not find any questions that 
could be used in specific ethnic groups to identify IPV clinically. Unlike the systematic 
review, my secondary data analysis does provide evidence that the four HARK questions 
can identify IPV in self-classified UK census categories of south Asian, African-
Caribbean and white groups. This is important as it means that on the basis of the existing 
evidence, the same questions can be used to identify IPV in individuals from different 
English speaking ethnic groups in primary care, in east London. Knowing that HARK has 
the same cut off in all three groups with high diagnostic indices is of note clinically as it 
allows HARK to be used in the same way in these groups. Clinicians and researchers of 
IPV can be reassured that there is no evidence from my systematic review and secondary 
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data analysis that the validity of questions varies significantly between different English 
speaking ethnic groups. A cluster randomised trial testing an educational intervention to 
improve the health care response to domestic violence used the four HARK questions as 
an electronic prompt to ask about IPV in response to given clinical presentations, for 
example depression and pelvic pain.[234] In this study (IRIS), the HARK questions have 
been found to serve as a reminder to clinicians to ask about IPV in multiethnic patient 
populations in Bristol and Hackney (personal communication). These clinicians and 
researchers can now be more confident that HARK has some validity in a variety of 
different ethnic groups. 
 
Though the change from pre- to post-test probability of IPV produced by the kick 
question was greater than when using the four combined HARK questions, the kick 
question‟s sensitivity and NPV was lower. This would make it less likely for the four 
HARK questions to be replaced with just the kick question in the real world, despite 
Sackett‟s assertion about the supremacy of predictive values over sensitivity and 
specificity.[61] However in time limited scenarios, for example in emergency 
departments, it may be reasonable to use the kick question, as opposed to all four HARK 
questions. Conversely using the four HARK questions, starting with the humiliation 
question, may be interpreted as a gentler introduction to the difficult subject of IPV. In 
African-Caribbean women the first question when exploring the possibility of IPV being 
present may prove to be the afraid question which could then be followed by the kick 
question. 
 
I have judged my research findings in the context of previous research and considered the 
potential clinical implications of my results. I now evaluate my appraisal of the quality of 
the methodology and the use of the ethnicity data in the 20 primary studies included in 
the systematic review and my secondary data analysis. 
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4.5. Quality Appraisal 
 
In this section, I consider the role of QUADAS in evaluating the methodology of the 20 
individual studies in my systematic review. The outstanding methodological issues 
related to the heterogeneity and hierarchy of the range of methods seen in these 20 
systematic review papers as a whole are then also considered. Following this, I discuss 
my use of a simple checklist to appraise the use of ethnicity data in these 20 papers. 
Subsequently I evaluate the methodology of my secondary data analysis, focussing on the 
power of this analysis which is related to the use of ethnicity data and the use of a good 
reference standard. 
 
 
4.5.1.  Evaluating quality appraisal of methodology of the 
systematic review studies by QUADAS 
 
The role of QUADAS in evaluating the methodology of the individual studies in my 
systematic review is considered below by highlighting QUADAS items which 
differentiate between studies and reflecting on QUADAS items which are not self 
explanatory. Further detail is given about these items to help contextualise them. See 
table 5 (page 127) for the QUADAS quality items in relation to each study. 
 
The first QUADAS item, whether the spectrum of patients is representative, identified 
that three of the studies were known group comparisons with extreme groups[215, 219, 
221] whilst a fourth involved high risk post partum women.[225] The three known group 
comparison studies were fundamentally different from those with more representative 
populations. This not only affected the degree of correlation and internal consistency 
reliability but also the diagnostic accuracy indices generated (see section 3.2.4.2.). This 
makes these studies incomparable with studies that do actually use a representative 
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spectrum of patients. Additionally the external validity of these studies is limited. The 
results are less generalisable to a general clinical population, including those women who 
have experienced varying degrees of IPV and have not required the services of a refuge 
shelter. 
 
The second item, whether inclusion criteria have been stated, identified three studies 
which did not state inclusion criteria.[212, 213, 224] One of these did state exclusion 
criteria but the selection of participants was still not fully described.[213] QUADAS does 
not evaluate whether inclusion criteria are either appropriate or justified. For example, in 
the Zink study an inclusion criterion was to have been with a steady partner for at least 
one year.[216] This probably accounted for 81% of the study population being married. 
This may have decreased the prevalence of IPV in that study population (11%) which 
would have affected the PPVs and NPVs but not the low sensitivity (45%) of the index 
questions. 
 
The third item, whether an acceptable reference standard was used, reveals that there 
were at least seven studies that definitely did not use an acceptable reference 
standard[208, 210, 215, 217, 222, 223, 225] with five studies in which it was unclear 
whether an acceptable reference standard was used.[198, 218-221] Hence there were 
eight studies that did use only an acceptable reference standard.[200, 209, 211-214, 216, 
224] An acceptable reference standard is one which is likely to correctly classify the 
target condition (i.e. IPV). An apparent reference standard for IPV once modified 
requires further evidence that it remains an acceptable reference standard. Multiple 
modified comparators in the systematic review papers had not been previously 
psychometrically tested. For example, in Peralta‟s study[214] the modified reference 
standard (a six question version of the Conflict Tactic Scale) made it impossible to 
interpret the poor diagnostic accuracy indices generated. Instead this study should either 
have used an established reference standard or considered the use of other research 
methods that were not reliant on having a reference standard (for example convergent 
validity). However, it is clear that within the research area of IPV there is no universal 
consensus on a reference standard to measure IPV. 
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The modified comparators included those that were translated into different languages, 
for example Tiwari and colleagues[212] used the 39 question revised Chinese CTS 
(CTS2) whilst Reichenheim and colleague[213] used the 12 question physical violence 
scale of the modified revised Portuguese CTS2 (12 item mCTS2). In these instances I 
was reliant on the authors‟ comments having been unable to access the supporting 
references. Some of these studies also included index questions that had been translated 
into different languages. For example McFarlane and colleagues[224] offered the index 
questions in English and Spanish. No details were given on how the content validation of 
the Spanish AAS was achieved. It was difficult to say whether there was enough detail to 
replicate the foreign language versions of index and reference standard questions. 
 
The tenth and eleventh items were concerned with review bias which refers to whether 
the index test results were interpreted without knowledge of the reference standard results 
(one QUADAS item) and whether the reference standard results were interpreted without 
knowledge of the index test results (further QUADAS item). This blind analysis of the 
index tool and the reference standard respectively is equivalent to “blinding” in 
traditional intervention studies. This is in an attempt to avoid review bias which could 
boost diagnostic accuracy measures. Table 5 shows that for all the studies bar one it was 
not known whether review bias was avoided. In the one study where analysis was known 
to be blinded, this information was not actually reported in the published paper but was 
acquired from the authors and confirmed from the original study protocol. However in all 
20 studies, adding up individual‟s scores for sets of questions is an objective exercise 
which involves no subjectivity and is not vulnerable to review bias. Therefore it would 
have been safe to have omitted the two items concerned with review bias from QUADAS 
for this systematic review. For further details, see section 4.6. 
 
Having covered the role of QUADAS in evaluating the methodology of the 20 individual 
studies in my systematic review, I now consider some outstanding methodological issues. 
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4.5.2.  Outstanding methodological issues related to the 
systematic review 
 
I now consider the methodological issues related to my systematic review which were not 
covered by the QUADAS items. This firstly includes the heterogeneity of methods 
followed by a proposal for the hierarchy seen in the methods present in the 20 papers 
identified in the systematic review. 
 
 
4.5.2.1. Heterogeneity of methods 
 
The Results chapter showed that the primary studies in the systematic review reported a 
variety of methods, trying to find evidence of validity for questions to identify IPV (i.e. 
were questions thought to identify IPV, identifying IPV?). These methods included 
diagnostic accuracy as well as traditional validation methods (criterion correlation, 
convergent validity, known group comparisons and internal consistency reliability). The 
heterogeneity of methods made it difficult to compare studies. 
 
The inclusion criteria for my systematic review reduced the heterogeneity of study 
methods partly by stipulating that the comparator tool was either a standard reference 
criterion or other test intended to measure a construct similar or related to IPV (see 
section 2.2.2.). This in effect excluded studies that may have compared their index 
questions to external variables as opposed to a comparator tool. For example, in Coker‟s 
study[218] the index questions were also compared to self reported poor mental health 
and the number of physician visits in the last year. This type of association study between 
index scores and external variables (see section 1.3.6.2.2.1.) is reasonable especially 
when comparator tools are contested. Coker‟s study was included in my systematic 
review as the method also included comparison of the index questions to a comparator 
tool. There were other studies that were excluded as there was no comparison of the 
index questions to a comparator tool. For example, a known group comparison in which 
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there was no comparison of the translated Spanish WAST to a comparator tool was 
excluded from my systematic review.[235] On the one hand this was an asset, as 
decreasing heterogeneity of methods makes it easier to compare studies. Conversely this 
could be construed as a limitation excluding potentially important studies which may 
have produced evidence of validity for questions in a difficult arena in which there is no 
consensus about the ideal reference standard (see third QUADAS item, section 4.5.1.). 
 
My computation of diagnostic accuracy in two studies[217, 218] was potentially a useful 
strategy to aid comparisons between studies. A previous systematic review also used this 
strategy.[7] The diagnostic accuracy data generated were easier to interpret than 
correlation data (i.e. coefficients, relative risks or overlapping numbers and percentages
1
) 
with regards to deciding whether a set of questions should be used in a clinical context 
based on their accuracy, as well as the questions then being easier to interpret when used 
in clinical contexts. The limitation of diagnostic accuracy data is the need for an efficient 
and appropriate reference standard and adequate categorical data (see section 4.5.2.2.). 
The WEB and modified ISA-P (used in the Bonomi and Coker studies respectively) are 
not dissimilar to the comparators treated as standard criterions from the onset in some 
studies. For example, a modified version of the ISA-P was used as a standard criterion in 
the study conducted by Chen and colleagues.[198] However it was incorrect to force 
comparator tools (WEB and modified ISA-P) to take on the function of reference 
standards when their utility as reference standards has not been confirmed. The Coker 
study data suggested that WEB‟s positive predictive value for identifying IPV was only 
52%. This in turn made it unfeasible to interpret the diagnostic accuracy data that had 
been generated for the BRFSS. As well as being an inefficient reference standard, the 
WEB was probably also an inappropriate comparator tool. The authors pointed out that: 
“…both the BRFSS and WEB identified some women as abused that would have been 
missed
 by the other instrument...” 
                                                 
1
 The numbers and percentages of women who scored positive on two tools, i.e. overlapped, were provided 
as a result in the Bonomi and Coker study. 
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Hence the BRFFS and the WEB may have been measuring different things, probably 
different aspects of IPV, making it inappropriate to use the WEB as a comparator tool to 
assess the performance of the BRFSS. 
 
For my systematic review, I had planned to pool numbers by combining the results from 
studies about the same index questions in specific ethnic groups. This was not possible 
due to the heterogeneity of the comparator tools used (the majority of which were 
modified in different ways), the heterogeneity of the index questions used (for example, 
even when studies said that they were using the AAS in the Abstract, this invariably 
turned out to be different versions of the AAS questions) and the heterogeneity of the 
methods used, as described above. 
 
 
4.5.2.2. Hierarchy of methods 
 
Diagnostic accuracy studies do appear to be superior to criterion correlation studies 
within the subcategory of criterion performance studies. This is supported by my 
comparison of studies using both diagnostic accuracy and criterion correlation, in the 
Results (see section 3.2.2.8.). However criterion correlation studies have an important 
role if data cannot be used categorically, (see section 1.3.4.). A diagnostic accuracy 
method cannot then be used to assess the validity of questions. The HARK study data 
generated an optimal cut-off point in its entire study population as well as each of the 
three ethnic groups. This is evidence for the categorical rather than dimensional structure 
of the data. 
 
I have discussed the heterogeneity and hierarchy of the range of methods seen in these 20 
systematic review papers. I now consider my use of a simple checklist to appraise the use 
of ethnicity data in these 20 papers. 
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4.5.3.  Evaluating quality appraisal of the use of ethnicity 
data in the systematic review studies by a five 
criterion checklist (DECSS) 
 
The role of my five criterion checklist (DECSS) in evaluating the use of ethnicity data in 
the individual studies in my systematic review is considered below. See table 6 (Results, 
page 131) for these criteria in relation to each study. 
 
I derived the individual criteria from published guidance on the use of ethnicity in health 
research. The role of this checklist was to appraise the use of ethnicity data in the primary 
studies included in the systematic review. These criteria essentially examine the ethnicity 
terms used in papers, how they are used and check to see whether confounding of 
ethnicity by socioeconomic status has been considered. See below. 
 
Five criterion checklist (DECSS) for quality appraisal of the use of ethnicity data 
 
Table 6 shows that out of the total of 20 studies in my systematic review, 18 described 
the ethnicity of the study population in some fashion. This table displays the complexity 
of ethnicity which can be defined in many ways (for example, using language, 
geographical origin, national census categories – see section 1.4.1.). This can make it 
difficult to have a straightforward answer to what at first seems like a simple question: 
 
1. D: Is ethnicity described? 
2. E: What are the terms used to describe ethnicity? 
3. C: Is the classification system using ethnicity justified? 
4. S: Is ethnicity self-assigned? 
5.  S: If the study analyses differences in ethnic groups are 
socio-economic factors considered or controlled for? 
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does a study describe ethnicity? This confusion is seen in some of the primary studies in 
my systematic review. For example, Chen and colleagues[198] conflate culture with 
language and socio-economic status whilst describing “Race / ethnicity.” 
 
It was striking that despite the terms being used (“ethnicity,” “race / ethnicity,” “race” 
etc.) the same group names were generally being used (white, black, Hispanic etc.). See 
table 2 (box headed “ethnicity”) on page 115 and table 6 on page 131. Four studies used 
the phrase “race / ethnicity,”[198, 216, 217, 222] whilst three studies used the words 
“ethnicity” and “race” interchangeably.[208, 210, 224] Two studies used the word “race” 
but used the same group names as in studies that explicitly were purported to be studying 
ethnicity (i.e. African American, Hispanic, Asian, white).[214, 218] The majority of these 
classification systems appear to be based on skin colour with some containing additional 
information on country of origin and language. This supports the observation in my 
background (see sections 1.4.1.1. and 1.4.1.2.) that in published papers, there is little 
difference in how “ethnicity,” “race” or “race / ethnicity” are used. 
 
In my background I also suggested that the term “race” is outmoded as words such as 
Africans, Asians and Caucasians do not relate to any distinct genetic differences in 
humans.[140] The papers included in my systematic review show that these racial 
categories persist within biomedicine[140] as they do in every day life. For example, 
Ernst at al‟s relatively recent study from 2004[214] still used the misleading word 
“Caucasian.” Bhopal points out that this is widely used as a synonym for “white” though 
it actually means originating in the Caucasus region, referring to Indo-Europeans.[134] 
 
None of the studies justified the classification systems that they used. One study used 
national census categories to check the representativeness of its study population,[200] 
i.e. there was direct use made of the classification system. 
 
In seven studies ethnicity was self-assigned.[200, 208, 210, 214, 217, 222, 224] In this 
last study, it was unclear what happened to participants who attended for an interview 
and whether their ethnicity was still self-assigned. In the remaining studies it was not 
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clear whether ethnicity was self-assigned or assigned by others. For ethnic classifications 
to be valid they should preferably be self assigned, (see section 1.4.1.). 
 
Out of the 12 studies whose study populations contained different groups, four studies 
analysed the differences between groups.[198, 208, 216, 224] Two of these studies 
compared the evidence for validity of questions trying to identify IPV in different ethnic 
groups with consideration of socio-economic status.[198, 216] One of these two studies 
argued that it had found a difference between groups but did not formally check for 
confounding by socioeconomic status.[198] 
 
The majority of the studies whose study populations contained different groups did not 
analyse the differences between groups. There was also no further processing of their 
ethnicity data apart from in one study out of the eight.[200] Collecting ethnicity data 
without analysing it further adds to the description of the study population, along with the 
participants‟ age, sex and socioeconomic status. This helps the reader judge how 
pertinent any particular research finding is to their own clinical population. However the 
downside of the almost ubiquitous presence of unprocessed ethnicity data in IPV 
identification studies is that it creates an impression that an ethnic difference does exist in 
IPV identification. This is in contrast to the actual findings of my research that there is 
nothing to suggest a difference in IPV identification between ethnic groups. If researchers 
believe that ethnicity impacts on IPV identification, their studies should be organised so 
as to measure its impact. If researchers believe that ethnicity does not impact on IPV 
identification but their studies contain diverse populations to increase the external 
validity of their findings then the impact of ethnicity does not need to be measured but 
the ethnic profile of the sample should be characterised to assess the extent to which it is 
representative of the local general population. Epstein expanding on his Inclusion / 
Difference paradigm affirms that when including a diverse study population one may 
want to see if it is representative of the actual population but this should not mean that 
one is looking for an ethnic difference in the study variable being studied unless one has a 
pre-existing premise supporting an ethnic difference.[140] 
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In my background, my premise was that cultural differences in attitudes towards IPV 
could affect disclosure in different ethnic groups which in turn could also affect how 
accurately some questions identify IPV in different ethnic groups in a health setting (see 
section 1.4.1.3.). Therefore from my initial perspective, considering that the majority of 
studies contained both ethnicity and socio-economic data, the fact that only four studies 
analysed any differences in ethnic groups is a missed opportunity for investigators who 
could have compared the evidence for validity of questions trying to identify IPV in 
different ethnic groups. However there are resource implications for a study to be 
sufficiently powered to look at ethnic differences. This may explain why most studies 
have not analysed the ethnic differences in IPV identification. 
 
In conclusion, I consider that my list of five set criteria (DECSS) has allowed the task of 
appraising the use of ethnicity data in the systematic review studies to be achieved in a 
standardised manner. This short checklist is easy to apply to studies unlike the existing 
lengthy published guidance.[137, 148, 165, 166, Malley-Morrison, 2007 #440] Published 
guidance about the use of ethnicity appears to be mostly ignored in the topic area of IPV 
identification. It has also been overlooked further afield.[236] 
 
 
4.5.4.  Evaluating the secondary data analysis – 
methodology and use of ethnicity data 
 
I now consider the methodological issues and the use of ethnicity data in my secondary 
data analysis. Firstly, the major methodological strength of my secondary analysis was 
that I calculated confidence intervals for all my results which provided a measure of the 
precision of my results, unlike the majority of the studies included in the systematic 
review. The confidence intervals suggested that my secondary analysis was 
underpowered to confidently confirm that there were no statistically significant 
differences in the validity of the HARK questions at identifying IPV in different ethnic 
groups. 
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In the original HARK study, a power calculation established the size of the study 
population required.[200] A power calculation was not possible for my secondary 
analysis as the size of the study population was already fixed with predetermined 
numbers of participants in each ethnic group. The systematic review showed that a robust 
investigation into the role of ethnicity on IPV identification had not previously been 
conducted. This indicated that my secondary analysis was of value, as it would be able to 
inform the design of a future definitive study into the ethnic differences in IPV 
identification. 
 
This future study would need a total sample size of 2,142 (i.e. 238 in each group) if there 
were nine different ethnic groups. These nine groups would be more specifically defined 
than the current three groups. This study could then potentially show that clinically 
important differences in the validity of the HARK questions at identifying IPV is unlikely 
– assuming that clinically important differences are in the order of 20%, with study 
power being 80%. This sample size calculation is based on the assumption that the 
change from pre-test to post-test probability of IPV in all groups is 50% which is 
consistent with the current data. 
 
The second methodological strength of my secondary analysis was that I used the 
Composite Abuse Scale (CAS) as my reference standard. Based on published evidence 
this appears to be a good reference standard for measuring IPV.[101, 115] In my original 
HARK paper, I state that  
“The CAS has an internal reliability (Cronbach's alpha) of .90 or more for each sub-scale, 
and all item-total score correlations of .6 or above. It has also been validated with a large 
(1,836) sample of patients in general practice settings within primary care. It is based on 
a concept of IPV that includes coercion, not simply violent acts arising out of conflict. It 
is recommended as an IPV research assessment tool by the National Centre for Injury 
Prevention and Control as it has demonstrated reliability and validity for measuring the 
self-reported incidence and prevalence of IPV. It has evidence of content, construct, 
criterion and factorial validity.”[200] 
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The CAS represents self-reported verified measurable violence unlike existing tools.[50] 
I believe that on the basis of this evidence the CAS deserves a consensus recognising it as 
the best current reference standard with which to measure IPV. This consensus currently 
does not exist (see third QUADAS criterion, section 5.5.1.). Evaluating the HARK 
questions against the CAS allows HARK‟s accuracy for identifying IPV among women 
in the general population to be demonstrated. CAS‟s most important limitation is that it 
does not have a record of being tested in the ethnic groups in which I was trying to 
validate the HARK questions. However neither did any of the other acceptable reference 
standards. 
 
In my secondary analysis I amalgamated data into larger groups (African-Caribbean, 
south Asian and white) in an attempt to increase power to make comparisons between 
groups. I felt that this was justified as the participants within each aggregated group may 
share cultural beliefs affecting how they may respond to questions asking about IPV, 
perhaps related to their historical connections with distinct geographical regions, i.e. 
Africa, the Indian subcontinent and Europe respectively. The advantage of using these 
aggregated groups was that this increased the power of my analysis to make comparisons 
between groups without increasing the resources that I needed. The limitation of this 
approach was the accompanying assumption that the cultural beliefs shared by women 
within each group (for example a first generation Nigerian immigrant with a second 
generation Jamaican woman) had more in common than the cultural beliefs shared by a 
woman from one group with a woman from one of the other two groups (for example, the 
Nigerian woman with a white English woman). This type of assumption is supported by 
qualitative research that suggests racism may affect abused individuals‟ responses in 
surveys and their experiences of abuse.[237] Racism has also been intimated to be used 
by men to gain their partner‟s forgiveness[238] with the role of black-led churches at 
times of personal distress recognised.[238, 239] However this should not distract from 
the differences within these groups – for example, African communities have often 
recently immigrated to London compared to more settled Caribbean communities. 
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Studies of ethnic differences always have to balance studying specific well defined ethnic 
groups versus resource constraints requiring the study of larger less well defined groups. 
These larger groups often end up describing participants‟ skin colour and / or continent of 
origin rather than their ethnicity. Hence the groups in the secondary analysis also appear 
to be based on skin colour despite the HARK study being based on national census 
categories of ethnicity and the background to this thesis making a case for IPV 
identification being affected by culture as opposed to skin colour. 
 
The wide overlapping confidence intervals generated for the diagnostic indices for each 
aggregated ethnic group (see tables 7, 8 and 9) means that the size of each group was still 
too small and / or that the differences between the groups were of an order that were too 
slight to be detected by my data analysis. The results may be consistent with there being 
no real ethnic differences in the validity of questions to identify IPV. This would be 
confirmed by having a sufficient number of participants in each ethnic group and the 
generation of overlapping narrow confidence intervals for the diagnostic indices. 
 
I have considered how I appraised the quality of the methodology and of the use of 
ethnicity data in the 20 primary studies included in the systematic review and my 
secondary data analysis. I now turn back to QUADAS, an evidence based quality 
assessment tool. In the next section, I consider QUADAS‟s limitations which were 
highlighted when I used it to appraise my systematic review. I then compare QUADAS to 
the Standards
 
for Reporting of Diagnostic Accuracy (STARD) statement. 
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4.6.  Limitations of QUADAS 
 
Quality appraisal of the primary studies with QUADAS highlighted important 
methodological weaknesses and biases (see section 4.5.1.). However some limitations of 
QUADAS were also isolated in that not all of the methodological problems in studies 
were identified. I now consider some of the limitations of QUADAS and then compare 
QUADAS to the Standards
 
for Reporting of Diagnostic Accuracy (STARD) statement. 
STARD arose more directly from the Consolidated Standards of Reporting Trials 
(CONSORT) initiative.[240] It was developed by a group
 
of scientists and editors in 
2003.[241-243] 
 
QUADAS has no item for sample size or whether a power calculation has been used to 
estimate the sample size required. Hence a number of studies with extremely small 
sample sizes[219, 221] were not down graded and studies with large sample sizes were 
not upgraded.[211, 217] QUADAS also does not have a criterion to evaluate whether 
statistical tests are used correctly. For example only categorical data permits diagnostic 
accuracy indices to be calculated. There was also no criterion addressing the importance 
of using confidence intervals to assess the precision of results. I think that an improved 
QUADAS should contain items that: 
1. judge adequacy of sample size in relation to study aims 
2. evaluate whether statistical tests are used correctly 
3. recognise the use of confidence intervals 
 
The initial list of 28 possible items for inclusion in QUADAS included[202]: 
 Was an appropriate sample size calculation performed and were sufficient patients 
included in the study? 
 Were appropriate results presented (sensitivity, specificity, likelihood ratios, 
diagnostic odds ratios and predictive values) and were these calculated 
appropriately? 
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 Was a measure of precision of the results presented (confidence intervals, 
standard errors)? 
 
These 28 items were rated using a consensus Delphi procedure which finally resulted in 
14 items.[202] The process of the Delphi procedure was described in detail. The precise 
reasons why particular items were excluded were not stated. A summary of evidence 
from a review of methodological literature on diagnostic test assessment and a review of 
the tools used to assess the quality of diagnostic tests in relation to each of these items 
was given to the diagnostic experts who comprised the panel in the Delphi procedure. 
This was to assist the panel members in their task of rating each item for inclusion in 
QUADAS, the quality assessment tool. 
 
For both the excluded items on sample size calculation and results presented (see above), 
the review of methodological literature on diagnostic test assessment showed that no 
studies were available providing evidence of either empirical or theoretical evidence of 
bias or an absence of bias and variation. The review of the tools used to assess the quality 
of diagnostic tests showed that between 25 to 49% of these tools covered both 
appropriate sample size calculation and the results presented. 
 
For the excluded item on precision of results, the review of methodological literature on 
diagnostic test assessment showed that there were no studies providing evidence of either 
empirical or theoretical evidence of bias, or evidence of an absence of bias and variation. 
0 to 24% of tools used to assess the quality of diagnostic tests covered this item on the 
precision of results. 
 
The Delphi procedure received completed questionnaires from eight of the eleven 
diagnostic experts initially invited. Five panel members endorsed the Delphi procedure. 
One did not. He stated: “I fundamentally believe that it is not possible to develop a 
reliable discriminatory diagnostic assessment tool that will apply to all, or even the 
majority of diagnostic test studies.” The two remaining panel members were unclear 
about whether to endorse the Delphi procedure.[202] 
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In common with the previous research done into QUADAS, I also found that a combined 
quality score should not be used.[205] The range seen in the number of items fulfilled by 
each study included in the systematic review varied from eight to 12 when the two items 
concerned with review bias were removed (see section 4.5.1.). This limited range did not 
demonstrate the actual wider variety uncovered in study quality. For example, the 
McFarlane study fulfilled ten items which would initially appear to indicate reasonable 
quality. I think that the un-interpretable results (no numerical data presented) are more 
important with respect to study quality than the other ten items. This supports the view 
that a combined quality score should not be used due to unresolved weighting 
issues.[205] 
 
However the systematic review also showed examples where the range seen in the 
number of QUADAS items fulfilled did seem to indicate something tangible. For 
example examining the two studies which reported differences in validity evidence 
between ethnic groups,[198, 216] the first fulfilled nine items whilst the second fulfilled 
twelve items. This difference seems to represent a true difference in the overall 
methodological quality of these two studies. Though the Zink study fulfilled the 
maximum number of QUADAS quality items it still did not support the use of its five 
non-graphic questions for identifying IPV in either white or African American 
populations. Indeed having fulfilled the maximum number of quality items, adds weight 
to the fact that these questions are not valid in these populations. 
 
Having considered the limitations of QUADAS, I now compare QUADAS to the STARD 
statement. 
 
 
4.6.1. Comparison of QUADAS to STARD 
 
The objective of QUADAS is to assess studies of diagnostic accuracy included in 
systematic reviews whilst the objectives of STARD are to improve the quality (i.e. 
accuracy and completeness) of the reporting of diagnostic accuracy studies, allowing the 
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bias potential and generalisability of a study to be assessed.[241] Unlike QUADAS, 
STARD includes criteria to  
 describe the methods for calculating or comparing measures of diagnostic 
accuracy, and the statistical methods used to quantify uncertainty (for example, 
95% confidence intervals) - which would be affected by the sample size. 
 report estimates of diagnostic accuracy and measures of statistical uncertainty (for 
example, 95% confidence intervals). 
 
These issues have not been addressed by QUADAS. Additionally STARD touches upon 
test reliability with items on reproducibility
2
  
 Describe methods for calculating test reproducibility, if done. 
 Report estimates of test reproducibility, if done. 
QUADAS contained no items to look at these characteristics in the index tool although 
incongruously further planned work to assess QUADAS includes checking its 
consistency and reliability.[202] 
 
For STARD, as for QUADAS, the literature was searched to find 75 potential items but 
unlike QUADAS a two day consensus meeting was used to reduce this to a 25 item 
checklist and a flow diagram, using evidence whenever it was available. The STARD 
consensus meeting was attended by 39 specialists (STARD steering committee, 9 
members and STARD group, 30 members), resulting in every-one signing up to the final 
STARD statement. Overall I think that STARD appears to have a number of advantages 
over QUADAS including greater professional endorsement. 
 
However neither QUADAS nor the STARD are designed to appraise studies that 
predominantly use validation paradigm methods. Hence the fact that correlation 
coefficients and Cronbach‟s alphas were not used appropriately in different studies would 
not have been identified by either. Hardly any of the papers using correlation coefficients 
presented their scatter plots. The meaning of any particular correlation coefficient is 
                                                 
2
 Reliability refers to the reproducibility of a measurement. 
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assisted by presenting the associated scatter plot displaying the bivariate distribution 
between the test score and other measure – a point not captured by QUADAS or STARD. 
Additionally neither QUADAS nor STARD have items assessing the validity evidence 
based on response processes or questions‟ content. In traditional diagnostic accuracy 
studies concerned with medical tests this may be irrelevant but when assessing questions 
that form part of a history these characteristics become central, especially if questions 
have been translated for evaluation in different ethnic groups. 
 
QUADAS is constrained because it is a single tool trying to apply to all diagnostic 
accuracy studies. It has been described as the generic part of a more extensive tool which 
would include topic specific items, for example for questionnaire scales.[202] Indeed it 
may be that a separate new appraisal tool is required to assess the quality of studies in 
systematic reviews that apply the concept of clinical test validation. This is when 
researchers take the view that no acceptable reference standard exists,[3] and validation 
paradigm methods are used. Topic specific items may then include checking that 
correlation coefficients and Cronbach‟s alpha are used appropriately. This assessment 
requires a clear description of the theoretical basis of a construct that a questionnaire is 
trying to tap. Items assessing the evidence of validity based on response processes or 
questions‟ content would also be useful, especially if examining questions in different 
languages whilst looking at ethnic differences. 
 
I have considered QUADAS‟s limitations whilst comparing it to the STARD statement 
and discussed how neither QUADAS nor STARD have been designed to appraise studies 
that predominantly use validation paradigm methods. I now discuss the strengths and 
limitations of my thesis. 
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4.7. Strengths and limitations of my thesis 
 
I now discuss the strengths and limitations of my thesis as a whole, as opposed to those 
covered above which mainly relate separately to the systematic review and secondary 
analysis. 
 
 
4.7.1. Strengths 
 
The strengths of my thesis include that it directly builds on the work previously carried 
out in identifying IPV, that it uses my comprehensive categorisation of evidence of 
validity which conveys a lucid understanding of validity, my attention to detail with a 
focus on first principles, my highlighting of the ability of index questions to alter the 
probability of IPV, my use of a checklist (DECCS) to appraise the use of ethnicity data in 
studies and my recognition that all individuals have an ethnic identity. I expand on each 
of these strengths below. 
 
The foremost strength of my thesis is that it directly builds on the work previously carried 
out in identifying IPV whilst also contributing to future research. The original HARK 
study was planned after reviewing the index questions in the literature being used to 
identify IPV. Thus the HARK questions arose from the AAS questions.[200] The original 
HARK paper includes a full description of how the HARK questions were adapted from 
the AAS questions with discussion about the AAS questions‟ strengths and weaknesses. 
The HARK questions attempted to build on the strengths of the AAS whilst eliminating 
its weaknesses. Following this non-systematic review of index questions, my work 
evolved into a systematic review of index questions to identify IPV in specific ethnic 
groups with my accompanying secondary data analysis. My thesis will now be able to 
contribute to a potentially authoritative study which precisely defines questions that are 
valid in some specific ethnic groups to identify IPV as well as being able to confirm that 
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there are not any significant differences in the validity of these questions between ethnic 
groups (see section 4.5.4. and 5.3.). 
 
My comprehensive categorisation of evidence of validity (see section 1.3.6.) is also a 
major strength of my thesis as it allowed me to thoroughly review all the evidence of 
validity presented in the papers included in my systematic review as well as my 
secondary analysis. This framework also accommodated evidence of validity from papers 
that did not fulfil the inclusion criteria of my systematic review (for example, Fogarty 
and Brown‟s study[235]). I devised this framework by integrating the evidence derived 
from diagnostic accuracy studies and more traditional validation methods including 
validity evidence based on response processes and test content. None of the previous four 
systematic reviews had looked methodically at these latter two attributes of index 
questions. I think that validity evidence based on response processes and test content are 
fundamental factors to consider when evaluating index questions. Most recently Streiner 
and Norman noted that the Standards
 
for Reporting of Diagnostic Accuracy (STARD) 
statement and the Standards for educational and psychological testing were useful 
guidelines for reporting test results.[103] I believe that my integration of diagnostic 
accuracy methods and traditional validation methods goes an important step further by 
considering together in one framework how validity can be measured and how different 
sources of validity potentially relate to one another. 
 
My clarity regarding the concept of validity is also a thesis strength. This is reflected by 
the use of up to date terminology i.e. that all validity is construct validity as opposed to 
the traditional three Cs of validity (criterion, construct and content validity). Following 
on from this is that validity (an outcome) is very different from validation (a process). 
Linked to this is that validation is an ongoing process which changes the degree of 
confidence that one draws about the inferences made about participants according to the 
scores they have obtained on answering index questions. This in turn highlights the 
importance of using confidence intervals which convey the precision of the result. 
Confidence intervals featured prominently in the original HARK study and my secondary 
data analysis unlike in the majority of the primary studies in my systematic review. 
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A further strength of my work has been my attention to detail with a readiness to return to 
first principles for each subject covered (for example, measuring validity and defining 
ethnicity). This was also seen in relation to the statistical methods used in studies. Hence 
I consistently considered how various statistics were used rather than taking numerical 
results at face value. This has led to my questioning of results that other systematic 
reviewers have accepted. 
 
The importance that I have attached to the ability of index questions to change the pre- 
test probability of IPV to a different post-test probability of IPV is also a strength. I stated 
that the most clinically useful index questions are those that are found to produce the 
largest difference between the specific study prevalence and the PPV of the index 
questions in that study. The rationale behind this has been explained in the Background 
(see section 1.3.6.2.1.1.). Therefore the sensitivity of index questions for identifying IPV 
is not paramount as proposed by some[232] nor are just the predictive values as 
suggested by others.[61] I think that using the difference between pre- to post-test 
probabilities gives the most useful information about the functional ability of index 
questions to identify IPV. It also underscores that it is not questions that are valid. Instead 
validity applies to the application of questions in a particular study population, with its 
own unique IPV prevalence and not to the questions them-selves.[89] 
 
A further strength is my compilation of five set criteria (DECSS) to appraise the use of 
ethnicity data in studies. This checklist (DECSS) has potential use for researchers 
planning studies into ethnicity, for peer reviewers evaluating studies about ethnicity and 
for publishers deciding whether to publish studies on ethnicity. This in turn may serve to 
increase the quality of studies by biomedical researchers examining ethnicity and ethnic 
differences or at least to improve the quality of the reporting of these studies. 
 
Lastly, a fundamental strength of my research is the underlying concept that all 
individuals have an ethnic identity. Empirically this translated into my systematic review 
having no inclusion or exclusion criteria that were concerned with ethnicity. 
Consequently some of the included studies examined ethnic majorities (for example, 
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Bonomi et al‟s study of white Americans[217]) as opposed to studies which only 
examined ethnic minorities. The Oxford Dictionary defines “ethnic minority” as a usually 
identifiable group differentiated from the main population of a community by racial 
origin or cultural background.[90] Historically many majority community researchers 
have studied only ethnic minorities which detracts not only from the ethnicity of other 
white minority groups (for example, the Irish in the UK) but also the ethnicity of the 
majority group. Most importantly presuming that all individuals have an ethnic identity 
offers a straightforward strategy for avoiding stigmatising and the “we / they” dichotomy 
between researchers (who are often from majority communities) and ethnic minorities. 
Stigmatising and the “we / they” dichotomy has been described as a major challenge 
when writing about ethnicity.[137] Other strategies to avoid the “we / they” dichotomy 
such as ensuring more researchers from minority communities (such as myself) are 
probably harder to achieve especially in the short term. Not using ethnicity as either an 
inclusion or exclusion criterion also resulted in more papers being included in the 
systematic review and a wider variety of validation methods being appraised which 
improved the robustness of inferences made. This was an additional strength. 
 
 
4.7.2.  Limitations 
 
The limitations of my research are related to a lack of financial resources which resulted 
in not being able to use more than one reviewer of data, not being able to use an expert 
panel to assess validity evidence based on test content and a restricted examination of 
language and its relationship to ethnicity. I now expand on each of these limitations 
below. 
 
Due to limited resources I was unable to use two reviewers to read eligible papers, record 
data, independently assess study eligibility and study quality for my systematic review. 
Consequently a third reviewer was also not required as judicator which is normally 
needed when the first two reviewers do not agree. Linked to this was also not having an 
expert panel to assess validation from the content of the index questions. Instead all of 
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these roles were conducted by me. It could be argued that I had conflicting interests as I 
was also the lead author of one of the papers included in the systematic review, especially 
as this paper was then also found to perform well with regards to QUADAS and other 
criteria (for example, validation according to its content). However due to my awareness 
of this limitation from the onset, I used objective criteria which were less vulnerable to 
biased interpretation by me. I would also consider that I acquired expertise in IPV 
identification through my lead role in developing the HARK questions and careful 
consideration of their content. This involved me judging the content of other index 
questions in order to ensure that the HARK questions built on the strengths of existing 
questions whilst avoiding their flaws. I think that this has increased my ability to judge 
validation for identifying IPV from the content of index questions. 
 
A further limitation of my research was that language failed to be captured. The majority 
of the systematic review studies and my secondary analysis were conducted in English 
speaking ethnic groups in the developed world.[165, 200, 208-211, 214-220, 222] 
Women who did not speak English were mostly excluded by these studies. Yet language 
is an important component of ethnicity (see section 1.4.1.) and marker of acculturation 
which may be a factor responsible for ethnic differences in IPV identification. Globally 
language is also interpreted more consistently than ethnicity, whereas ethnicity at its root 
is a sociological concept interpreted differently around the world. For example, Brazil is 
an ethnically diverse society but studies from Brazil rarely describe or look at differences 
in ethnicity. This is related to multiple socio-political and historical factors.[244] 
Examining IPV identification in different language groups may expose key differences. 
 
I have now discussed my results and their implications, considering them also within the 
context of my thesis‟ strengths and limitations. Next in my final chapter, I present my 
overall conclusions and consider future research required. 
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Chapter 5: Conclusions and Future Research 
 
 
5.1. Overview 
 
In this chapter, I will present the conclusions of my thesis. I will also reflect on the extent 
to which my research questions have been answered. This is followed by 
recommendations for future research required in this field. This includes measuring 
validity using different categories of evidence, improving future systematic reviews and 
methodological studies of quality appraisal tools, including the DECCS. 
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5.2. Conclusions 
 
My thesis conclusions are first that the only questions shown to have some validity for 
identifying IPV in specific ethnic groups were the four HARK questions and second that 
no evidence suggested that the validity of questions used to identify IPV varied 
significantly between different ethnic groups. 
 
This was based on my secondary data analysis that showed using a cut-off score of ≥ 1 
the four HARK questions had high diagnostic indices for identifying IPV in self-
classified UK census categories of African-Caribbean, south Asian, and white groups. In 
contrast the systematic review offered no evidence of questions that were valid for 
identifying IPV in specific ethnic groups, including white groups. Neither the systematic 
review nor the secondary data analysis provided any evidence that the validity of 
questions used to identify IPV varied significantly between different ethnic groups. 
 
Thus my principal research question, (what is the evidence for the validity of questions 
trying to identify IPV in specific ethnic groups?) has been answered by my research. My 
second research question (does the evidence for the validity of questions trying to 
identify IPV vary between different ethnic groups) has been answered in that the current 
evidence for validity of questions trying to identify IPV has not been found to vary 
between different ethnic groups. However both of my two research questions have not 
been completely addressed as the evidence for the validity of questions trying to identify 
IPV in specific ethnic groups is limited. 
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5.3. Future research 
 
Future studies should provide evidence for the validity of the HARK questions to identify 
IPV in specific ethnic groups, using other methods apart from diagnostic accuracy. My 
categorisation of evidence of validity (see section 1.3.6) demonstrates that a variety of 
different evidence derived from different methods would support the validity of the 
HARK questions. I now describe future studies that could be used to collect category A 
evidence (evidence for the validity of the HARK questions that is based on the 
consequences of testing), category B (evidence for the validity of the HARK questions 
that is based on relations to other variables), category D evidence (evidence for the 
validity of the HARK questions that is based on response processes) and category E 
evidence (evidence for the validity of the HARK questions that is based on test content). 
Category C evidence (evidence for the validity of the HARK questions that is based on 
internal structure) is also considered. 
 
Category A evidence for index questions trying to identify IPV, including the HARK 
questions, is absent from the literature but would be the most useful evidence to generate 
from studies in the future. This recognises that despite the good diagnostic accuracy of 
the HARK questions at identifying IPV they are only of value if they improve outcomes 
for women experiencing IPV. This is consistent with the GRADE approach to grading the 
quality of evidence and strength of recommendations for diagnostic tests.[245]  
 
An efficient way of generating category A evidence may be to employ studies which are 
already using the HARK questions and performing secondary analysis of their data. This 
includes the IRIS study which was based in the UK[234] as well as studies that are 
planned for two sites in the US and Germany, (personal communications). The IRIS 
study is the first European randomised controlled trial of an educational intervention to 
assess the health care response to domestic violence. The primary outcome is the referral 
of women to specialist domestic violence agencies. Intervention practices have had the 
HARK questions integrated into their electronic medical records. The Metro Alliance for 
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Healthy Families in the Minneapolis-St. Paul metropolitan area, in Dakota County, in the 
US plan to use the HARK questions whilst designing evidence based training for their 
health visitors. They aim to collect outcome measures in order to use evidence to 
implement, improve and expand their health visiting programme. Additionally a nurse 
researcher will be piloting the HARK questions in emergency rooms, in family practices, 
in an obstetrics and gynaecology practice and a student infirmary at a university in 
Upstate New York. If the pilot is satisfactory, the plan is to incorporate the HARK 
questions into the electronic health record of all patients in 25 practices. Researchers in 
Germany have translated the HARK questions into German in order to use it in research 
in Germany. 
 
Secondary data analysis of existing trials may potentially lead to answers about the 
consequences of using the HARK questions, i.e. whether using the HARK questions 
leads to any improvement in the health outcomes for women who are identified as 
experiencing IPV in different ethnic groups. Careful consideration would need to be 
given regarding consent for the secondary analysis of data as well as the reliability of the 
recording of health outcomes and ethnicity on primary care computer systems. 
 
Category B evidence could include further criterion performance studies in different 
settings. Assessing HARK‟s diagnostic accuracy outside of the UK in other developed 
regions (for example Australia and North America) as well as developing nations would 
be logical. Criterion correlation is an alternative method to diagnostic accuracy if the IPV 
construct is measured using a continuous as opposed to a categorical scale, (see section 
1.3.4. and section 1.3.6.2.1.). 
 
Further Category B evidence includes association studies examining the association 
between HARK scores and external variables. These could include the number in the 
preceding year of primary care consultations or referrals for specialist care or 
prescriptions issued. Association studies do not make an assumption that a reference 
standard exists for identifying IPV. It would be possible to look at the association 
between the use of HARK as an electronic prompt and external variables by using the 
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EMIS-WEB database of routinely collected information from primary care in north east 
London. This database allows one to identify the 877 women identified as disclosing IPV 
during the IRIS study in intervention and control practices. 
 
Future studies should also examine the evidence of HARK‟s validity based on response 
processes and test content whilst using an independent panel of IPV experts who are not 
directly linked to the development of the HARK questions. Content validation could be 
achieved by generating a content validity index for each individual HARK question. This 
is the proportion of judges who rate the question on three or four when content relevance 
is represented by a four point scale. One symbolises totally irrelevant content and four 
extremely relevant content.[246] This process could simultaneously be carried out for 
other tools that I have classified as having satisfactory content validity (for example, the 
BRFSS), to allow a more objective quantitative comparison of index questions. 
 
Future studies do not need to investigate the evidence of the HARK questions‟ validity 
based on internal structure. This is not indicated as the four HARK questions essentially 
embrace different subscales of IPV which is a multidimensional construct. Hence internal 
consistency need not be considered. Additionally neither inter observer reliability nor 
intra observer reliability need to be measured as the HARK score is not vulnerable to 
either inter or intra observer variation as adding up an individual‟s HARK score is an 
objective exercise. Test – retest reliability of the HARK questions may be useful but it 
would be difficult to assess the optimum time for re-administration of the HARK 
questions. Too short a time period may not be adequately testing the actual test – retest 
reliability whilst too long a period may result in changes in a woman‟s experience of IPV. 
Therefore changes in HARK scores may not actually reflect the HARK questions‟ true 
test-retest reliability. 
 
It would be useful to update the current systematic review regularly, for example, every 
five years. A future systematic review could include a more heterogeneous range of 
methods examining validity including association studies. This would be indicated if the 
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literature of IPV identification continues to show a lack of consensus regarding a 
reference standard for identifying IPV. 
 
Future systematic reviews of IPV identification would also be improved by having better 
tools to appraise the quality of studies. This would be achieved by organising 
methodological studies examining quality appraisal tools. For example, further research 
to develop an evidence based tool which is able to appraise the quality of studies using 
validation paradigm methods would be useful (see section 4.6.1.). As with QUADAS, 
this new appraisal tool should ideally be: “…systematically developed and 
evaluated…for its usability and validity.[202]” Therefore though I have suggested 
possible items for inclusion in this new tool, in section 4.6., these items should ideally be 
confirmed for inclusion by being identified using a mixture of empirical evidence (if any 
is found using a systematic review) and expert opinion. This process could be formalised 
using a Delphi procedure which focuses on consensus. 
 
My five criterion checklist, DECSS that assessed the use of ethnicity data in IPV 
identification studies should ideally be scrutinised by established researchers of ethnicity 
and ethnic differences. It is unclear whether this is best achieved using a Delphi 
procedure or a face to face consensus meeting of recognized researchers. Whatever the 
precise process, this may ultimately result in a revised DECSS checklist which should 
have its function assessed in other subject areas apart from IPV identification. 
 
A definitive study to answer my second research question (does the evidence for the 
validity of questions trying to identify IPV vary between different ethnic groups?) would 
need a sample size of 2,142 with 238 participants in each of nine ethnic groups to 
confirm that there are no statistically significant clinical differences in the validity of the 
HARK questions at identifying IPV in different ethnic groups. This would avoid using 
aggregated ethnic groups. If there were no real ethnic differences in the validity of 
questions to identify IPV, the diagnostic indices would have narrow overlapping 
confidence intervals. 
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It may be more productive for future studies to use language as a vehicle for investigating 
ethnicity. Technically these studies would be difficult to set up and resource – see the 
issues discussed in the background on translation of questions, section 1.3.6.6.1.. Costs 
may be minimised by the use of online data collection, as described by Sackett.[247] If 
differences between language groups were more marked than between groups based on 
national census categories, smaller numbers of study participants may be required which 
could reduce costs. Overall this could be cheaper than funding a study requiring 2,142 
participants. In an increasingly competitive funding environment this is an important 
consideration. 
 
A range of different types of evidence of validity in different ethnic groups would support 
the case for including the HARK questions‟ in the Quality and Outcomes Framework. 
This is an incentive programme for all general practice surgeries in England. However 
the strongest evidence for inclusion would be to show that by using the HARK questions 
to identify IPV, one was able to improve the health outcomes for women experiencing 
IPV, i.e. category A evidence, regardless of their ethnicity. Nonetheless health policies 
are not based solely on evidence.[248] I judge that IPV already deserves consideration for 
inclusion in the Quality and Outcomes Framework due to its importance as a public 
health problem affecting not only the long term health of women who experience it but 
also the children who witness it. This combined with these women being relatively 
isolated yet having repeated contact with primary care and wanting support from health 
professionals[72] supports inclusion. 
 
My final conclusions are that my research is contributing to a gradual coming of age of 
evidence based diagnosis with the incorporation of validation methods and the study of 
ethnicity within the field of gender violence health related research. I have tried to show 
above how these processes in the future will lead to better research questions and answers 
for women experiencing IPV. This discourse should not divert individual health workers 
from always being open to spontaneous IPV disclosure, responding suitably to women 
disclosing IPV and providing a patient centred approach focussing on cultural 
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competence[152] whilst avoiding stereotypes of the ethnic groups from which individual 
women originate. 
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APPENDIX A: 
Reference standards to identify IPV 
 
 
Conflict Tactics Scale (CTS) 
19 item scale assesses abuse within the past year. Seven point frequency scale (never, 
once, twice, 3-5 times, 6-10 times, 11-20 times, >20 times). Items range in severity from 
low in coerciveness to physical violence. Total scores vary from 15 to 105. Three 
subscales: verbal reasoning (three items, alpha= 0.69), verbal aggression (seven items, 
alpha= 0.84), and violence (nine items, alpha= 0.93). 
Straus MA. Measuring Intrafamily Conflict and Violence: The Conflict Tactics (CT) 
Scales. Jounal of Marriage and The Family 1979;75-88. 
 
Conflict Tactics Scale- Revised (CTS2)  
The CTS2 is based on CTS. It includes more items for the three subscales and has two 
extra subscales (sexual coercion and physical injury from assault). Thus there is a total of 
78 items representing five subscales. Each question is asked once for the respondent and 
for respondent‟s partner. “His/her” or “him/her” changed to “my partner.” Greater 
distinction between minor and severe acts. Answering format simplified. Order of items 
mixed up. Good internal consistency across all five subscales (alphas for negotiation = 
0.86; psychological aggression= 0.79; physical assault = 0.86; sexual coercion = 0.87 and 
injury 0.95). 
Straus MA, Hamby SL, Boney-McCoy S, Sugarman DB. The Revised Conflict Tactics 
Scales (CTS2). Development and Preliminary Psychometric Data. Journal of Family 
Issues 1996; 17(3):283-316. 
 
Index of Spousal Abuse (ISA) 
Has 30 questions which can be administered in written or oral format. It assesses for 
physical (ISA-P, 11 items, alpha= 0.91) and non-physical (ISA-NP, 19 items, alpha= 
0.93) abuse, using a Likert scale of one (never) to five (very frequently). Items are 
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weighted, summed and standardized for each scale. A complex weighted calculation 
required for final score. Scores range from 0 to 100. Higher scores represent more severe 
abuse. Cut off scores for non-physical abuse = 25, for physical abuse = 10.  
Hudson WW, McIntosh SR. The Assessment of Spouse Abuse: Two Quantifiable 
Dimensions. Journal of Marriage and The Family 1981;873-888 
Later a modified version of the ISA-P with 15 items developed for which Cronbach‟s 
alpha = 0.93. 
Hudson WW. Partner Abuse Scale Physical. Tempe, Ariz: Walmyr Publishing; 1991. 
 
Composite Abuse Scale (CAS) 
The CAS consists of 30 items taken from the Conflict Tactics Scale, Measures of Wife 
Abuse, Inventory of Spouse Abuse and the Psychological Maltreatment of Women 
Inventory. It assesses physical, emotional and sexual abuse. It is composed of four 
dimensions of abuse: severe combined abuse, emotional abuse, physical abuse and 
harassment. 
 
Dimensions and items of the Composite Abuse Scale: 
Severe combined abuse: 
Kept me from medical care 
Used a knife or gun or other weapon 
Locked me in the bedroom 
Put foreign objects in my vagina 
Refused to let me work outside the home 
Raped me 
Tried to rape me 
Took my wallet and left me stranded 
Emotional abuse: 
Told me that I was crazy 
Tried to convince family, friends and children that I was crazy 
Became upset if dinner/housework wasn't done when they thought it should be 
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Told me that I wasn't good enough 
Tried to keep me from seeing or talking to my family 
Told me that I was stupid 
Tried to turn my family, friends and children against me 
Did not let me socialise with my female friends 
Told me that I was ugly 
Told me no one would ever want me 
Blamed me for their violence 
Physical abuse: 
Shook me 
Hit or tried to hit me with something 
Pushed, grabbed or shoved me 
Kicked me, bit me or hit with a fist 
Slapped me 
Threw me 
Beat me up 
Harassment: 
Harassed me over the telephone 
Harassed me at work 
Followed me 
Hung around outside my house 
Hegarty K, Sheehan M, Schonfeld C. A multidimensional definition of partner abuse: 
Development and preliminary validation of the Composite Abuse Scale. Journal of 
Family Violence 1999; 14(4):399-415. 
Hegarty K, Fracgp, Bush R, Sheehan M. The composite abuse scale: further development 
and assessment of reliability and validity of a multidimensional partner abuse measure in 
clinical settings. Violence Vict 2005; 20(5):529-547. 
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Background
Violence against women is a global issue affecting mil-
lions who experience it and have to live with its conse-
quences [1]. Intimate partner violence (IPV) including
physical, sexual and emotional abuse is a major public
health problem.
The WHO Violence Against Women study [2] found that
the prevalence of lifetime physical violence and sexual
violence by an intimate partner, among ever-partnered
women varied from 15 to 71% in urban and rural settings
in 10 countries. The prevalence of IPV is higher among
women seeking primary care than in community surveys
of the same geographic populations [3].
In a study in 12 east London general practices it was found
that 41% of women waiting to see their general practi-
tioner (GP) or practice nurse had experienced physical
violence from a partner or former partner. 17% had expe-
rienced it within the past year [4].
IPV causes short and long term health problems. From
controlled studies in a wide range of settings, we know
that these include injury, chronic pain, gastrointestinal
and gynaecological conditions (including sexually trans-
mitted diseases) [5]. Consequences of IPV extend to peri-
natal health with it being an independent risk factor for
deficit in gestational weight gain during pregnancy [6]
and strong evidence of an IPV association with low birth
weight [7].
The psychological health problems associated with
domestic violence are no less serious and have psycholog-
ical parallels with the trauma of being taken hostage and
subjected to torture [8]. The most prevalent mental health
sequelae of IPV are depression and post-traumatic stress
disorder [9].
Women who have experienced physical or psychological
violence are fifteen times more likely to abuse alcohol and
nine times more likely to abuse drugs than are non-
abused women, and there is evidence that substance
abuse is a consequence as well as a potential cause of IPV
[10]. Children exposed to domestic violence also often
experience emotional and behavioural problems [11]. In
the developing world it has been shown that children
exposed to severe and recurrent IPV are more likely to be
admitted with severe acute malnutrition [12].
It is difficult to calculate the exact societal economic
impact of IPV but the costs are high. In the United States
annual costs of intimate partner rape, physical assault,
and stalking exceed $5.8 billion, nearly $4.1 billion of
which is for direct medical and mental health care services
[13]. In the United Kingdom the annual cost to the
national health service of physical assaults is £1.2 billion
[14].
The Department of Health in England now recommends
that "All trusts should be working towards routine
enquiry" [15]. In the US, the Family Violence Prevention
fund consensus guidelines recommend that all adolescent
and adult patients should be routinely asked about
domestic violence [16]. Although there is ongoing debate
about the evidence for screening or routine enquiry [17],
there is unquestionably a need for clinicians to ask about
domestic violence more often than they currently do.
A study of women attending general practices in east Lon-
don found that only 17% of women experiencing IPV
reported that their doctor had asked them about domestic
violence [4]. We know that women who are experiencing
violence want to disclose this to trusted doctors and get
support [18], but that a high proportion of women who
are experiencing abuse do not disclose this spontaneously
in clinical consultations [4].
Short questions that reliably identify women experiencing
IPV who present in clinical settings are a pre-requisite for
developing an appropriate response from health services
to this substantial public health problem [19].
Many primary health care professionals, including general
practitioners (GPs) and practice nurses, occasionally
enquire about domestic violence. It has not been ade-
quately determined whether their questions identify
women experiencing IPV.
Short tests
We have identified eleven short tools (see Additional file
1), for identification of women experiencing IPV [20-30].
Only three were validated in primary care settings [20-22].
The first study did not consider sexual abuse and had an
unrepresentative sample: it was able to differentiate
between self identified survivors of abuse and non-abused
patients; there was no evidence that it was able to identify
women who had experienced IPV in a general practice
population [20]. The second reported no sensitivity or
specificity; instead there was correlation between their
tool and the reference test (Abuse Risk Inventory, r = 0.69,
p = 0.01) but this does not necessarily indicate a valid and
specific measure of IPV [21]. The third tool, a single ques-
tion about safety, had low sensitivity, positive and nega-
tive predictive values (9%, 63% & 57% respectively) [22].
Outside of primary care settings, another two instruments
did not consider sexual abuse [23,24]. One reported no
sensitivity or specificity; only those who were positive on
the index test were recruited into the study [23]. The sen-
sitivity, specificity and positive predictive value of the
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other test were too low for use by clinicians (65%, 80% &
51% respectively) [24].
The sixth tool [25] had a low positive predictive value:
56%. The seventh instrument started with an open ques-
tion which makes it difficult to use as a standardised tool
[26] and the eighth, Webster's "self-report check list," was
not validated against an appropriate reference standard so
there was no calculation of test indices [27]. Two further
studies evaluated single item measures [28,29] and con-
cluded that these may not be adequate in assessing for
domestic violence.
We believe that the eleventh instrument, the AAS [30] has
the most potential. Its strengths include that it covers a
wide definition of partner violence which includes sexual
abuse; a number of the aforementioned tools do not
include sexual abuse [20,23,24,28]. It has 5 items rather
than an unsatisfactory single item as is the case with a
number of the tools [22,28,29]. Additionally it has a sim-
ple scoring system which we believe is important in brief
general practice consultations unlike the likert scales used
in 2 of the tools [20,25], the multiple scoring protocols in
one [21] and an open question in another [26]. Finally, it
has also been validated against an appropriate reference
standard, the Index of Spouse Abuse (ISA) [31] unlike
some [27].
However we also feel that the AAS has a number of weak-
nesses. Although the investigators concluded that the AAS
questions were valid, this was based on a correlation
between the score on a three-question version of the AAS
and the ISA. No sensitivity or specificity was reported. Fur-
thermore, the AAS validation was only within the setting
of antenatal care in the US [30]. We do not know whether
this is generalisable to other health care settings and in
other countries, preventing its implementation into UK
clinical practice [32].
More recently, in 2004, the test performance of the AAS
was evaluated against the modified version of the conflict
tactics scale (CTS 2) [33]. The AAS's sensitivity for minor
physical violence was 32% and for severe physical vio-
lence was 61%. It was concluded that it was not sensible
to use the AAS as a screening tool until more evidence was
gathered.
In our study we have adapted the AAS, for use in a general
practice setting, to form the HARK questionnaire (see
table 1). We tested the HARK against the 30-item Com-
posite Abuse Scale (CAS, see table 2) [34].
Methods
We conducted a cross-sectional survey of women in GP
waiting rooms. The fifty-one general practices in New-
ham, a multi-ethnic inner city area of London, were strat-
ified according to the number of doctors and the
proportion of south Asian names on the practice register
[35]. Equal numbers of practices were selected from each
stratification group using a randomisation programme
(SPSS version X). This was in an attempt to ensure that the
practice population reflected the local area population.
Each practice was sent a recruitment letter with informa-
tion about the study. If practices expressed an interest, a
research team member met with the primary care team to
answer any questions. We excluded practices that did not
have a private room available, as then privacy for the sur-
vey could not be provided. If a practice decided not to take
part or was excluded, the reason for this was documented
and another practice was randomly selected from within
the same stratification group.
We approached consecutive women in practice reception
areas waiting to see a doctor or nurse. We included
women aged more than 17 years who in the last year had
been in an intimate relationship. We excluded women
who were accompanied by children over four years of age
or by another adult, were too unwell to complete the
questionnaires, unable to understand English or unable to
give informed consent. In the waiting room, women were
asked to participate in a study designed to improve
women's health care. We sought consent for the adminis-
tration of the HARK and CAS questionnaires in a private
room. All participants were given information on local
domestic violence services. The East London and City eth-
ics committee approved the study.
The number of potentially eligible subjects was recorded
by the researcher in the waiting room. A record was made
of the number of women who were excluded due to the
exclusion criteria, those who the researchers were unable
to approach at very busy times, women who were
approached and agreed that they would be seen by the cli-
Table 1: HARK questions – one point is given for every yes 
answer
H HUMILIATION
Within the last year, have you been humiliated or 
emotionally abused in other ways by your partner or your 
ex-partner?
A AFRAID
Within the last year, have you been afraid of your partner 
or ex-partner?
R RAPE
Within the last year, have you been raped or forced to 
have any kind of sexual activity by your partner or ex-
partner?
K KICK
Within the last year, have you been kicked, hit, slapped or 
otherwise physically hurt by your partner or ex-partner?
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nician first and then undertake the study but were not
seen again ("did not come back"), those who refused par-
ticipation in the waiting room and those who declined
consent in the private room.
The HARK and CAS were self-administered. We expected
to be able to recruit approximately 500 women. On the
assumption that the prevalence of IPV in the past year was
20%, we calculated that there was a 90% chance of esti-
mating sensitivity at 76% or above with this sample size.
The Composite Abuse Scale – the reference standard
The CAS is a relatively robust standard for identifying IPV
in primary care settings. It has an internal reliability
(Cronbach's alpha) of .90 or more for each sub-scale, and
all item-total score correlations of .6 or above [34]. It has
also been validated with a large (1,836) sample of patients
in general practice settings [36]. It is based on a concept of
IPV that includes coercion, not simply violent acts arising
out of conflict. It is recommended as an IPV research
assessment tool by the National Centre for Injury Preven-
tion and Control [37], as it has demonstrated reliability
and validity for measuring the self-reported incidence and
prevalence of IPV. It has evidence of content, construct,
criterion and factorial validity. The CAS measures four
dimensions of abuse inflicted on a woman by her partner:
physical abuse (PA), emotional abuse (EA), severe com-
bined abuse (SCA) and harassment. A preliminary cut-off
score of 3 divides women presenting as abused or non-
abused in general practice settings [36]. The 30 items are
listed in table 2.
HARK – the index test
The acronym HARK denotes four short questions which
represent different components of IPV. "Hark" is an
archaic verb that means "to listen attentively." HARK
arose out of an adaptation of the AAS. In HARK there is a
focus only on IPV (not including that committed by a
stranger), the pregnancy related item has been removed
(so that it can be used in all women), for clarity emotional
and physical violence are separated out into 2 items
(rather than being combined in 1), "humiliation" was
added (as it was thought to be plainer English and have a
wider remit then "emotional abuse"), "rape" was added
(to try to help cue a woman's memory by using language
similar to her own) whilst items relating to fear and phys-
ical violence were directly retained from the AAS. The
HARK questions are listed in table 1.
None of the women who were identified as having suf-
fered abuse requested the researcher to make a direct refer-
ral in order to access specialised services.
Outcomes measures
The rate of current IPV within the last twelve months was
calculated for the CAS (using the cut off score of ≥3) with
95% confidence intervals. This is equal to the prevalence
or pre-test probability of IPV within the last twelve
months.
The rates of IPV within the last twelve months were also
calculated with 95% confidence intervals for the HARK, at
different cut off scores (e.g. HARK cut off score ≥2, means
a HARK score of either 2, 3 or 4). Each woman was iden-
tified as being positive or negative for IPV for each HARK
cut off score and for the CAS cut off score of ≥3. We could
then calculate HARK's sensitivity, specificity, positive pre-
dictive value (PPV – also known as the post-test probabil-
ity), negative predictive value (NPV), likelihood ratios
(LRs) with 95% confidence intervals and post-test odds (=
pre-test odds × LR) at different HARK cut off scores [38].
A receiver operator characteristic (ROC) curve was con-
structed by plotting the sensitivity of each different HARK
Table 2: Dimensions and items of the Composite Abuse Scale
Severe combined 
abuse
Kept me from medical care
Used a knife or gun or other weapon
Locked me in the bedroom
Put foreign objects in my vagina
Refused to let me work outside the home
Raped me
Tried to rape me
Took my wallet and left me stranded
Emotional abuse Told me that I was crazy
Tried to convince family, friends and children 
that I was crazy
Became upset if dinner/housework wasn't done 
when they thought it should be
Told me that I wasn't good enough
Tried to keep me from seeing or talking to my 
family
Told me that I was stupid
Tried to turn my family, friends and children 
against me
Did not let me socialise with my female friends
Told me that I was ugly
Told me no one would ever want me
Blamed me for their violence
Physical abuse Shook me
Hit or tried to hit me with something
Pushed, grabbed or shoved me
Kicked me, bit me or hit with a fist
Slapped me
Threw me
Beat me up
Harassment Harassed me over the telephone
Harassed me at work
Followed me
Hung around outside my house
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cut off against the false positive rate (= 100 - specificity) at
the different HARK cut offs. This was used to determine an
optimal cut off HARK score which maximised the true
positives whilst minimising the false positives.
Multilevel LRs [38] were also calculated at different HARK
scores (e.g. a HARK score of 2 means 2 only, not ≥2, i.e. 2,
3 or 4) with 95% confidence intervals and corresponding
post-test odds. 95% confidence intervals were calculated
in EXCEL. Multilevel LRs allow exploration of the diag-
nostic usefulness of individual HARK scores.
We have used a variety of different methods to assess
HARK's diagnostic accuracy at identifying IPV. Sensitivity
and specificity interpret the HARK results retrospectively
whereas PPVs and NPVs establish the predictive properties
of the HARK in the future. The PPV is the proportion of
women with a specific HARK result who are experiencing
IPV. LRs express a result in terms of the actual chances of
a woman experiencing IPV if her HARK score reaches a
particular level. A LR for a given HARK result gives the
odds that the test result comes from a person who is expe-
riencing IPV. Unlike PPV and NPV, LRs are a good deal
more constant with changes in prevalence. The post test
odds allow background prevalence to be factored into the
LR. Multilevel LRs express HARK's accuracy with level-spe-
cific likelihood ratios. They can be calculated at different
HARK scores (e.g. 1) as opposed to cut offs (e.g. ≥1). They
ensure that the maximum information is derived from the
total range of possible HARK results (0 to 4).
Results
We approached 24 practices and 12 agreed to participate;
11 declined and one was excluded as it had no private
room. Two hundred and thirty two women were recruited
from May to October 2003. Figure 1 shows recruitment of
individual participants to the study. Seven hundred and
thirty seven women did not meet the inclusion criteria.
Fourteen women were not approached because there were
too many women in the waiting room for all to be
approached. Two hundred and three women "did not
come back." One hundred and eighty six women declined
participation in the waiting room. Eleven women
declined consent in the private room. The response rate of
54% (232/(232 + 186 + 11) was adjusted for the women
who "did not come back."
The average age of participants was 35 years (range 18–70
years). 51% were in a paid job and 53% owned a house or
flat. 40% of participants described their ethnic origin as
white British, 25% as black British, African or Caribbean
and 18% as Indian, Pakistani or Bangladeshi.
Outcomes measures
The CAS identified 53 cases of current IPV in the study
population. This produced a prevalence (pre-test proba-
bility) of current IPV of 23% (95% C.I. 17% to 28%) with
pre-test odds of 0.30 (95% C.I. 0.23 to 0.38). Pretest odds
are prevalence divided by one minus prevalence.
Table 3 gives the sensitivity, specificity, PPV, NPV, LRs and
post-test odds of HARK at different cut off scores. The
receiver operator characteristic curve (figure 2) demon-
strated that a HARK score ≥1 is the optimal cut off for
detecting IPV. The predictive properties of the HARK score
of ≥1 are highlighted in table 3. The HARK test accuracy
(using a cut-off of ≥1) is 92%. This represents the propor-
tion of true positives and true negatives as a proportion of
all results.
Table 3: The sensitivity, specificity, PPV, NPV, LR & post-test odds with 95% confidence intervals of HARK at different cut off scores
Hark cut off 
scores
% of study 
sample
Sensitivity 
with 95% C.I.
Specificity 
with 95% C.I.
Positive 
predictive 
value with 
95% C.I.
Negative 
predictive 
value with 
95% C.I.
Likelihood 
ratio with 
95% C.I.
Post-test 
odds
= 4 1% 4% (3% to 13%) 100% (98% to 
100%)
100% (22 to 
100%)
78% (72% to 
83%)
Undefined Undefined
≥3 6% 26% (15% to 
40%)
100% (98% to 
100%)
100% (81% to 
100%)
82% (76% to 
87%)
Undefined Undefined
≥2 13% 51% (37% to 
65%)
98% (95% to 
100%)
90% (73% to 
98%)
87% (82% to 
91%)
30 (10 to 96) 9
≥1 22% 81% (69% to 
90%)
95% (91% to 
98%)
83% (70% to 
91%)
94% (90% to 
97%)
16 (8 to 31) 5
≥0 100% 100% (93% to 
100%)
0% (0% to 2%) 23% (18% to 
29%)
error 1 0.3
When the specificity is 100%, the likelihood ratio and post test odds are undefined.
Confidence intervals for likelihood ratios are approximate since they were calculated by the delta method which is less reliable when some cell 
sizes are small (Armitage P, Matthews JNS, Berry G. Statistical methods in medical research. Oxford; Blackwell, 1994).
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Multilevel LRs calculated at different HARK scores with
95% confidence intervals and corresponding post-test
odds are shown in table 4.
Discussion
The four HARK questions accurately identify women
experiencing IPV in the past year and may help women
disclose IPV in general practice. The estimated specificity
(95%, 95% C.I. 91% to 98%) of the HARK score of ≥1 was
higher than the sensitivity (81%, 95% C.I. 69% to 90%).
The PPV (post-test probabilities) of HARK, which increase
as the HARK score increases, also provide evidence that
HARK is an effective short tool for identifying IPV.
The most straightforward way of using the HARK is as a
simple test with a cut off of ≥1. Therefore if a clinician asks
these four questions and their patient scores ≥1, this will
identify 81% of women affected by IPV (as judged by the
CAS). This is assuming that the tool performs in the same
way that it did when a researcher administered it. There is
an 83% probability that a woman with this score has
experienced IPV in the past year (positive predictive
value); and she is 16 times more likely to have been
affected by IPV in the last year than some-one with a
HARK score of 0 (likelihood ratio of a positive result).
The multilevel LRs and corresponding post-test odds
make more use of the data from the test as it avoids
dichotomising the HARK score into IPV present or not
present [39]. When a woman is asked the four HARK
questions she does not actually have a positive or negative
score for IPV; instead she may score 0, 1, 2, 3 or 4 and each
score has a different meaning (i.e. different likelihood
ratio and post-test odds for IPV – see table 4). When an
individual answers "no" to all of the HARK questions the
likelihood ratio and post test odds (0.2 and 0.1 respec-
tively) suggest that IPV is probably not present; whereas
answering "yes" to three or four HARK questions produces
a specificity of 100%, meaning that IPV is present.
Answering "yes" to one or two of the HARK questions is
less specific.
The majority of women who are experiencing IPV do not
spontaneously disclose to clinicians. HARK can poten-
tially accurately and quickly identify a high proportion of
these women. This is a pre-requisite for effective interven-
tion allowing the successful management of IPV in gen-
Receiver operator characteristic curve showing sensitivity of different HARK scores verse  1 - specificityFigure 2
Receiver operator characteristic curve showing sensitivity of 
different HARK scores verses 1 - specificity.
Figure 2: Receiver operator characteristic curve showing sensitivity 
of different HARK scores verses 1 – specificity.
 
0.0
0.2
0.4
0.6
0.8
1.0
0.0 0.2 0.4 0.6 0.8 1.0
1-Specificity
Sensitivity
≥0
≥1
≥2
≥3
=4
Table 4: Multilevel likelihood ratios with 95% confidence intervals 
and post-test odds of individual HARK scores.
HARK score 
(number of 
"yeses")
Likelihood ratio 
with 95% C.I.
Post-test odds
3 or 4 Undefined Undefined
2 14.6 (4.3 to 49.4) 4.3
1 9.01 (3.7 to 21.9) 2.67
0 0.2 (0.1 to 0.4) 0.1
Flow diagram to show recruitment of participants to the studyigure 1
Flow diagram to show recruitment of participants to the 
study.
Figure 1: Flow diagram to show recruitment of participants to the 
study 
Potentially 
eligible women
HARK completed 
232
Abnormal result, 
HARK≥1 = 51
Normal result, 
HARK<1 = 181
Reference standard (CAS) completed 
51
Reference standard (CAS) completed
181
IPV present 
41
IPV present 
9
IPV absent 
172
IPV absent 
10
Too busy to be 
approached 14
Did not come back 
203
Declined participation
in waiting room 186 
Consent declined 
in private room 11
Inclusion criteria 
not met 737
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eral practice. It has been shown that women want to
disclose IPV to health care professionals, particularly pri-
mary care clinicians [18].
The high pre-test probability (prevalence) of IPV (23%) is
consistent with other prevalence studies in primary health
care settings [3].
To increase the external validity of the study, we recruited
a wide range of practices, including small single handed
ones with less than 3,000 patients which are common in
inner city areas in the United Kingdom. However small
practices had fewer patients in the waiting room available
for recruitment than had been anticipated; with the
recruitment of participants taking longer than planned.
Consequently we were only able to recruit 46% of our tar-
get sample size within the timeframe of the study, result-
ing in less precise estimates of test accuracy, reflected in
wider confidence intervals. Nevertheless our study is
larger than some other validation studies of short instru-
ments and our estimates of test characteristics are rela-
tively precise.
Eighty two percent of women who did not fulfil the inclu-
sion criteria were accompanied. The ethics committee that
approved our proposal specified that potential partici-
pants should only be approached if they were unaccom-
panied in order to decrease the likelihood of an abusive
partner discovering that the participant had completed a
questionnaire on domestic violence. We did include
women who were accompanied by children under the age
of five years, as it was felt that a child this young was
unlikely to jeopardise a participant's safety.
Overall women were enthusiastic about participation
once they found out that the study was about domestic
violence: only eleven women declined consent in the pri-
vate room. One hundred and eighty six women declined
participation in the waiting room but these women did
not know that the study was specifically about domestic
violence.
The National Census 2001 figures allowed us to compare
our study population to the local population in the bor-
ough of Newham. The average age of the study population
was 3 years older than the average age in the local popu-
lation (32 years). The percentage of the study population
in a paid job was 12% higher and the percentage that
owned a house or flat was 9% higher than that in the local
population (39% and 44% respectively). The percentage
of the study population that described their ethnic origin
as white British was 6% higher than that in the local pop-
ulation (34%) whilst the percentage that described their
ethnic origin as Indian, Pakistani or Bangladeshi was 11%
lower than that in the local population (29%). This com-
parison shows that despite our attempts, the study popu-
lation were not totally representative of the local
population. We believe that the higher socio-economic
status of our study sample (as reflected by the higher per-
centage in a paid job and owning a house or flat) com-
pared to the local population may reflect a response bias
meaning that perhaps those women with lower socio-eco-
nomic status and at greater risk of IPV were less likely to
have taken part in this study. This may have affected the
calculation of the prevalence, PPV and NPV of HARK.
However there is no reason why this would necessarily
affect the sensitivity/specificity calculations unless the
46% of women who did not take part in the study
answered differently with regards to only one of the
instruments (the HARK or the CAS). This is unlikely.
The strengths of this study are that it tested a short tool
that can be used in routine general practice, against an
abuse measure validated in primary care. Additionally,
HARK's external validity has been increased by being con-
ducted in a range of practices with a study population of
varied ethnicity.
Limitations included the response rate of 54%, decreasing
the external validity of the study. Although we consider
the CAS to be the best research measure for IPV in a health
care setting, we cannot exclude the possibility that not all
women who were found to be positive for IPV with the
HARK but negative with the CAS were false positives.
Other investigators have found that when using two sets
of validated questions each may identify some women as
abused that would have been missed by the other tool
[40].
The HARK questions could be incorporated into elec-
tronic medical records in primary care to prompt clini-
cians to ask about recent intimate partner violence and to
encourage disclosure by patients. Future research should
test the effectiveness of HARK in clinical consultations as
part of system level interventions to improve the response
of primary care to IPV.
Conclusion
Intimate partner violence against women is common and
causes short and long-term ill health. Previously ques-
tions about intimate partner violence to elicit disclosure
have been insufficiently validated for use in general prac-
tice or family medicine populations, particularly outside
the US. The four short HARK questions accurately identify
women experiencing intimate partner violence in the past
year.
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APPENDIX C: 
Search strings 
 
 
Cochrane Collaboration central register (CENTRAL/CCTR) search 
string 
 
ID Search  
#1 Battered Women in All Fields in all products  
#2 Spouse Abuse in All Fields in all products  
#3 Domestic Violence in All Fields in all products  
#4 
abuse* near/3 wom*n in Title, Abstract or Keywords in all 
products 
 
#5 
abuse* near/3 partner* in Title, Abstract or Keywords in all 
products 
 
#6 
abuse* near/3 spous* in Title, Abstract or Keywords in all 
products 
 
#7 
(wife or wives) near/3 batter* in Title, Abstract or Keywords in 
all products 
 
#8 
(wife or wives) near/3 abuse* in Title, Abstract or Keywords in 
all products 
 
#9 
partner* near/3 violen* in Title, Abstract or Keywords in all 
products 
 
#10 spous* near/3 violen* in Title, Abstract or Keywords in all  
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products 
#11 
dat* near/3 violen* in Title, Abstract or Keywords in all 
products 
 
#12 
(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7 OR #8 OR #9 OR 
#10 OR #11) 
 
#13 Child Abuse in All Fields in all products  
#14 Child Abuse, Sexual in All Fields in all products  
#15 (#13 OR #14)  
#16 (#12 AND NOT #15)  
 
 
Medline Search String 
 
NOTE:  
No. 58 is the total number of hits without mother$ 
No. 62 is the additional hits found with the inclusion of mother$ 
  
 
# Search History  
1 *Battered Women/  
2 *Spouse Abuse/  
3 *Domestic Violence/  
4 (abuse$ adj3 wom#n).tw.  
5 (abuse$ adj3 partner$).tw.  
6 (abuse$ adj3 spous$).tw.  
7 ((wife or wives) adj3 batter$).tw.  
  
246 
8 ((wife or wives) adj3 abuse$).tw.  
9 (partner$ adj3 violen$).tw.  
10 (spous$ adj3 violen$).tw.  
11 (dat$ adj3 violen$).tw.  
12 or/1-11  
13 *Child Abuse/  
14 *Child Abuse, Sexual/  
15 12 not (13 or 14)  
16 *Women/  
17 Female/  
18 (wom#n or female$).tw.  
19 *Adolescent/  
20 (adolescen$ or teen$).tw.  
21 or/16-20  
22 screening.mp. or exp Mass Screening/  
23 screen$.tw.  
24 identif$.tw.  
25 detect$.tw.  
26 exp Diagnosis, Oral/ or exp Diagnosis/ or exp Nursing Diagnosis/ or diagnosis.mp.  
27 diagnostic test.mp. or exp Diagnostic Tests, Routine/  
28 medical history taking.mp. or exp Medical History Taking/  
29 self disclosure.mp. or exp Self Disclosure/  
30 (routine$ adj3 (ask$ or question$ or enquir$)).tw.  
31 screening tool$.tw.  
32 or/22-31  
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33 advocacy.mp. or exp Patient Advocacy/  
34 exp Counseling/ or counsel$.mp.  
35 mentor$.mp. or exp Mentors/  
36 crisis intervention.mp. or exp Crisis Intervention/  
37 risk assessment.mp. or exp Risk Assessment/  
38 exp Social Welfare/  
39 social support.mp. or exp Social Support/  
40 help seeking.mp.  
41 (information giving or giv$ information).mp.  
42 (advice giving or giv$ advice).mp.  
43 health behavior.mp. or exp Health Behavior/  
44 patient education.mp. or exp Patient Education/  
45 safety.mp. or exp Safety/  
46 safety behav$.mp.  
47 psychotherapy.mp. or exp Psychotherapy/  
48 psychological therapy.mp.  
49 problem solv$.mp. or exp Health Education/  
50 self efficacy.mp. or exp Self Efficacy/  
51 intervention.mp. or exp Intervention Studies/  
52 evaluation.mp. or exp Evaluation Studies/  
53 program evaluation.mp. or exp Program Evaluation/  
54 or/33-53  
55 15 and 32  
56 15 and 21 and 54  
57 55 or 56  
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58 mother$.mp. [mp=ti, ot, ab, nm, hw]  
59 16 or 17 or 18 or 19 or 20 or 58  
60 15 and 59 and 54  
61 55 or 60  
62 61 not 57  
 
 
 
CINAHL search string 
No. Search term  
1 (BATTERED ADJ WOMEN).TI,AB.  
2 
BATTERED-WOMEN.MJ. OR PARTNER-ABUSE.MJ. OR DOMESTIC-
VIOLENCE.MJ. OR SPOUSE-ABUSE.MJ. 
 
3 (ABUSE$ NEAR (WOM$ OR PARTNER$ OR SPOUS$)).TI,AB.  
4 ((WIFE OR WIVES) NEAR (BATTER$ OR ABUSE$)).TI,AB.  
5 (VIOLEN$ NEAR (PARTNER$ OR SPOUS$ OR DATE OR DATING)).TI,AB.  
6 1 OR 2 OR 3 OR 4 OR 5  
7 (CHILD ADJ ABUSE).TI,AB.  
8 CHILD-ABUSE.MJ. OR CHILD-ABUSE-SEXUAL.MJ.  
9 6 NOT (7 OR 8)  
10 (WOM$ OR FEMALE$).TI,AB.  
11 WOMEN.W..MJ.  
12 MOTHER$.TI,AB.  
13 MOTHERS.W..DE.  
14 (ADOLESCEN$ OR TEEN$).TI,AB.  
15 ADOLESCENT-HEALTH.MJ.  
16 10 OR 11 OR 12 OR 13 OR 14 OR 15  
17 SCREEN$.TI,AB.  
18 HEALTH-SCREENING#.DE.  
19 (IDENTIF$ OR DETECT$).TI,AB.  
20 DIAGNOS$3.TI,AB.  
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21 DIAGNOSIS#.W..DE.  
22 (DIAGNOSTIC ADJ TEST).TI,AB.  
23 
CLINICAL-ASSESSMENT-TOOLS#.DE. OR DIAGNOSTIC-TESTS-ROUTINE#.DE. 
OR INSTRUMENT-VALIDATION#.DE. 
 
24 (MEDICAL ADJ HISTORY).TI,AB.  
25 PATIENT-HISTORY-TAKING#.DE.  
26 (PATIENT ADJ ASSESSMENT).TI,AB.  
27 PATIENT-ASSESSMENT#.DE.  
28 (SELF ADJ DISCLOSURE).TI,AB.  
29 SELF-DISCLOSURE#.DE.  
30 (ROUTINE NEAR (ASK$ OR QUESTION$ OR ENQUIR$)).TI,AB.  
31 (SCREENING ADJ TOOL).TI,AB.  
32 
17 OR 18 OR 19 OR 20 OR 21 OR 22 OR 23 OR 24 OR 25 OR 26 OR 27 OR 28 
OR 29 OR 30 OR 31 
 
33 ADVOCACY.TI,AB.  
34 PATIENT-ADVOCACY#.DE. OR CONSUMER-ADVOCACY#.DE.  
35 COUNSEL$.TI,AB.  
36 COUNSELING#.W..DE.  
37 (SOCIAL ADJ WORK).TI,AB.  
38 MENTOR$.TI,AB.  
39 MENTORSHIP#.W..DE.  
40 (CRISIS ADJ INTERVENTION).TI,AB.  
41 CRISIS-INTERVENTION#.DE.  
42 (RISK ADJ ASSESSMENT).TI,AB.  
43 RISK-ASSESSMENT#.DE.  
44 (SOCIAL ADJ WELFARE).TI,AB.  
45 SOCIAL-WELFARE#.DE.  
46 (SOCIAL ADJ SUPPORT).TI,AB.  
47 SUPPORT-PSYCHOSOCIAL#.DE. OR SOCIAL-NETWORKS#.DE.  
48 (SUPPORT ADJ GROUP$).TI,AB.  
49 SUPPORT-GROUPS#.DE.  
50 (HELP ADJ SEEKING).TI,AB.  
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51 HELP-SEEKING-BEHAVIOR#.DE.  
52 (GIV$ NEAR (INFORMATION OR ADVICE)).TI,AB.  
53 PATIENT-EDUCATION#.DE. OR HEALTH-PROMOTION#.DE.  
54 (HEALTH ADJ BEHAVIO$).TI,AB.  
55 HEALTH-BEHAVIOR#.DE. OR HEALTH-EDUCATION#.DE.  
56 SAFETY.TI,AB.  
57 SAFETY#.W..DE. OR PATIENT-SAFETY#.DE.  
58 PSYCHOTHERAPY.TI,AB.  
59 PSYCHOTHERAPY#.W..DE.  
60 (PSYCHOLOGICAL ADJ THERAPY).TI,AB.  
61 (PROBLEM ADJ SOLV$).TI,AB.  
62 PROBLEM-SOLVING#.DE.  
63 (SELF ADJ EFFICACY).TI,AB.  
64 SELF-EFFICACY#.DE.  
65 (INTERVENTION$ OR EVALUATION$).TI,AB.  
66 INTERVENTION$.TI,AB.  
67 EVALUATION$.TI,AB.  
68 (PROGRAM ADJ EVALUATION).TI,AB.  
69 PROGRAM-EVALUATION#.DE.  
70 
33 OR 34 OR 35 OR 36 OR 37 OR 38 OR 39 OR 40 OR 41 OR 42 OR 43 OR 44 
OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 OR 52 OR 53 OR 54 OR 55 OR 
56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 63 OR 64 OR 65 OR 66 OR 67 
OR 68 OR 69 
 
71 9 AND 32  
72 9 AND 16 AND 70  
73 71 OR 72  
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BNID search string 
No. Database Search term  
1 
British Nursing 
Index - 1994 to 
date 
(BATTERED ADJ WOMEN).TI,AB.  
2 
British Nursing 
Index - 1994 to 
date 
(SPOUSE ADJ ABUSE).TI,AB.  
3 
British Nursing 
Index - 1994 to 
date 
(DOMESTIC ADJ VIOLENCE).TI,AB.  
4 
British Nursing 
Index - 1994 to 
date 
DOMESTIC-VIOLENCE.DE.  
5 
British Nursing 
Index - 1994 to 
date 
(BATTER$ NEAR (WOM$ OR SPOUS$)).TI,AB.  
6 
British Nursing 
Index - 1994 to 
date 
(BATTER$ NEAR (PARTNER$ OR WIFE OR 
WIVES)).TI,AB. 
 
7 
British Nursing 
Index - 1994 to 
date 
(ABUS$ NEAR (WOM$ OR SPOUS$)).TI,AB.  
8 
British Nursing 
Index - 1994 to 
date 
(ABUS$ NEAR (PARTNER$ OR WIFE OR 
WIVES)).TI,AB. 
 
9 
British Nursing 
Index - 1994 to 
date 
(VIOLEN$ NEAR (WOM$ OR SPOUS$)).TI,AB.  
10 
British Nursing 
Index - 1994 to 
date 
(VIOLEN$ NEAR (PARTNER$ OR WIFE OR 
WIVES)).TI,AB. 
 
11 
British Nursing 
Index - 1994 to 
date 
(VIOLEN$ NEAR DAT$).TI,AB.  
12 
British Nursing 
Index - 1994 to 
date 
1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 
OR 10 OR 11 
 
13 
British Nursing 
Index - 1994 to 
date 
(CHILD ADJ ABUSE).TI,AB.  
14 
British Nursing 
Index - 1994 to 
date 
CHILD-ABUSE-AND-NEGLECT.DE. OR CHILD-
ABUSE-SEXUAL.DE. 
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15 
British Nursing 
Index - 1994 to 
date 
12 NOT (13 OR 14)  
 
 
EMBASE search string 
 
Search history: EMBASE 
No. Search term  
1 
BATTERED-WOMAN.MJ. OR PARTNER-VIOLENCE.MJ. OR DOMESTIC-
VIOLENCE.MJ. OR FAMILY-VIOLENCE.MJ. OR BATTERING.W..MJ. 
 
2 (ABUSE$ NEAR WOM$).TI,AB.  
3 (ABUSE$ NEAR PARTNER$).TI,AB.  
4 (ABUSE$3 NEAR SPOUS$3).TI,AB.  
5 ((WIFE OR WIVES) NEAR BATTER$).TI,AB.  
6 ((WIFE OR WIVES) NEAR ABUSE$).TI,AB.  
7 (PARTNER$ NEAR VIOLEN$).TI,AB.  
8 (SPOUS$ NEAR VIOLEN$).TI,AB.  
9 (DAT$3 NEAR VIOLEN$3).TI,AB.  
10 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9  
11 (CHILD ADJ ABUSE).TI,AB.  
12 CHILD-ABUSE.MJ.  
13 CHILD-SEXUAL-ABUSE.MJ.  
14 (CHILD$4 ADJ ABUSE ADJ SEXUAL).TI,AB.  
15 (CHILD$4 ADJ SEXUAL ADJ ABUSE).TI,AB.  
16 10 NOT (11 OR 12 OR 13 OR 14 OR 15)  
17 WOMEN.MJ.  
18 FEMALE.MJ.  
19 (WOM$3 OR FEMALE$3).TI,AB.  
20 (ADOLESCEN$ OR TEEN$).TI,AB.  
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21 17 OR 18 OR 19 OR 20  
22 16 AND 21  
23 SCREENING-TEST#.DE.  
24 (MASS ADJ SCREENING).TI,AB.  
25 MASS-SCREENING#.DE.  
26 SCREEN$3.TI,AB.  
27 IDENTIF$.TI,AB.  
28 DETECT$3.TI,AB.  
29 DIAGNOSIS#.DE.  
30 (DIAGNOSTIC ADJ TEST).TI,AB.  
31 DIAGNOSTIC-TEST#.DE.  
32 (MEDICAL ADJ HISTORY ADJ TAKING).TI,AB.  
33 (SELF ADJ DISCLOSURE).TI,AB.  
34 SELF-DISCLOSURE#.DE.  
35 (ROUTINE$3 NEAR (ASK$3 OR QUESTION$5 OR ENQUIR$3)).TI,AB.  
36 (SCREENING ADJ TOOL$).TI,AB.  
37 SCREENING#.W..DE.  
38 
23 OR 24 OR 25 OR 26 OR 27 OR 28 OR 29 OR 30 OR 31 OR 32 OR 33 OR 34 
OR 35 OR 36 OR 37 
 
39 16 AND 38  
40 ADVOCACY.TI,AB.  
41 PATIENT-ADVOCACY#.W..DE.  
42 CONSUMER-ADVOCACY#.W..DE.  
43 PATIENT-COUNSELING#.W..DE.  
44 COUNSEL$.TI,AB.  
45 MENTOR$.TI,AB.  
46 (CRISIS ADJ INTERVENTION).TI,AB.  
47 CRISIS-INTERVENTION#.W..DE.  
48 (RISK ADJ ASSESSMENT).TI,AB.  
49 RISK-ASSESSMENT#.DE.  
50 (SOCIAL ADJ WELFARE).TI,AB.  
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51 SOCIAL-WELFARE#.DE.  
52 (SOCIAL ADJ SUPPORT).TI,AB.  
53 SOCIAL-SUPPORT#.DE.  
54 (HELP ADJ SEEKING).TI,AB.  
55 HELP-SEEKING-BEHAVIOR#.DE.  
56 (INFORMATION ADJ GIVING).TI,AB.  
57 MEDICAL-INFORMATION#.DE.  
58 (GIV$3 ADJ INFORMATION).TI,AB.  
59 (ADVICE ADJ GIVING).TI,AB.  
60 (GIV$3 ADJ ADVICE).TI,AB.  
61 (HEALTH ADJ BEHAVIOR).TI,AB.  
62 HEALTH-BEHAVIOR#.DE.  
63 (PATIENT ADJ EDUCATION).TI,AB.  
64 PATIENT-EDUCATION#.DE. OR HEALTH-EDUCATION#.DE.  
65 SAFETY.TI,AB.  
66 SAFETY#.DE.  
67 PSYCHOTHERAPY.TI,AB.  
68 (PSYCHOLOGICAL ADJ THERAPY).TI,AB.  
69 (PROBLEM ADJ SOLV$3).TI,AB.  
70 PROBLEM-SOLVING#.DE.  
71 (HEALTH ADJ EDUCATION).TI,AB.  
72 (SELF ADJ EFFICACY).TI,AB.  
73 INTERVENTION.TI,AB.  
74 PATIENT-SAFETY#.DE.  
75 EVALUATION.TI,AB.  
76 PSYCHOTHERAPY#.DE.  
77 
40 OR 41 OR 42 OR 43 OR 44 OR 45 OR 46 OR 47 OR 48 OR 49 OR 50 OR 51 
OR 52 OR 53 OR 54 OR 55 OR 56 OR 57 OR 58 OR 59 OR 60 OR 61 OR 62 OR 
63 OR 64 OR 65 OR 66 OR 67 OR 68 OR 69 OR 70 OR 71 OR 72 OR 73 OR 74 
OR 75 OR 76 
 
78 22 AND 77  
79 39 OR 78  
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80 MOTHER$.TI,AB.  
81 DIAGNOSIS.TI,AB.  
82 ((MEDICAL OR PATIENT) ADJ HISTORY).TI,AB.  
83 21 OR 80  
84 38 OR 81 OR 82  
85 16 AND 84  
86 16 AND 83 AND 77  
87 85 OR 86  
 
 
 
National research register search string 
 
 
 
#1. ((batter* near woman) or (batter* near women) or (batter* near spouse) or 
(batter* near wife) or (batter* near wives) or (batter* near partner)) 
 
#2. ((abuse* near woman) or (abuse* near women) or (abuse* near spouse) or 
(abuse* near wife) or (abuse* near wives) or (abuse* near partner)) 
 
#3. ((violen* near woman) or (violen* near women) or (violen* near spouse) 
or (violen* near wife) or (violen* near wives) or (violen* near partner)) 
 
#4. ((violen* near dat*) or (domestic near violence) or (family near violence))  
#5. ((child* near abuse*) or (child* near sex* near abuse*))  
#6. (#1 or #2 or #3 or #4)  
#7. (#6 and (not #5))  
 
Top of Form 
(#6 and (not #5)) - 169 hits  
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Save selected     Unselect all 
 
 
 
 NRR Records from Regional and National Research Programmes  
 NRR Records from Research Centres: Single-Centre Projects 
 
NRR Records from Research Centres: Lead Centres for Multi-Centre 
Projects 
 
NRR Records from Research Centres: Participating Centres for Multi-
Centre Projects  
 MRC Clinical Trials Directory 
 CRD Register of Reviews (0 out of 276)  
 Abstracts from The Cochrane Database of Systematic Reviews 
 
Bottom of Form 
 
 
 
Health Management Information Consortium search string 
 
 
#85 #83 not #84    
 
#84 ( child* abuse )or( child* sexual abuse )    
 
#83 (( violen* near dat* )or( violen* near domestic )or( violen* near family )) or (( violen* near spous* )or( violen* 
near partner* )or( violen* near wi* )) or (( abuse* near partner* )or( abuse* near wi* )or( violen* near wom?n )) 
or (( batter* near wi* )or( abuse* near wom?n )or( abuse* near spous* )) or (( batter* near wom?n )or( batter* 
near spous* )or( batter* near partner* )) 
   
 
#82 ( violen* near dat* )or( violen* near domestic )or( violen* near family )    
 
#81 ( violen* near spous* )or( violen* near partner* )or( violen* near wi* )    
 
#80 ( abuse* near partner* )or( abuse* near wi* )or( violen* near wom?n )    
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#79 ( batter* near wi* )or( abuse* near wom?n )or( abuse* near spous* )    
 
#78 ( batter* near wom?n )or( batter* near spous* )or( batter* near partner* ) 
   
 
 
Midwives Information and Resource Service (MIDIRS) search string 
 
(batter* or abuse* or violen*) and (wom* or spous* or partner* or wife or wives or 
domestic or dating) and not (child* abuse or child* sexual abuse) 
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APPENDIX D: 
Data collection form 
 
Primary Reviewer  
 
Author 
(publication year) 
 
Title 
 
 
 
 
Ref Code  
Year data 
collected   
 
 
Tools used 
 
         
Comparator:  
 
                    
Index:  
 
                  
 
Sample used: N abused: N non-abused: 
Original population 
 
 
Pre-enrolment 
exclusions 
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Numbers eligible 
 
 
Numbers refusing 
 
 
Recruited 
 
 
Randomised 
 
  
Attrition   
Sample size 
calculation? 
 
Demographics 
Age: 
                Mean 
SD 
Range 
 
 
 
 
Ethnicity 
 
  
Education 
 
  
Employed 
 
  
Income 
 
  
Marital status 
 
 
  
 
Mean yrs of 
marriage 
  
Currently   
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pregnant 
  
Setting  
 
 
Inclusion criteria 
 
 
 
 
Exclusion criteria 
 
 
 
 
Tool presentation 
 
  
Whom presented 
tools 
 
  
 
Results:   
 
Prevalence 
 
 
Reliability: 
1. Test Reliability 
 
2. Test-Retest 
 
3. Parallel Forms 
Coefficient 
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4. Internal 
Consistency 
Coefficient* 
 
 
5. Inter-Rater 
Reliability 
 
 
Validity: 
 
1. Content 
 
2. Criterion 
(Concurrent; 
Predictive) 
 
3. Construct 
(Convergent; 
Discriminant) 
 
 
 
2x2 Table 
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Sensitivity 
 
Specificity 
 
PPV 
 
NPV 
 
LRpos 
 
LRneg 
 
AUC 
 
DOR 
 
Any other 
statistical 
analyses 
computed: 
 
 
 
 
Conclusions  
Strengths of 
paper (author) 
 
Limitations of 
paper (author) 
 
  
263 
1st reviewer 
comments 
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APPENDIX E: 
Secondary data analyses 
 
 
Tables showing diagnostic indices with 95% CIs and Figures showing 
Receiver operator characteristic curves 
 
For south Asian groups (n = 48) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of IPV using CAS cut 
off score of ≥3 
12/48 25.0% 0.1411 – 0.398946 
= 14% to 40% 
Pre-test odds (12/48) 
(36/48)  
0.3333  
 
 
Hark Cut-off ≥1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/12 75.0% 0.428357 – 0.933064 
= 43% to 93% 
Specificity 35/36 97.2% 0.837965 - 0.998548 
= 84% to 100% 
Positive predictive value 9/10 90.0% 0.541155 - 0.994758 
= 54% to 99% 
Negative predictive value 35/38 92.1% 0.775159 - 0.979387 
= 77% to 98% 
Likelihood ratio (9/12) 
(1/36) 
27 3.803329 - 191.674164 
= 4 to 192 
Post-test odds (12/48) x(9/12) 
(36/48)   (1/36) 
8.9999  
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HARK 
POS ≥1 
CASPOS 
1 
CASPOS 
0 
1 9 1 
0 3 35 
 
 
Hark Cut-off ≥0 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 12/12 100.0% 0.698747 – 1 
= 70% to 100% 
Specificity 0/36 0.0% 0 - 0.120066 
= 0% to 12% 
Positive predictive value 12/48 25.0% 0.1411 - 0.398946 
= 14% to 40% 
Negative predictive value 0/0 Undefined  
Likelihood ratio (12/12) 
(36/36) 
1.00 1 to 1 
Post-test odds (12/48) x(12/12) 
(36/48)   (36/36) 
0.3333  
 
HARK 
POS ≥0 
CASPOS 
1 
CASPOS 
0 
1 12 36 
0 0 0 
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Hark Cut-off ≥2 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 5/12 41.7% 0.164993 - 0.714007 
= 16% to 71% 
Specificity 35/36 97.2% 0.837965 - 0.998548 
= 84% to 100% 
Positive predictive value 5/6 83.3% 0.364823 - 0.991238 
= 36% to 99% 
Negative predictive value 35/42 83.3% 0.6804 - 0.92493 
= 68% to 92% 
Likelihood ratio (5/12) 
(1/36) 
14.9999 1.940285 - 115.962319 
= 2 to 116 
Post-test odds (12/48) x(5/12) 
(36/48)   (1/36) 
4.9999  
 
HARK 
POS ≥2 
CASPOS 
1 
CASPOS 
0 
1 5 1 
0 7 35 
 
 
Hark Cut-off ≥3 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 2/12 16.7% 0.029409 - 0.491185 
= 3% to 49% 
Specificity 36/36 100.0% 0.879934 – 1 
= 88% to 100% 
Positive predictive value 2/2 100.0% 0.197868 – 1 
= 20% to 100% 
Negative predictive value 36/46 78.3% 0.632407 - 0.885496 
= 63% to 88% 
Likelihood ratio (2/12) 
(0/36) 
Undefined  
Post-test odds (12/48) X (2/12) 
(36/48))    (0/36) 
Undefined  
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HARK 
POS ≥3 
CASPOS 
1 
CASPOS 
0 
1 2 0 
0 10 36 
 
 
Hark Cut-off = 4 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 0/12 0.0% 0 - 0.301253 
= 0% to 30% 
Specificity 36/36 100.0% 0.879934 – 1 
= 88% to 100% 
Positive predictive value 0/0 Undefined  
Negative predictive value 36/48 75.0% 0.601054 - 0.8589 
= 60% to 86% 
Likelihood ratio (0/12) 
(0/36) 
Undefined  
Post-test odds (12/48) X (0/12) 
(36/48)     (0/36) 
Undefined  
 
HARK 
POS ≥4 
CASPOS 
1 
CASPOS 
0 
1 0 0 
0 12 36 
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For African-Caribbean groups (n = 59) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of IPV using CAS cut 
off score of ≥3 
19/59 32.20% 0.209686 - 0.457632 
= 21% to 46% 
Pre-test odds (19/59) 
(40/59)  
0.4749  
 
 
Hark Cut-off ≥1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 17/19 89.5% 0.654618 - 0.981555 = 
65% to 98% 
Specificity 37/40 92.5% 0.785239 - 0.980428 
= 78% to 98% 
Positive predictive value 17/20 85.0% 0.611375 - 0.960434 
= 61% to 96% 
Negative predictive value 37/39 94.9% 0.813703 - 0.991068 
= 81% to 99% 
Likelihood ratio (17/19) 
(3/40) 
11.93 3.974289 - 35.810357  
= 4 to 36 
Post-test odds (19/59) x(17/19) 
(40/59)   (3/40) 
5.6655  
 
HARK 
POS ≥1 
CASPOS 
1 
CASPOS 
0 
1 17 3 
0 2 37 
 
Hark Cut-off ≥0 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 19/19 100.0% 0.790795 – 1 
= 79% to 100% 
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Specificity 0/40 0.0% 0 - 0.109124 
= 0 to 11% 
Positive predictive value 19/59 32.2% 0.209686 - 0.457632 
= 21% to 46% 
Negative predictive value 0/0 Undefined  
Likelihood ratio (19/19) 
(40/40) 
1.00 1 to 1 
Post-test odds (19/59) x(19/19) 
(40/59)   (40/40) 
0.4749  
 
HARK 
POS ≥0 
CASPOS 
1 
CASPOS 
0 
1 19 40 
0 0 0 
 
 
Hark Cut-off ≥2 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/19 47.4% 0.25212 - 0.70505  
= 25% to 70% 
Specificity 40/40 100.0% 0.89088 – 1 
= 89% to 100% 
Positive predictive value 9/9 100.0% 0.62881 – 1 
= 63% - 100% 
Negative predictive value 40/50 80.0% 0.65856 - 0.89498 
= 66% to 89% 
Likelihood ratio (9/19) 
(0/0) 
Undefined  
Post-test odds (19/59) x(9/19) 
(40/59)   (0/0) 
Undefined  
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HARK 
POS ≥2 
CASPOS 
1 
CASPOS 
0 
1 9 0 
0 10 40 
 
 
Hark Cut-off ≥3 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 6/19 31.6% 0.135554 - 0.565019 
= 13% to 56% 
Specificity 40/40 100.0% 0.890876 – 1 
= 89% to 100% 
Positive predictive value 6/6 100.0% 0.516818 – 1 
= 52% to 100% 
Negative predictive value 40/53 75.5% 0.614233 - 0.858096 
= 61% to 86% 
Likelihood ratio (6/19) 
(0/0) 
Undefined  
Post-test odds (19/59) x(6/19) 
(40/59)   (0/0) 
Undefined  
 
HARK 
POS ≥3 
CASPOS 
1 
CASPOS 
0 
1 6 0 
0 13 40 
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Hark Cut-off = 4 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 1/19 5.3% 0.002754 - 0.281074 
= 0% to 28% 
Specificity 40/40 100.0% 0.890876 – 1 
= 89% to 100% 
Positive predictive value 1/1 100.0% 0.054621 – 1 
= 5% to 100% 
Negative predictive value 40/58 68.96% 0.553084 - 0.801021 
= 55% to 80% 
Likelihood ratio (1/19) 
(0/0) 
Undefined  
Post-test odds (19/59) x(1/19) 
(40/59)   (0/0) 
Undefined  
 
HARK 
POS ≥4 
CASPOS 
1 
CASPOS 
0 
1 1 0 
0 18 40 
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For white groups (n = 112) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of IPV using CAS cut 
off score of ≥3 
20/112 23% 0.11502 - 0.264745 
= 11% to 26% 
Pre-test odds (20/112) 
(92/112)  
0.2174  
 
 
Hark Cut-off ≥1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 15/20 75.0% 0.505885 - 0.904067 
= 51% to 90% 
Specificity 88/92 95.652% 0.886193 - 0.985981 
= 89% to 99% 
Positive predictive value 15/19 78.9% 0.539021 - 0.930293 
= 54% to 93% 
Negative predictive value 88/93 94.6% 0.873243 - 0.980039 
= 87% to 98% 
Likelihood ratio (15/20) 
(4/92) 
17.25 6.401518 - 46.483114 
= 6 to 46 
Post-test odds (20/112) x(15/20) 
(92/112)   (4/92) 
3.75015  
 
 
 
 
 
 
 
 
 
 
 
 
HARK 
POS≥1 
CASPOS 
1 
CASPOS 
0 
1 15 4 
0 5 88 
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Hark Cut-off ≥0 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 20/20 100.0% 0.799547 – 1 
= 80% to 100% 
Specificity 0/92 0.0% 0 - 0.049947 
= 0% to 5% 
Positive predictive value 20/112 17.857% 0.11502 - 0.264745 
= 11% to 26% 
Negative predictive value 0/0 Undefined  
Likelihood ratio (20/20) 
(92/92) 
1.00 1 to 1 
Post-test odds (20/112) x(20/20) 
(92/112)   (92/92) 
0.2174  
 
 
 
 
 
 
 
 
 
Hark Cut-off ≥2 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 13/20 65.0% 0.40949 - 0.836913 
= 41% to 84% 
Specificity 90/92 97.8% 0.916209 - 0.996226 
= 92% to 100% 
Positive predictive value 13/15 86.7% 0.58389 - 0.976562 
= 58% to 98% 
Negative predictive value 90/97 92.8% 0.852018 - 0.968009 
= 85% to 97% 
Likelihood ratio (13/20) 
(2/92) 
29.90 7.31469 - 122.221172 
= 7 to 122 
Post-test odds (20/112) x(13/20) 
(92/112)   (2/92) 
6.50  
 
HARK 
POS≥0 
CASPOS 
1 
CASPOS 
0 
1 20 92 
0 0 0 
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Hark Cut-off ≥3 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 6/20 30.0% 0.128391 - 0.543307 
= 13% to 54% 
Specificity 92/92 100.0% 0.950053 – 1 
= 95% to 100% 
Positive predictive value 6/6 100.0% 0.516818 – 1 
= 52% to 100% 
Negative predictive value 92/106 86.8% 0.785 - 0.923301 
= 79% to 92% 
Likelihood ratio (6/20) 
(0/92) 
Undefined*  
Post-test odds (20/112) x(6/20) 
(92/112)   (0/92) 
Undefined  
*VassarStats: defines this as infinity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HARK 
POS≥2 
CASPOS 
1 
CASPOS 
0 
1 13 2 
0 7 90 
HARK 
POS≥3 
CASPOS 
1 
CASPOS 
0 
1 6 0 
0 14 92 
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Hark Cut-off = 4 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 1/20 5.0% 0.002616 - 0.269443 
= 0% to 27% 
Specificity 92/92 100.0% 0.950053 – 1 
= 95% to 100% 
Positive predictive value 1/1 100.0% 0.054621 – 1 
= 55% to 100% 
Negative predictive value 92/111 82.9% 0.743036 - 0.89125 
= 74% to 89% 
Likelihood ratio (1/20) 
(0/92) 
Undefined*  
Post-test odds (20/112) x(1/20) 
(92/112)   (0/92) 
Undefined  
*VassarStats: defines this as infinity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
HARK 
POS≥4 
CASPOS 
1 
CASPOS 
0 
1 1 0 
0 19 92 
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Comparing the three receiver operator characteristic curves in the 
African-Caribbean, south Asian and white groups: 
 
                              ROC                    -Asymptotic Normal-- 
ethnicity          Obs       Area     Std. Err.      [95% Conf. Interval] 
------------------------------------------------------------------------- 
1                   48     0.8588       0.0669        0.72762     0.98998 
2                   59     0.9276       0.0394        0.85035     1.00000 
3                  112     0.8625       0.0514        0.76183     0.96317 
------------------------------------------------------------------------- 
Ho: area(1) = area(2) = area(3) 
    chi2(2) =     1.38       Prob>chi2 =   0.5022 
   
This shows that there is no significant variation in the areas under the curves for these 
three different ethnic groups. 
 
 
 
Individual HARK questions 
 
Humiliation question 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of IPV using CAS cut 
off score of ≥3 
53/232 23% 17% to 28% 
Pre-test odds (53/232) / (179/232) 0.3 0.2 to 0.4 
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Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 37/53 69.8% 0.55488 - 0.81260 
= 55% to 81% 
Specificity 170/179 94.97% 0.90371 – 0.97527 
= 90% to 97% 
Positive predictive value 37/46 80.4% 0.65622 - 0.90138 
= 66% to 90% 
Negative predictive value 170/186 91.4% 0.86167 - 0.94844 
= 86% to 95% 
Likelihood ratio (37/53) 
(9/179) 
13.88 7.1703 - 26.88657 
= 7 to 27 
Post-test odds (53/232)  x  (37/53) 
(179/232)    (9/179) 
4.16  
 
 
 
Humiliation question in south Asian groups 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 7/12 58.3% 0.28599 - 0.83501 
= 29% - 83% 
Specificity 35/36 97.2% 0.83796 - 0.99855 
= 84% - 100% 
Positive predictive value 7/8 87.5% 0.46679 - 0.99344 
= 47% - 99% 
Negative predictive value 35/40 87.5% 0.72397 - 0.95305 
= 72% - 95% 
Likelihood ratio (7/12) 
(1/36) 
21.00 2.86823 - 153.75337 
= 3 to 154 
Post-test odds (12/48) x (7/12) 
(36/48)    (1/36) 
6.99  
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Humiliation question in African-Caribbean groups 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 15/19 78.95% 0.53902 - 0.93029 
= 54% to 93% 
Specificity 37/40 92.5% 0.78524 - 0.98043 
= 78% to 98% 
Positive predictive value 15/18 83.33% 0.57735 - 0.95593 
= 58% to 96% 
Negative predictive value 37/41 90.2% 0.75941 - 0.96828 
= 76% to 97% 
Likelihood ratio (15/19) 
(3/40) 
10.53 3.45929 to 32.03069 
= 3 to 32 
Post-test odds (19/59) x (15/19) 
(40/59)    (3/40) 
5.00  
 
 
Humiliation question in white groups 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 13/20 65.0% 0.40949 - 0.83691 
= 41% to 84% 
Specificity 88/92 95.65% 0.88619 - 0.98598 
= 89% to 99% 
Positive predictive value 13/17 76.5% 0.49762 - 0.92177 
= 50% to 92% 
Negative predictive value 88/95 92.6% 0.84907 - 0.96733 
= 85% to 97% 
Likelihood ratio (13/20) 
(4/92) 
14.95 5.43988 - 41.08594 
= 5 to 41 
Post-test odds (20/112) x (13/20) 
(92/112)    (4/92) 
3.25  
 
 
  
279 
Afraid question 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 25/53 47.2% 0.33518 - 0.61230 
= 33% to 61% 
Specificity 176/179 98.3% 0.94789 - 0.99566 
= 95% to 100% 
Positive predictive value 25/28 89.3% 0.7063 - 0.97191 
= 71% to 97% 
Negative predictive value 176/204 86.3% 0.80603 - 0.90536 
= 81% to 90% 
Likelihood ratio (25/53) 
(3/179) 
28.14 8.84355 - 89.57056 
= 9 to 90 
Post-test odds (53/232) x (25/53) 
(179/232)   (3/179) 
8.44  
 
 
 
Afraid question in south Asian groups 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 4/12 33.3% 0.11273 - 0.64563 
= 11% to 65% 
Specificity 35/36 97.2% 0.83796 - 0.99855 
= 84% to 100% 
Positive predictive value 4/5 80.0% 0.29879 - 0.98947 
= 30% to 99% 
Negative predictive value 35/43 81.4% 0.66082 - 0.91078 
= 66% to 91% 
Likelihood ratio (4/12) 
(1/36) 
12.00 1.48181 - 97.17867 
= 1 to 97 
Post-test odds (12/48)  x  (4/12) 
(36/48)      (1/36) 
4.00  
 
  
280 
Afraid question in African-Caribbean groups 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/19 47.4% 0.25212 - 0.70505 
= 25% to 70% 
Specificity 40/40 100.0% 0.89088 – 1 
= 89% to 100 
Positive predictive value 9/9 100.0% 0.62881 – 1 
= 63% to 100% 
Negative predictive value 40/50 80.0% 0.65856 - 0.89498 
= 66% to 89% 
Likelihood ratio (9/19) 
(0/40) 
Undefined  
Post-test odds (19/59) x (9/19) 
(40/59)    (0/40) 
Undefined  
 
 
 
Afraid question in white groups 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 12/20 60.0% 0.36412 - 0.80022 
= 36% to 80% 
Specificity 90/92 97.8% 0.91621 - 0.99623 
= 92% to 100% 
Positive predictive value 12/14 85.7% 0.56151 - 0.97486 
= 56% to 97% 
Negative predictive value 90/98 91.8% 0.84084 - 0.96154 
= 84% to 96% 
Likelihood ratio (12/20) 
(2/92) 
27.60 6.69341 - 113.80737 
= 7 to 114 
Post-test odds (20/112) x (12/20) 
(92/112)    (2/92) 
5.99  
 
  
281 
Rape question 
Only three women answered “yes” to this question; none were south Asian, two were 
African-Caribbean, one was white. 
 
Rape question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity  5.7%  
Specificity  100.0%  
Positive predictive value 3/3 100.0%  
Negative predictive value 179/229 78.2%  
Likelihood ratio (/) 
(/) 
  
Post-test odds (/) x (/) 
(/)   (/) 
  
 
 
 
Rape question in Asian groups 
 
Rape question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 0/12 0.0%  
Specificity 36/36 100.0%  
Positive predictive value 0/0 Undefined  
Negative predictive value 36/48 75.0%  
Likelihood ratio (/) 
(/) 
Undefined  
Post-test odds (/) x (/) 
(/)   (/) 
Undefined  
 
 
 
 
 
 
 
  
282 
Rape question in African-Caribbean groups 
 
Rape question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity  10.5%  
Specificity  100.0%  
Positive predictive value 2/2 100.0%  
Negative predictive value 40/57 70.2%  
Likelihood ratio (/) 
(/) 
Undefined  
Post-test odds (/) x (/) 
(/)   (/) 
Undefined  
 
 
 
Rape question in white groups 
 
Rape question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity  5.0%  
Specificity  100.0%  
Positive predictive value 1/1 100.0%  
Negative predictive value 92/111 82.9%  
Likelihood ratio (/) 
(/) 
Undefined  
Post-test odds (/) x (/) 
(/)   (/) 
Undefined  
 
 
 
 
 
 
 
 
  
283 
Kick question 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 21/53 39.6% 0.26760 - 0.53984 
= 27% to 54% 
Specificity 179/179 100.0% 0.973813 – 1 
= 97% to 100% 
Positive predictive value 21/21 100.0% 0.80760 – 1 
= 81% to 100% 
Negative predictive value 179/211 84.8% 0.79112 - 0.89250 
= 79% to 89% 
Likelihood ratio (21/53) 
(0/179) 
Undefined  
Post-test odds (53/232)  x  (21/53) 
(179/232)    (0/179) 
Undefined  
 
 
 
Kick question in south Asian groups 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 5/12 41.7% 0.16499 - 0.71401 
= 16% to 71% 
Specificity 36/36 100.% 0.71401 – 1 
71% to 100% 
Positive predictive value 5/5 100% 0.46294 – 1 
= 46% to 100% 
Negative predictive value 36/43 83.7% 0.68698 - 0.92672 
= 69% to 93% 
Likelihood ratio (5/12) 
(0/36) 
Undefined  
Post-test odds (12/48) x (5/12) 
(36/48)    (0/36) 
Undefined  
 
  
284 
Kick question in African-Caribbean groups 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 7/19 36.8% 0.1723 - 0.61367 
= 17% to 61% 
Specificity 40/40 100.0% 0.89088 – 1 
= 89% to 100% 
Positive predictive value 7/7 100.0% 0.56093 – 1 
= 56% to 100% 
Negative predictive value 40/52 76.9% 0.62826 - 0.87019 
= 63% to 87% 
Likelihood ratio (7/19) 
(0/40) 
Undefined  
Post-test odds (19/59) x (7/19) 
(40/59)    (0/40) 
Undefined  
 
 
 
Kick question in white groups 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/20 45.0% 0.23829 - 0.67952 
= 24% to 68% 
Specificity 92/92 100.0% 0.95005 – 1 
= 95% to 100% 
Positive predictive value 9/9 100.0% 0.62881 – 1 
= 63% to 100% 
Negative predictive value 92/103 89.3% 0.81306 - 0.94288 
= 81% to 94% 
Likelihood ratio (9/20) 
(0/92) 
Undefined  
Post-test odds (20/112) x (9/20) 
(92/112)    (0/92) 
Undefined  
 
  
285 
Individual HARK questions and dimensions of IPV, as defined by CAS 
 
Humiliation question (hark21) & Emotional IPV (eaposi) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
47/232 20.3%  
Pre-test odds (47/232) 
(185/232)  
0.254  
 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 33/47 70.2% 0.54924 - 0.8221 
= 55% to 82% 
Specificity 172/185 92.9% 0.88024 - 0.9605 
= 88% to 96% 
Positive predictive value 33/46 71.7% 0.56319 - 0.83542 
= 56% to 83% 
Negative predictive value 172/186 92.4% 0.87442 - 0.95668 
= 87% to 96% 
Likelihood ratio (33/47) 
(13/185) 
9.99 5.72890 - 17.42679 
= 6 to 17 
Post-test odds (47/232)  x  (33/47) 
(185/232)    (13/185) 
2.54  
 
 
 
 
 
 
 
 
 
  
286 
Humiliation question (hark21) & EA (eaposi) in south Asian groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
12/48 25.0% 0.1411 - 0.39895 
= 14% to 40% 
Pre-test odds (12/48) 
(36/48)  
0.3333  
 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 7/12 58.3% 0.28599 - 0.83500 
=29% to 83% 
Specificity 35/36 97.2% 0.83796 - 0.99855 
= 84% to 100% 
Positive predictive value 7/8 87.5% 0.46679 - 0.99344 
= 47% to 99% 
Negative predictive value 35/40 87.5% 0.72397 - 0.95305 
= 72% to 95% 
Likelihood ratio (7/12) 
(1/36) 
20.9999 2.86823 - 153.75337 
= 3 to 154 
Post-test odds (12/48) x (7/12) 
(36/48)    (1/36) 
6.9999  
 
 
 
 
 
 
 
 
 
 
 
 
  
287 
Humiliation question (hark21) & EA (eaposi) in African-Caribbean groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
15/59 25.4% 0.15373 - 0.38699 
= 15% to 39% 
Pre-test odds (15/59) 
(44/59)  
0.341  
 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 12/15 80.0% 0.51373 - 0.94685 
= 51% to 95% 
Specificity 38/44 86.4% 0.71954 - 0.94332 
= 72% to 94% 
Positive predictive value 12/18 66.7% 0.41155 - 0.85643 
= 41% to 86% 
Negative predictive value 38/41 92.7% 0.78995 - 0.98091 
= 79% to 98% 
Likelihood ratio (12/15) 
(6/44) 
5.87 2.67465 - 12.86813 
= 3 to 13 
Post-test odds (15/59) x (12/15) 
(44/59)    (6/44) 
2.00  
 
 
 
 
 
 
 
 
 
 
 
  
288 
Humiliation question (hark21) & EA (eaposi) in white groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
19/112 17.0% 0.10775 - 0.25481 
= 11% to 26% 
Pre-test odds (19/112) 
(93/112)  
0.20430  
 
 
Humiliation question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 13/19 68.4% 0.43498 - 0.86445 
= 43% to 86% 
Specificity 89/93 95.7% 0.88736 - 0.98613 
= 89% to 99% 
Positive predictive value 13/17 76.5% 0.49762 - 0.92177 
= 50% to 92% 
Negative predictive value 89/95 93.7% 0.86228 - 0.97407 
= 86% to 97% 
Likelihood ratio (13/19) 
(4/93) 
15.91 5.81622 - 43.50958 
= 6 to 43 
Post-test odds (19/112) x (13/19) 
(93/112)    (4/93) 
3.25  
 
 
 
 
 
 
 
 
 
  
289 
Afraid question (hark22) & Emotional IPV (eaposi) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
47/232 20.3%  
Pre-test odds (47/232) 
(185/232)  
0.254  
 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 24/47 51.1% 0.36256 - 0.65699 
= 36% to 66% 
Specificity 181/185 97.8% 0.94199 - 0.99305 
= 94% to 99% 
Positive predictive value 24/28 85.7% 0.66438 - 0.95322 
= 66% to 95% 
Negative predictive value 181/204 88.7% 0.83371 - 0.92569 
= 83% to 93% 
Likelihood ratio (24/47) 
(4/185) 
23.62 8.61104 - 64.77305 
= 9 to 65 
Post-test odds (47/232)  x  (24/47) 
(185/232)    (41/185) 
5.99  
 
 
 
 
 
 
 
 
 
 
 
 
  
290 
Afraid question (hark22) & EA (eaposi) in south Asian groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
12/48 25.0% 0.1411 - 0.39895 
= 14% to 40% 
Pre-test odds (12/48) 
(36/48)  
0.3333  
 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 4/12 33.3% 0.11273 - 0.64563 
= 11% to 65% 
Specificity 35/36 97.2% 0.83796 - 0.99855 
= 84% to 100% 
Positive predictive value 4/5 80% 0.29879 - 0.98947 
= 30% to 99% 
Negative predictive value 35/43 81.4% 0.66082 - 0.91078 
= 66% to 91% 
Likelihood ratio (4/12) 
(1/36) 
11.99 1.48181 - 97.17867 
= 1 to 97 
Post-test odds (12/48) x (4/12) 
(36/48)    (1/36) 
3.9999  
 
 
 
 
 
 
 
 
 
 
 
 
  
291 
Afraid question (hark22) & EA (eaposi) in African-Caribbean groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
15/59 25.4% 0.15373 - 0.38699 
= 15% to 39% 
Pre-test odds (15/59) 
(44/59)  
0.341  
 
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/15 60.0% 0.32891- 0.82543 
= 33% to 82% 
Specificity 44/44 100.0% 0.89999 - 1 
= 90% to 100% 
Positive predictive value 9/9 100.0% 0.62881 - 1 
= 63% to 100% 
Negative predictive value 44/50 88.0% 0.74997 - 0.95026 
= 75% to 95% 
Likelihood ratio (9/15) 
(0/44) 
Undefined  
Post-test odds (15/59) x (9/15) 
(44/59)    (0/44) 
Undefined  
 
 
 
 
 
 
 
 
 
 
 
  
292 
Afraid question (hark22) & EA (eaposi) in white groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of EA as defined by 
CAS EA Qs ≥3 
19/112 17.0% 0.10775 - 0.25481 
= 11% to 26% 
Pre-test odds (19/112) 
(93/112)  
0.20430  
 
Afraid question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 11/19 57.9% 0.33968 - 0.78879 
= 34% to 79% 
Specificity 90/93 96.8% 0.90192 - 0.991632 
= 90% to 99% 
Positive predictive value 11/14 78.6% 0.48816 - 0.94294 
= 49% to 94% 
Negative predictive value 90/98 91.8% 0.84084 - 0.96154 
= 84% to 96% 
Likelihood ratio (11/19) 
(3/93) 
17.95 5.52933 - 58.25444 
= 5 to 58 
Post-test odds (19/112) x (11/19) 
(93/112)    (3/93) 
3.66  
 
 
 
 
 
 
 
 
 
 
 
 
  
293 
Kick question (hark24) & Physical IPV (paposi) 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of PA as defined by 
CAS PA Qs ≥1 
41/232 17.7% 0.05823 - 0.13690 
= 6% to 14% 
Pre-test odds (41/232) 
(191/232) 
0.21466  
 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 21/41 51.2% 0.35365 - 0.66849 
= 35% to 67% 
Specificity 191/191 100.0% 0.97542 - 1 
= 97% to 100% 
Positive predictive value 21/21 100.0% 0.80760 - 1 
= 81% to 100% 
Negative predictive value 191/211 90.5% 0.85539 - 0.93970 
= 85% to 94% 
Likelihood ratio (21/41) 
(0/191) 
Undefined  
Post-test odds (41/232)  x  (21/41) 
(191/232)    (0/191) 
Undefined  
 
 
 
 
 
 
 
 
 
 
 
 
  
294 
Kick question (hark24) & Physical IPV (paposi) in south Asian groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of PA as defined by 
CAS PA Qs ≥1 
9/48 18.7% 0.09438 - 0.33104 
= 9% to 33% 
Pre-test odds (9/48) 
(39/48)  
0.23077  
 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 5/9 55.5% 0.22653 - 0.84657 
= 23% to 85% 
Specificity 39/39 100.0% 0.888332 - 1 
= 89% to 100% 
Positive predictive value 5/5 100% 0.46294 - 1 
= 46% to 100% 
Negative predictive value 39/43 90.7% 0.76946 - 0.96978 
= 77% to 97% 
Likelihood ratio (5/9) 
(0/39) 
Undefined  
Post-test odds (9/48)  x  (5/9) 
(39/48)    (0/39) 
Undefined  
 
 
 
 
 
 
 
 
 
 
  
295 
Kick question (hark24) & Physical IPV (paposi) in African-Caribbean 
groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of PA as defined by 
CAS PA Qs ≥1 
15/59 25.4% 0.15373 - 0.38699 
= 15% to 39% 
Pre-test odds (15/59) 
(44/59)  
0.341  
 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 7/15 46.7% 0.22276 - 0.72577 
= 22% to 73% 
Specificity 39/39 100.0% 0.89999 - 1 
= 90% to 100% 
Positive predictive value 7/7 100.0% 0.56093 - 1 
= 56% to 100% 
Negative predictive value 44/52 84.6% 0.71367 - 0.92664 
= 71% to 93% 
Likelihood ratio (7/15) 
(0/39) 
Undefined  
Post-test odds (15/59) x (7/15) 
(44/59)    (0/39) 
Undefined  
 
 
 
 
 
 
 
 
 
  
296 
Kick question (hark24) & Physical IPV (paposi) in white groups 
 
Description Calculation of ratio Calculated 
ratio 
95% CI 
Prevalence of PA as defined by 
CAS PA Qs ≥1 
16/112 14.3% 0.08637 - 0.22461 
= 9% to 22% 
Pre-test odds (16/112) 
(96/112) 
0.167  
 
 
Kick question = 1 Calculation of ratio Calculated 
ratio 
95% CI 
Sensitivity 9/16 56.2% 0.30554 - 0.79246 
= 30% to 79% 
Specificity 96/96 100.0% 0.95205 - 1 
= 95% to 100% 
Positive predictive value 9/9 100.0% 0.62881 - 1 
= 63% to 100% 
Negative predictive value 90/98 93.2% 0.860218 - 0.96989 
= 86% to 97% 
Likelihood ratio (9/16) 
(0/96) 
Undefined  
Post-test odds (16/112) x (9/16) 
(96/112)    (0/96) 
Undefined  
 
Note: 
All values are calculated from the original 2x2 contingency table data in order to avoid 
rounding errors (i.e. LR is not calc by Sens/1-spec  but, for example, by (43/53) / (9/179) 
as otherwise the rounding errors are considerable) 
 
